CODE,STR,SAB
8000/0,"Neoplasm, benign",ICDO3_2nd
8000/0,"Tumor, benign",ICDO3_2nd
8000/0,"Unclassified tumor, benign",ICDO3_2nd
8000/1,"Neoplasm, uncertain whether benign or malignant",ICDO3_2nd
8000/1,"Neoplasm, NOS",ICDO3_2nd
8000/1,"Tumor, NOS",ICDO3_2nd
8000/1,"Unclassified tumor, borderline malignancy",ICDO3_2nd
8000/1,"Unclassified tumor, uncertain whether benign or malignant",ICDO3_2nd
8000/3,"Neoplasm, malignant",ICDO3_2nd
8000/3,"Blastoma, NOS",ICDO3_2nd
8000/3,"Tumor, malignant, NOS",ICDO3_2nd
8000/3,Cancer,ICDO3_2nd
8000/3,Malignancy,ICDO3_2nd
8000/3,"Unclassified tumor, malignant",ICDO3_2nd
8000/6,"Neoplasm, metastatic",ICDO3_2nd
8000/6,"Neoplasm, secondary",ICDO3_2nd
8000/6,Tumor embolus,ICDO3_2nd
8000/6,"Tumor, metastatic",ICDO3_2nd
8000/6,"Tumor, secondary",ICDO3_2nd
8000/9,"Neoplasm, malignant, uncertain whether primary or metastatic",ICDO3_2nd
8000/9,"Unclassified tumor, malignant, uncertain whether primary or metastatic",ICDO3_2nd
8001/0,"Tumor cells, benign",ICDO3_2nd
8001/1,"Tumor cells, uncertain whether benign or malignant",ICDO3_2nd
8001/1,"Tumor cells, NOS",ICDO3_2nd
8001/3,"Tumor cells, malignant",ICDO3_2nd
8002/3,"Malignant tumor, small cell type",ICDO3_2nd
8003/3,"Malignant tumor, giant cell type",ICDO3_2nd
8004/3,"Malignant tumor, spindle cell type",ICDO3_2nd
8004/3,"Malignant tumor, fusiform cell type",ICDO3_2nd
8005/0,"Clear cell tumor, NOS",ICDO3_2nd
8005/3,"Malignant tumor, clear cell type",ICDO3_2nd
8010/0,"Epithelial tumor, benign",ICDO3_2nd
8010/2,"Carcinoma in situ, NOS",ICDO3_2nd
8010/2,"Intraepithelial carcinoma, NOS",ICDO3_2nd
8010/3,"Carcinoma, NOS",ICDO3_2nd
8010/3,"Epithelial tumor, malignant",ICDO3_2nd
8010/3,Heterotopia-associated carcinoma,ICDO3_2nd
8010/6,"Carcinoma, metastatic, NOS",ICDO3_2nd
8010/6,Secondary carcinoma,ICDO3_2nd
8010/9,Carcinomatosis,ICDO3_2nd
8011/0,"Epithelioma, benign",ICDO3_2nd
8011/3,"Epithelioma, malignant",ICDO3_2nd
8011/3,"Epithelioma, NOS",ICDO3_2nd
8012/3,"Large cell carcinoma, NOS",ICDO3_2nd
8013/3,Large cell neuroendocrine carcinoma,ICDO3_2nd
8013/3,Combined large cell neuroendocrine carcinoma,ICDO3_2nd
8014/3,Large cell carcinoma with rhabdoid phenotype,ICDO3_2nd
8015/3,Glassy cell carcinoma,ICDO3_2nd
8020/3,"Carcinoma, undifferentiated, NOS",ICDO3_2nd
8020/3,"Carcinoma, poorly differentiated, NOS",ICDO3_2nd
8020/3,Anaplastic undifferentiated carcinoma,ICDO3_2nd
8020/3,Dedifferentiated carcinoma,ICDO3_2nd
8021/3,"Carcinoma, anaplastic, NOS",ICDO3_2nd
8022/3,Pleomorphic carcinoma,ICDO3_2nd
8023/3,Nuclear protein in testis (NUT)-associated carcinoma,ICDO3_2nd
8023/3,NUT carcinoma,ICDO3_2nd
8023/3,NUT midline carcinoma,ICDO3_2nd
8030/3,Giant cell and spindle cell carcinoma,ICDO3_2nd
8031/3,Giant cell carcinoma,ICDO3_2nd
8032/3,"Spindle cell carcinoma, NOS",ICDO3_2nd
8033/3,Pseudosarcomatous carcinoma,ICDO3_2nd
8033/3,Sarcomatoid carcinoma,ICDO3_2nd
8034/3,Polygonal cell carcinoma,ICDO3_2nd
8035/3,Carcinoma with osteoclast-like giant cells,ICDO3_2nd
8035/3,Squamous carcinoma with osteoclast-like giant cells,ICDO3_2nd
8035/3,Undifferentiated carcinoma with osteoclast-like giant cells,ICDO3_2nd
8040/0,"Tumorlet, benign",ICDO3_2nd
8040/0,Diffuse idiopathic neuroendocrine cell hyperplasia,ICDO3_2nd
8040/1,"Tumorlet, NOS",ICDO3_2nd
8041/3,"Small cell carcinoma, NOS",ICDO3_2nd
8041/3,Reserve cell carcinoma,ICDO3_2nd
8041/3,Round cell carcinoma,ICDO3_2nd
8041/3,Small cell neuroendocrine carcinoma,ICDO3_2nd
8041/3,"Small cell carcinoma, pulmonary type",ICDO3_2nd
8042/3,Oat cell carcinoma,ICDO3_2nd
8043/3,"Small cell carcinoma, fusiform cell",ICDO3_2nd
8044/3,"Small cell carcinoma, intermediate cell",ICDO3_2nd
8044/3,"Small cell carcinoma, hypercalcemic type",ICDO3_2nd
8045/3,Combined small cell carcinoma,ICDO3_2nd
8045/3,Mixed small cell carcinoma,ICDO3_2nd
8045/3,Combined small cell-adenocarcinoma,ICDO3_2nd
8045/3,Combined small cell-large cell carcinoma,ICDO3_2nd
8045/3,Combined small cell-squamous cell carcinoma,ICDO3_2nd
8046/3,Non-small cell carcinoma,ICDO3_2nd
8050/0,"Papilloma, NOS",ICDO3_2nd
8050/2,"Papillary carcinoma in situ, NOS",ICDO3_2nd
8050/3,"Papillary carcinoma, NOS",ICDO3_2nd
8051/0,Verrucous papilloma,ICDO3_2nd
8051/3,"Verrucous carcinoma, NOS",ICDO3_2nd
8051/3,Verrucous epidermoid carcinoma,ICDO3_2nd
8051/3,Verrucous squamous cell carcinoma,ICDO3_2nd
8052/0,"Squamous cell papilloma, NOS",ICDO3_2nd
8052/0,Keratotic papilloma,ICDO3_2nd
8052/0,Squamous papilloma,ICDO3_2nd
8052/0,"Benign keratosis, NOS",ICDO3_2nd
8052/0,Seborrhoeic keratosis,ICDO3_2nd
8052/0,Solar lentigo,ICDO3_2nd
8052/0,Lichen planus-like keratosis,ICDO3_2nd
8052/2,"Papillary squamous cell carcinoma, non-invasive",ICDO3_2nd
8052/2,Papillary squamous cell carcinoma in situ,ICDO3_2nd
8052/3,Papillary squamous cell carcinoma,ICDO3_2nd
8052/3,Papillary epidermoid carcinoma,ICDO3_2nd
8053/0,"Squamous cell papilloma, inverted",ICDO3_2nd
8054/0,Warty dyskeratoma,ICDO3_2nd
8054/3,Warty carcinoma,ICDO3_2nd
8054/3,Condylomatous carcinoma,ICDO3_2nd
8054/3,Warty-basaloid carcinoma,ICDO3_2nd
8060/0,Squamous papillomatosis,ICDO3_2nd
8060/0,"Papillomatosis, NOS",ICDO3_2nd
8070/0,Actinic keratosis,ICDO3_2nd
8070/0,Arsenical keratosis,ICDO3_2nd
8070/0,PUVA keratosis,ICDO3_2nd
8070/2,"Squamous cell carcinoma in situ, NOS",ICDO3_2nd
8070/2,"Epidermoid carcinoma in situ, NOS",ICDO3_2nd
8070/2,"Intraepidermal carcinoma, NOS",ICDO3_2nd
8070/2,Intraepithelial squamous cell carcinoma,ICDO3_2nd
8070/3,"Squamous cell carcinoma, NOS",ICDO3_2nd
8070/3,"Squamous cell carcinoma, usual type",ICDO3_2nd
8070/3,"Epidermoid carcinoma, NOS",ICDO3_2nd
8070/3,Squamous carcinoma,ICDO3_2nd
8070/3,Squamous cell epithelioma,ICDO3_2nd
8070/6,"Squamous cell carcinoma, metastatic, NOS",ICDO3_2nd
8071/2,Differentiated intraepithelial neoplasia,ICDO3_2nd
8071/2,Differentiated penile intraepithelial neoplasia (PeIN),ICDO3_2nd
8071/2,Differentiated vulvar intraepithelial neoplasia (VIN),ICDO3_2nd
8071/3,"Squamous cell carcinoma, keratinizing, NOS",ICDO3_2nd
8071/3,"Epidermoid carcinoma, keratinizing",ICDO3_2nd
8071/3,"Squamous cell carcinoma, large cell, keratinizing",ICDO3_2nd
8071/3,Keratoacanthoma,ICDO3_2nd
8072/0,Large cell acanthoma,ICDO3_2nd
8072/3,"Squamous cell carcinoma, large cell, nonkeratinizing, NOS",ICDO3_2nd
8072/3,"Epidermoid carcinoma, large cell, nonkeratinizing",ICDO3_2nd
8072/3,"Squamous cell carcinoma, nonkeratinizing, NOS",ICDO3_2nd
8073/3,"Squamous cell carcinoma, small cell, nonkeratinizing",ICDO3_2nd
8073/3,"Epidermoid carcinoma, small cell, nonkeratinizing",ICDO3_2nd
8074/3,"Squamous cell carcinoma, spindle cell",ICDO3_2nd
8074/3,"Epidermoid carcinoma, spindle cell",ICDO3_2nd
8074/3,"Squamous cell carcinoma, sarcomatoid",ICDO3_2nd
8074/3,Pseudovascular squamous cell carcinoma,ICDO3_2nd
8075/3,"Squamous cell carcinoma, adenoid",ICDO3_2nd
8075/3,"Squamous cell carcinoma, acantholytic",ICDO3_2nd
8075/3,"Squamous cell carcinoma, pseudoglandular",ICDO3_2nd
8076/2,Squamous cell carcinoma in situ with questionable stromal invasion,ICDO3_2nd
8076/2,Epidermoid carcinoma in situ with questionable stromal invasion,ICDO3_2nd
8076/3,"Squamous cell carcinoma, microinvasive",ICDO3_2nd
8077/0,"Squamous intraepithelial neoplasia, low grade",ICDO3_2nd
8077/0,"Squamous intraepithelial neoplasia, grade I",ICDO3_2nd
8077/0,Low grade squamous intraepithelial lesion,ICDO3_2nd
8077/0,"Anal intraepithelial neoplasia, low grade",ICDO3_2nd
8077/0,"Cervical intraepithelial neoplasia, low grade",ICDO3_2nd
8077/0,"Esophageal squamous intraepithelial neoplasia (dysplasia), low grade",ICDO3_2nd
8077/2,"Squamous intraepithelial neoplasia, high grade",ICDO3_2nd
8077/2,"Squamous intraepithelial neoplasia, grade II",ICDO3_2nd
8077/2,"Squamous intraepithelial neoplasia, grade III",ICDO3_2nd
8077/2,"Squamous dysplasia, high grade",ICDO3_2nd
8077/2,High grade squamous intraepithelial lesion,ICDO3_2nd
8077/2,"Anal intraepithelial neoplasia, grade III",ICDO3_2nd
8077/2,AIN III,ICDO3_2nd
8077/2,"Cervical intraepithelial neoplasia, grade III",ICDO3_2nd
8077/2,"CIN III, NOS",ICDO3_2nd
8077/2,CIN III with severe dysplasia,ICDO3_2nd
8077/2,"Esophageal squamous intraepithelial neoplasia (dysplasia), high grade",ICDO3_2nd
8077/2,"Vaginal intraepithelial neoplasia, grade III",ICDO3_2nd
8077/2,VAIN III,ICDO3_2nd
8077/2,"Vulvar intraepithelial neoplasia, grade III",ICDO3_2nd
8077/2,VIN III,ICDO3_2nd
8078/3,Squamous cell carcinoma with horn formation,ICDO3_2nd
8080/2,Queyrat erythroplasia,ICDO3_2nd
8081/2,Bowen disease,ICDO3_2nd
8081/2,"Intraepidermal squamous cell carcinoma, Bowen type",ICDO3_2nd
8082/3,Lymphoepithelial carcinoma,ICDO3_2nd
8082/3,Lymphoepithelioma,ICDO3_2nd
8082/3,Lymphoepithelioma-like carcinoma,ICDO3_2nd
8082/3,Schmincke tumor,ICDO3_2nd
8083/3,Basaloid squamous cell carcinoma,ICDO3_2nd
8083/3,Papillary-basaloid carcinoma,ICDO3_2nd
8084/0,Clear cell acanthoma,ICDO3_2nd
8084/3,"Squamous cell carcinoma, clear cell type",ICDO3_2nd
8085/3,"Squamous cell carcinoma, HPV positive",ICDO3_2nd
8086/3,"Squamous cell carcinoma, HPV negative",ICDO3_2nd
8090/1,Basal cell tumor,ICDO3_2nd
8090/3,"Basal cell carcinoma, NOS",ICDO3_2nd
8090/3,Basal cell epithelioma,ICDO3_2nd
8090/3,Rodent ulcer,ICDO3_2nd
8090/3,Pigmented basal cell carcinoma,ICDO3_2nd
8090/3,Basal cell carcinoma with adnexal differentiation,ICDO3_2nd
8091/3,Superficial basal cell carcinoma,ICDO3_2nd
8091/3,Multifocal superficial basal cell carcinoma,ICDO3_2nd
8091/3,Multicentric basal cell carcinoma,ICDO3_2nd
8092/3,"Infiltrating basal cell carcinoma, NOS",ICDO3_2nd
8092/3,"Infiltrating basal cell carcinoma, non-sclerosing",ICDO3_2nd
8092/3,"Infiltrating basal cell carcinoma, sclerosing",ICDO3_2nd
8092/3,"Basal cell carcinoma, desmoplastic type",ICDO3_2nd
8092/3,"Basal cell carcinoma, morpheic",ICDO3_2nd
8092/3,"Basal cell carcinoma, sarcomatoid",ICDO3_2nd
8093/3,"Basal cell carcinoma, fibroepithelial",ICDO3_2nd
8093/3,"Fibroepithelioma, NOS",ICDO3_2nd
8093/3,Fibroepithelioma of Pinkus type,ICDO3_2nd
8093/3,"Fibroepithelial basal cell carcinoma, Pinkus type",ICDO3_2nd
8093/3,Pinkus tumor,ICDO3_2nd
8094/3,Basosquamous carcinoma,ICDO3_2nd
8094/3,Mixed basal-squamous cell carcinoma,ICDO3_2nd
8095/3,Metatypical carcinoma,ICDO3_2nd
8096/0,Intraepidermal epithelioma of Jadassohn,ICDO3_2nd
8097/3,"Basal cell carcinoma, nodular",ICDO3_2nd
8097/3,"Basal cell carcinoma, micronodular",ICDO3_2nd
8098/3,Adenoid basal carcinoma,ICDO3_2nd
8100/0,Trichoepithelioma,ICDO3_2nd
8100/0,Brooke tumor,ICDO3_2nd
8100/0,Epithelioma adenoides cysticum,ICDO3_2nd
8100/0,Trichoblastoma,ICDO3_2nd
8100/0,Trichogerminoma,ICDO3_2nd
8100/3,Trichoblastic carcinoma,ICDO3_2nd
8100/3,Trichoblastic carcinosarcoma,ICDO3_2nd
8101/0,Trichofolliculoma,ICDO3_2nd
8102/0,Trichilemmoma,ICDO3_2nd
8102/3,Trichilemmocarcinoma,ICDO3_2nd
8102/3,Trichilemmal carcinoma,ICDO3_2nd
8103/0,Pilar tumor,ICDO3_2nd
8103/1,Proliferating trichilemmal cyst,ICDO3_2nd
8103/1,Proliferating trichilemmal tumor,ICDO3_2nd
8104/0,Pilar sheath acanthoma,ICDO3_2nd
8104/0,Tumor of follicular infundibulum,ICDO3_2nd
8110/0,"Pilomatricoma, NOS",ICDO3_2nd
8110/0,"Pilomatrixoma, NOS",ICDO3_2nd
8110/0,Calcifying epithelioma of Malherbe,ICDO3_2nd
8110/0,Melanocytic matricoma,ICDO3_2nd
8110/3,Pilomatrical carcinoma,ICDO3_2nd
8110/3,Pilomatrix carcinoma,ICDO3_2nd
8110/3,Matrical carcinoma,ICDO3_2nd
8110/3,"Pilomatricoma, malignant",ICDO3_2nd
8110/3,"Pilomatrixoma, malignant",ICDO3_2nd
8120/0,"Urothelial papilloma, NOS",ICDO3_2nd
8120/0,"Transitional cell papilloma, benign",ICDO3_2nd
8120/0,Transitional papilloma,ICDO3_2nd
8120/0,"Transitional cell papilloma, NOS",ICDO3_2nd
8120/0,Papilloma of bladder,ICDO3_2nd
8120/2,Urothelial carcinoma in situ,ICDO3_2nd
8120/2,Transitional cell carcinoma in situ,ICDO3_2nd
8120/3,"Transitional cell carcinoma, NOS",ICDO3_2nd
8120/3,"Urothelial carcinoma, NOS",ICDO3_2nd
8120/3,Transitional carcinoma,ICDO3_2nd
8120/3,Squamotransitional carcinoma,ICDO3_2nd
8121/0,"Sinonasal papilloma, exophytic",ICDO3_2nd
8121/0,"Schneiderian papilloma, NOS",ICDO3_2nd
8121/0,"Sinonasal papilloma, NOS",ICDO3_2nd
8121/0,"Sinonasal papilloma, fungiform",ICDO3_2nd
8121/0,"Urothelial papilloma, inverted",ICDO3_2nd
8121/0,"Transitional papilloma, inverted, NOS",ICDO3_2nd
8121/0,"Transitional cell papilloma, inverted, NOS",ICDO3_2nd
8121/1,"Sinonasal papilloma, inverted",ICDO3_2nd
8121/1,Columnar cell papilloma,ICDO3_2nd
8121/1,Cylindrical cell papilloma,ICDO3_2nd
8121/1,"Schneiderian papilloma, oncocytic",ICDO3_2nd
8121/1,"Schneiderian papilloma, inverted",ICDO3_2nd
8121/1,"Sinonasal papilloma, oncocytic",ICDO3_2nd
8121/3,Schneiderian carcinoma,ICDO3_2nd
8121/3,Cylindrical cell carcinoma,ICDO3_2nd
8122/3,"Urothelial carcinoma, sarcomatoid",ICDO3_2nd
8122/3,"Urothelial carcinoma, spindle cell",ICDO3_2nd
8122/3,"Transitional cell carcinoma, spindle cell",ICDO3_2nd
8122/3,"Transitional cell carcinoma, sarcomatoid",ICDO3_2nd
8123/3,Basaloid carcinoma,ICDO3_2nd
8124/3,Cloacogenic carcinoma,ICDO3_2nd
8130/1,Papillary urothelial neoplasm of low malignant potential,ICDO3_2nd
8130/1,Papillary transitional cell neoplasm of low malignant potential,ICDO3_2nd
8130/2,"Papillary urothelial carcinoma, non-invasive",ICDO3_2nd
8130/2,"Papillary transitional cell carcinoma, non-invasive",ICDO3_2nd
8130/3,Papillary urothelial carcinoma,ICDO3_2nd
8130/3,Papillary transitional cell carcinoma,ICDO3_2nd
8131/3,"Urothelial carcinoma, micropapillary",ICDO3_2nd
8131/3,"Transitional cell carcinoma, micropapillary",ICDO3_2nd
8140/0,"Adenoma, NOS",ICDO3_2nd
8140/1,Atypical adenoma,ICDO3_2nd
8140/1,"Bronchial adenoma, NOS",ICDO3_2nd
8140/2,"Adenocarcinoma in situ, NOS",ICDO3_2nd
8140/3,"Adenocarcinoma, NOS",ICDO3_2nd
8140/3,"Adenocarcinoma, usual type",ICDO3_2nd
8140/3,"Carcinoma of Skene, Cowper and Littre glands",ICDO3_2nd
8140/3,Endolymphatic sac tumor,ICDO3_2nd
8140/3,Parathyroid carcinoma,ICDO3_2nd
8140/3,Acinar adenocarcinoma of prostate,ICDO3_2nd
8140/6,"Adenocarcinoma, metastatic, NOS",ICDO3_2nd
8141/3,Scirrhous adenocarcinoma,ICDO3_2nd
8141/3,Carcinoma with productive fibrosis,ICDO3_2nd
8141/3,Scirrhous carcinoma,ICDO3_2nd
8142/3,Linitis plastica,ICDO3_2nd
8143/3,Superficial spreading adenocarcinoma,ICDO3_2nd
8144/0,"Adenoma, intestinal type",ICDO3_2nd
8144/3,"Adenocarcinoma, intestinal type",ICDO3_2nd
8144/3,"Adenocarcinoma, enteric",ICDO3_2nd
8144/3,"Carcinoma, intestinal type",ICDO3_2nd
8144/3,"Mucinous carcinoma, intestinal type",ICDO3_2nd
8145/3,"Carcinoma, diffuse type",ICDO3_2nd
8145/3,"Adenocarcinoma, diffuse type",ICDO3_2nd
8146/0,Monomorphic adenoma,ICDO3_2nd
8147/0,Basal cell adenoma,ICDO3_2nd
8147/3,Basal cell adenocarcinoma,ICDO3_2nd
8147/3,Basal cell carcinoma of prostate,ICDO3_2nd
8148/0,"Glandular intraepithelial neoplasia, low grade",ICDO3_2nd
8148/0,"Glandular intraepithelial neoplasia, grade I",ICDO3_2nd
8148/0,"Glandular intraepithelial neoplasia, grade II",ICDO3_2nd
8148/0,"Biliary intraepithelial neoplasia, low grade",ICDO3_2nd
8148/0,"Esophageal glandular dysplasia (intraepithelial neoplasia), low grade",ICDO3_2nd
8148/2,"Glandular intraepithelial neoplasia, high grade",ICDO3_2nd
8148/2,"Glandular intraepithelial neoplasia, grade III",ICDO3_2nd
8148/2,"Flat intraepithelial neoplasia, high grade",ICDO3_2nd
8148/2,"Biliary intraepithelial neoplasia, high grade",ICDO3_2nd
8148/2,"Biliary intraepithelial neoplasia, grade 3 (BilIN-3)",ICDO3_2nd
8148/2,"Esophageal glandular dysplasia (intraepithelial neoplasia), high grade",ICDO3_2nd
8148/2,"Esophageal intraepithelial neoplasia, high grade",ICDO3_2nd
8148/2,"Prostatic intraepithelial neoplasia, grade III",ICDO3_2nd
8148/2,PIN III,ICDO3_2nd
8148/2,"Prostatic intraepithelial neoplasia, high grade",ICDO3_2nd
8149/0,Canalicular adenoma,ICDO3_2nd
8150/0,Pancreatic neuroendocrine microadenoma,ICDO3_2nd
8150/0,"Pancreatic endocrine tumor, benign",ICDO3_2nd
8150/0,"Islet cell tumor, benign",ICDO3_2nd
8150/0,Pancreatic microadenoma,ICDO3_2nd
8150/3,"Pancreatic neuroendocrine tumor, nonfunctioning",ICDO3_2nd
8150/3,"Pancreatic endocrine tumor, nonfunctioning",ICDO3_2nd
8150/3,"Pancreatic endocrine tumor, NOS",ICDO3_2nd
8150/3,Islet cell adenoma,ICDO3_2nd
8150/3,Islet cell adenomatosis,ICDO3_2nd
8150/3,Nesidioblastoma,ICDO3_2nd
8150/3,"Islet cell tumor, NOS",ICDO3_2nd
8150/3,Islet cell adenocarcinoma,ICDO3_2nd
8150/3,Islet cell carcinoma,ICDO3_2nd
8151/3,"Insulinoma, NOS",ICDO3_2nd
8151/3,Beta cell adenoma,ICDO3_2nd
8151/3,Beta cell tumor,ICDO3_2nd
8152/3,Glucagonoma,ICDO3_2nd
8152/3,Alpha cell tumor,ICDO3_2nd
8152/3,Enteroglucagonoma,ICDO3_2nd
8152/3,Glucagon-like peptide-producing tumor,ICDO3_2nd
8152/3,L-cell tumor,ICDO3_2nd
8152/3,Pancreatic peptide and pancreatic peptide-like peptide within terminal tyrosine amide producing tumor,ICDO3_2nd
8152/3,PP/PYY producing tumor,ICDO3_2nd
8153/3,Gastrinoma,ICDO3_2nd
8153/3,G cell tumor,ICDO3_2nd
8153/3,Gastrin cell tumor,ICDO3_2nd
8154/3,Mixed neuroendocrine non-neuroendocrine neoplasm (MiNEN),ICDO3_2nd
8154/3,"Mixed pancreatic endocrine and exocrine tumor, malignant",ICDO3_2nd
8154/3,Mixed islet cell and exocrine adenocarcinoma,ICDO3_2nd
8154/3,Mixed acinar-endocrine carcinoma,ICDO3_2nd
8154/3,Mixed acinar-neuroendocrine carcinoma,ICDO3_2nd
8154/3,Mixed acinar-endocrine-ductal carcinoma,ICDO3_2nd
8154/3,Mixed ductal-endocrine carcinoma,ICDO3_2nd
8154/3,Mixed ductal-neuroendocrine carcinoma,ICDO3_2nd
8154/3,Mixed endocrine and exocrine adenocarcinoma,ICDO3_2nd
8155/3,Vipoma,ICDO3_2nd
8156/3,Somatostatinoma,ICDO3_2nd
8156/3,Somatostatin cell tumor,ICDO3_2nd
8158/3,ACTH-producing tumor,ICDO3_2nd
8158/3,"Endocrine tumor, functioning, NOS",ICDO3_2nd
8160/0,Bile duct adenoma,ICDO3_2nd
8160/0,Cholangioma,ICDO3_2nd
8160/3,Cholangiocarcinoma,ICDO3_2nd
8160/3,Bile duct adenocarcinoma,ICDO3_2nd
8160/3,Bile duct carcinoma,ICDO3_2nd
8161/0,Bile duct cystadenoma,ICDO3_2nd
8161/3,Bile duct cystadenocarcinoma,ICDO3_2nd
8162/3,Perihilar cholangiocarcinoma,ICDO3_2nd
8162/3,Klatskin tumor,ICDO3_2nd
8163/0,"Pancreatobiliary neoplasm, non-invasive",ICDO3_2nd
8163/0,Non-invasive pancreatobiliary papillary neoplasm with low grade dysplasia,ICDO3_2nd
8163/0,Non-invasive pancreatobiliary papillary neoplasm with low grade intraepithelial neoplasia,ICDO3_2nd
8163/2,"Papillary neoplasm, pancreatobiliary type, with high grade intraepithelial neoplasia",ICDO3_2nd
8163/2,Non-invasive pancreatobiliary papillary neoplasm with high grade dysplasia,ICDO3_2nd
8163/2,Non-invasive pancreatobiliary papillary neoplasm with high grade intraepithelial neoplasia,ICDO3_2nd
8163/3,Pancreatobiliary type carcinoma,ICDO3_2nd
8163/3,"Adenocarcinoma, pancreatobiliary type",ICDO3_2nd
8170/0,Liver cell adenoma,ICDO3_2nd
8170/0,Hepatocellular adenoma,ICDO3_2nd
8170/0,"Hepatoma, benign",ICDO3_2nd
8170/3,"Hepatocellular carcinoma, NOS",ICDO3_2nd
8170/3,"Hepatoma, NOS",ICDO3_2nd
8170/3,Hepatocarcinoma,ICDO3_2nd
8170/3,"Hepatoma, malignant",ICDO3_2nd
8170/3,Liver cell carcinoma,ICDO3_2nd
8171/3,"Hepatocellular carcinoma, fibrolamellar",ICDO3_2nd
8172/3,"Hepatocellular carcinoma, scirrhous",ICDO3_2nd
8172/3,Sclerosing hepatic carcinoma,ICDO3_2nd
8173/3,"Hepatocellular carcinoma, spindle cell variant",ICDO3_2nd
8173/3,"Hepatocellular carcinoma, sarcomatoid",ICDO3_2nd
8174/3,"Hepatocellular carcinoma, clear cell type",ICDO3_2nd
8175/3,"Hepatocellular carcinoma, pleomorphic type",ICDO3_2nd
8180/3,Combined hepatocellular carcinoma and cholangiocarcinoma,ICDO3_2nd
8180/3,Hepatocholangiocarcinoma,ICDO3_2nd
8180/3,Mixed hepatocellular and bile duct carcinoma,ICDO3_2nd
8190/0,Trabecular adenoma,ICDO3_2nd
8190/3,Trabecular adenocarcinoma,ICDO3_2nd
8190/3,Trabecular carcinoma,ICDO3_2nd
8191/0,Embryonal adenoma,ICDO3_2nd
8200/0,Eccrine dermal cylindroma,ICDO3_2nd
8200/0,Cylindroma of skin,ICDO3_2nd
8200/0,Cylindroma of breast,ICDO3_2nd
8200/0,Turban tumor,ICDO3_2nd
8200/3,Adenoid cystic carcinoma,ICDO3_2nd
8200/3,"Cylindroma, NOS",ICDO3_2nd
8200/3,"Adenocarcinoma, cylindroid",ICDO3_2nd
8200/3,Adenocystic carcinoma,ICDO3_2nd
8200/3,"Bronchial adenoma, cylindroid",ICDO3_2nd
8200/3,Thymic carcinoma with adenoid cystic carcinoma-like features,ICDO3_2nd
8201/2,Cribriform carcinoma in situ,ICDO3_2nd
8201/2,"Ductal carcinoma in situ, cribriform type",ICDO3_2nd
8201/3,"Cribriform carcinoma, NOS",ICDO3_2nd
8201/3,"Ductal carcinoma, cribriform type",ICDO3_2nd
8201/3,Cribriform comedo type carcinoma,ICDO3_2nd
8201/3,"Adenocarcinoma, cribriform comedo type",ICDO3_2nd
8202/0,Microcystic adenoma,ICDO3_2nd
8204/0,Lactating adenoma,ICDO3_2nd
8210/0,"Adenomatous polyp, NOS",ICDO3_2nd
8210/0,Polypoid adenoma,ICDO3_2nd
8210/2,Adenocarcinoma in situ in adenomatous polyp,ICDO3_2nd
8210/2,"Adenocarcinoma in situ in polyp, NOS",ICDO3_2nd
8210/2,"Carcinoma in situ in polyp, NOS",ICDO3_2nd
8210/2,Adenocarcinoma in situ in polypoid adenoma,ICDO3_2nd
8210/2,Adenocarcinoma in situ in tubular adenoma,ICDO3_2nd
8210/2,Carcinoma in situ in adenomatous polyp,ICDO3_2nd
8210/3,Adenocarcinoma in adenomatous polyp,ICDO3_2nd
8210/3,"Adenocarcinoma in polyp, NOS",ICDO3_2nd
8210/3,"Carcinoma in polyp, NOS",ICDO3_2nd
8210/3,Adenocarcinoma in polypoid adenoma,ICDO3_2nd
8210/3,Adenocarcinoma in tubular adenoma,ICDO3_2nd
8210/3,Carcinoma in adenomatous polyp,ICDO3_2nd
8211/0,"Tubular adenoma, NOS",ICDO3_2nd
8211/3,Tubular adenocarcinoma,ICDO3_2nd
8211/3,Tubular carcinoma,ICDO3_2nd
8212/0,Flat adenoma,ICDO3_2nd
8213/0,"Serrated adenoma, NOS",ICDO3_2nd
8213/0,Traditional serrated adenoma,ICDO3_2nd
8213/0,Mixed adenomatous and hyperplastic polyp,ICDO3_2nd
8213/0,"Sessile serrated adenoma, NOS",ICDO3_2nd
8213/0,Sessile serrated polyp,ICDO3_2nd
8213/0,Traditional sessile serrated adenoma,ICDO3_2nd
8213/3,Serrated adenocarcinoma,ICDO3_2nd
8214/3,Parietal cell carcinoma,ICDO3_2nd
8214/3,Parietal cell adenocarcinoma,ICDO3_2nd
8215/3,Adenocarcinoma of anal glands,ICDO3_2nd
8215/3,Adenocarcinoma of anal ducts,ICDO3_2nd
8220/0,Adenomatous polyposis coli,ICDO3_2nd
8220/0,"Adenomatosis, NOS",ICDO3_2nd
8220/0,Familial polyposis coli,ICDO3_2nd
8220/3,Adenocarcinoma in adenomatous polyposis coli,ICDO3_2nd
8221/0,Multiple adenomatous polyps,ICDO3_2nd
8221/3,Adenocarcinoma in multiple adenomatous polyps,ICDO3_2nd
8230/2,"Ductal carcinoma in situ, solid type",ICDO3_2nd
8230/2,"Intraductal carcinoma, solid type",ICDO3_2nd
8230/3,"Solid carcinoma, NOS",ICDO3_2nd
8230/3,"Solid adenocarcinoma, NOS",ICDO3_2nd
8230/3,Solid carcinoma with mucin formation,ICDO3_2nd
8230/3,Solid adenocarcinoma with mucin formation,ICDO3_2nd
8231/3,Carcinoma simplex,ICDO3_2nd
8240/3,"Neuroendocrine tumor, NOS",ICDO3_2nd
8240/3,"Carcinoid tumor, NOS",ICDO3_2nd
8240/3,"Carcinoid, NOS",ICDO3_2nd
8240/3,"Bronchial adenoma, carcinoid",ICDO3_2nd
8240/3,"Neuroendocrine carcinoma, low grade",ICDO3_2nd
8240/3,"Neuroendocrine carcinoma, well differentiated",ICDO3_2nd
8240/3,"Neuroendocrine tumor, grade 1",ICDO3_2nd
8240/3,Typical carcinoid,ICDO3_2nd
8241/3,Enterochromaffin cell carcinoid,ICDO3_2nd
8241/3,Argentaffinoma,ICDO3_2nd
8241/3,"Carcinoid tumor, argentaffin",ICDO3_2nd
8241/3,EC cell carcinoid,ICDO3_2nd
8241/3,Serotonin producing carcinoid,ICDO3_2nd
8241/3,Serotonin producing tumor,ICDO3_2nd
8242/3,Enterochromaffin-like cell tumor,ICDO3_2nd
8242/3,ECL cell carcinoid,ICDO3_2nd
8243/3,Goblet cell carcinoid,ICDO3_2nd
8243/3,Mucinous carcinoid,ICDO3_2nd
8243/3,Mucocarcinoid tumor,ICDO3_2nd
8244/3,Mixed adenoneuroendocrine carcinoma,ICDO3_2nd
8244/3,Combined carcinoid and adenocarcinoma,ICDO3_2nd
8244/3,Mixed carcinoid and adenocarcinoma,ICDO3_2nd
8244/3,Composite carcinoid,ICDO3_2nd
8244/3,MANEC,ICDO3_2nd
8244/3,Mixed carcinoid-adenocarcinoma,ICDO3_2nd
8245/1,Tubular carcinoid,ICDO3_2nd
8245/3,Adenocarcinoid tumor,ICDO3_2nd
8246/3,"Neuroendocrine carcinoma, NOS",ICDO3_2nd
8246/3,Poorly differentiated neuroendocrine neoplasm,ICDO3_2nd
8247/3,Merkel cell carcinoma,ICDO3_2nd
8247/3,Merkel cell tumor,ICDO3_2nd
8247/3,Primary cutaneous neuroendocrine carcinoma,ICDO3_2nd
8248/1,Apudoma,ICDO3_2nd
8249/3,"Neuroendocrine tumor, grade 2",ICDO3_2nd
8249/3,Atypical carcinoid tumor,ICDO3_2nd
8249/3,"Neuroendocrine carcinoma, moderately differentiated",ICDO3_2nd
8249/3,"Neuroendocrine tumor, grade 3",ICDO3_2nd
8250/0,Atypical adenomatous hyperplasia,ICDO3_2nd
8250/1,Pulmonary adenomatosis,ICDO3_2nd
8250/2,"Adenocarcinoma in situ of lung, non-mucinous",ICDO3_2nd
8250/3,Lepidic adenocarcinoma,ICDO3_2nd
8250/3,"Bronchiolo-alveolar adenocarcinoma, NOS",ICDO3_2nd
8250/3,"Bronchiolo-alveolar carcinoma, NOS",ICDO3_2nd
8250/3,Alveolar cell carcinoma,ICDO3_2nd
8250/3,Bronchiolar adenocarcinoma,ICDO3_2nd
8250/3,Bronchiolar carcinoma,ICDO3_2nd
8251/0,Alveolar adenoma,ICDO3_2nd
8251/3,Alveolar adenocarcinoma,ICDO3_2nd
8251/3,Alveolar carcinoma,ICDO3_2nd
8252/3,"Bronchiolo-alveolar carcinoma, non-mucinous",ICDO3_2nd
8252/3,"Bronchiolo-alveolar carcinoma, Clara cell",ICDO3_2nd
8252/3,"Bronchiolo-alveolar carcinoma, type II pneumocyte",ICDO3_2nd
8253/2,"Adenocarcinoma in situ of lung, mucinous",ICDO3_2nd
8253/3,"Adenocarcinoma of lung, mucinous",ICDO3_2nd
8253/3,"Bronchiolo-alveolar carcinoma, mucinous",ICDO3_2nd
8253/3,"Bronchiolo-alveolar carcinoma, goblet cell type",ICDO3_2nd
8254/3,"Adenocarcinoma of lung, mixed mucinous and non-mucinous",ICDO3_2nd
8254/3,"Bronchiolo-alveolar carcinoma, mixed mucinous and non-mucinous",ICDO3_2nd
8254/3,"Bronchiolo-alveolar carcinoma, Clara cell and goblet cell type",ICDO3_2nd
8254/3,"Bronchiolo-alveolar carcinoma, indeterminate type",ICDO3_2nd
8254/3,"Bronchiolo-alveolar carcinoma, type II pneumocyte and goblet cell type",ICDO3_2nd
8255/3,Adenocarcinoma with mixed subtypes,ICDO3_2nd
8255/3,Adenocarcinoma combined with other types of carcinoma,ICDO3_2nd
8256/3,"Minimally invasive adenocarcinoma, non-mucinous",ICDO3_2nd
8257/3,"Minimally invasive adenocarcinoma, mucinous",ICDO3_2nd
8260/0,"Papillary adenoma, NOS",ICDO3_2nd
8260/0,Glandular papilloma,ICDO3_2nd
8260/1,Aggressive papillary tumor,ICDO3_2nd
8260/3,"Papillary adenocarcinoma, NOS",ICDO3_2nd
8260/3,Papillary carcinoma of thyroid,ICDO3_2nd
8260/3,Papillary renal cell carcinoma,ICDO3_2nd
8261/0,"Villous adenoma, NOS",ICDO3_2nd
8261/0,Villous papilloma,ICDO3_2nd
8261/2,Adenocarcinoma in situ in villous adenoma,ICDO3_2nd
8261/3,Adenocarcinoma in villous adenoma,ICDO3_2nd
8262/3,Villous adenocarcinoma,ICDO3_2nd
8263/0,"Tubulovillous adenoma, NOS",ICDO3_2nd
8263/0,Villoglandular adenoma,ICDO3_2nd
8263/0,Papillotubular adenoma,ICDO3_2nd
8263/0,Tubulo-papillary adenoma,ICDO3_2nd
8263/2,Adenocarcinoma in situ in tubulovillous adenoma,ICDO3_2nd
8263/3,Adenocarcinoma in tubulovillous adenoma,ICDO3_2nd
8263/3,Villoglandular carcinoma,ICDO3_2nd
8263/3,Villoglandular variant of endometrioid adenocarcinoma,ICDO3_2nd
8263/3,Papillotubular adenocarcinoma,ICDO3_2nd
8263/3,Tubulopapillary adenocarcinoma,ICDO3_2nd
8264/0,"Papillomatosis, glandular",ICDO3_2nd
8264/0,Biliary papillomatosis,ICDO3_2nd
8265/3,"Micropapillary carcinoma, NOS",ICDO3_2nd
8265/3,Micropapillary adenocarcinoma,ICDO3_2nd
8270/0,Chromophobe adenoma,ICDO3_2nd
8270/3,Chromophobe carcinoma,ICDO3_2nd
8270/3,Chromophobe adenocarcinoma,ICDO3_2nd
8271/0,Lactotroph adenoma,ICDO3_2nd
8271/0,Prolactinoma,ICDO3_2nd
8272/0,"Pituitary adenoma, NOS",ICDO3_2nd
8272/0,Corticotroph adenoma,ICDO3_2nd
8272/0,Null cell adenoma,ICDO3_2nd
8272/0,Plurihormonal adenoma,ICDO3_2nd
8272/0,Gonodotroph adenoma,ICDO3_2nd
8272/0,Somatotroph adenoma,ICDO3_2nd
8272/0,Thyrotroph adenoma,ICDO3_2nd
8272/0,"Pituitary adenoma, ectopic",ICDO3_2nd
8272/3,"Pituitary carcinoma, NOS",ICDO3_2nd
8273/3,Pituitary blastoma,ICDO3_2nd
8280/0,Acidophil adenoma,ICDO3_2nd
8280/0,Eosinophil adenoma,ICDO3_2nd
8280/3,Acidophil carcinoma,ICDO3_2nd
8280/3,Acidophil adenocarcinoma,ICDO3_2nd
8280/3,Eosinophil adenocarcinoma,ICDO3_2nd
8280/3,Eosinophil carcinoma,ICDO3_2nd
8281/0,Mixed acidophil-basophil adenoma,ICDO3_2nd
8281/3,Mixed acidophil-basophil carcinoma,ICDO3_2nd
8290/0,Oxyphilic adenoma,ICDO3_2nd
8290/0,Oncocytic adenoma,ICDO3_2nd
8290/0,Oncocytoma,ICDO3_2nd
8290/0,"Follicular adenoma, oxyphilic cell",ICDO3_2nd
8290/0,Hurthle cell adenoma,ICDO3_2nd
8290/0,Hurthle cell tumor,ICDO3_2nd
8290/0,Spindle cell oncocytoma,ICDO3_2nd
8290/0,Oncocytic papillary cystadenoma,ICDO3_2nd
8290/3,Oxyphilic adenocarcinoma,ICDO3_2nd
8290/3,Oncocytic adenocarcinoma,ICDO3_2nd
8290/3,Oncocytic carcinoma,ICDO3_2nd
8290/3,Hurthle cell carcinoma,ICDO3_2nd
8290/3,Hurthle cell adenocarcinoma,ICDO3_2nd
8290/3,"Follicular carcinoma, oxyphilic cell",ICDO3_2nd
8300/0,Basophil adenoma,ICDO3_2nd
8300/0,Mucoid cell adenoma,ICDO3_2nd
8300/3,Basophil carcinoma,ICDO3_2nd
8300/3,Basophil adenocarcinoma,ICDO3_2nd
8300/3,Mucoid cell adenocarcinoma,ICDO3_2nd
8310/0,Clear cell adenoma,ICDO3_2nd
8310/3,"Clear cell adenocarcinoma, NOS",ICDO3_2nd
8310/3,"Clear cell carcinoma, NOS",ICDO3_2nd
8310/3,"Clear cell adenocarcinoma, mesonephroid",ICDO3_2nd
8310/3,"Clear cell renal cell carcinoma, NOS",ICDO3_2nd
8311/1,Hypernephroid tumor,ICDO3_2nd
8311/3,Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome-associated renal cell carcinoma,ICDO3_2nd
8311/3,MiT family translocation carcinoma,ICDO3_2nd
8311/3,Succinate dehydrogenase deficient renal cell carcinoma,ICDO3_2nd
8312/3,"Renal cell carcinoma, NOS",ICDO3_2nd
8312/3,Renal cell adenocarcinoma,ICDO3_2nd
8312/3,"Renal cell carcinoma, unclassified",ICDO3_2nd
8312/3,Grawitz tumor,ICDO3_2nd
8312/3,Hypernephroma,ICDO3_2nd
8313/0,Clear cell adenofibroma,ICDO3_2nd
8313/0,Clear cell cystadenofibroma,ICDO3_2nd
8313/1,Clear cell borderline tumor,ICDO3_2nd
8313/1,"Clear cell tumor, atypical proliferative",ICDO3_2nd
8313/1,Clear cell cystic tumor of borderline malignancy,ICDO3_2nd
8313/1,Clear cell adenofibroma of borderline malignancy,ICDO3_2nd
8313/1,Clear cell cystadenofibroma of borderline malignancy,ICDO3_2nd
8313/3,Clear cell adenocarcinofibroma,ICDO3_2nd
8313/3,Clear cell cystadenocarcinofibroma,ICDO3_2nd
8314/3,Lipid-rich carcinoma,ICDO3_2nd
8315/3,Glycogen-rich carcinoma,ICDO3_2nd
8315/3,Glycogen-rich clear cell carcinoma,ICDO3_2nd
8316/1,Multilocular cystic renal neoplasm of low malignant potential,ICDO3_2nd
8316/3,Cyst-associated renal cell carcinoma,ICDO3_2nd
8316/3,Acquired cystic disease-associated renal cell carcinoma,ICDO3_2nd
8316/3,Tubulocystic renal cell carcinoma,ICDO3_2nd
8317/3,"Renal cell carcinoma, chromophobe type",ICDO3_2nd
8317/3,Chromophobe cell renal carcinoma,ICDO3_2nd
8317/3,Hybrid oncocytic chromophobe tumor,ICDO3_2nd
8318/3,"Renal cell carcinoma, sarcomatoid",ICDO3_2nd
8318/3,"Renal cell carcinoma, spindle cell",ICDO3_2nd
8319/3,Collecting duct carcinoma,ICDO3_2nd
8319/3,Bellini duct carcinoma,ICDO3_2nd
8319/3,"Renal carcinoma, collecting duct type",ICDO3_2nd
8320/3,Granular cell carcinoma,ICDO3_2nd
8320/3,Granular cell adenocarcinoma,ICDO3_2nd
8321/0,Chief cell adenoma,ICDO3_2nd
8322/0,Water-clear cell adenoma,ICDO3_2nd
8322/3,Water-clear cell adenocarcinoma,ICDO3_2nd
8322/3,Water-clear cell carcinoma,ICDO3_2nd
8323/0,Mixed cell adenoma,ICDO3_2nd
8323/1,Clear cell papillary renal cell carcinoma,ICDO3_2nd
8323/3,Mixed cell adenocarcinoma,ICDO3_2nd
8324/0,Lipoadenoma,ICDO3_2nd
8324/0,Adenolipoma,ICDO3_2nd
8325/0,Metanephric adenoma,ICDO3_2nd
8330/0,"Follicular adenoma, NOS",ICDO3_2nd
8330/1,Atypical follicular adenoma,ICDO3_2nd
8330/3,"Follicular carcinoma, NOS",ICDO3_2nd
8330/3,"Follicular adenocarcinoma, NOS",ICDO3_2nd
8331/3,"Follicular adenocarcinoma, well differentiated",ICDO3_2nd
8331/3,"Follicular carcinoma, well differentiated",ICDO3_2nd
8332/3,"Follicular adenocarcinoma, trabecular",ICDO3_2nd
8332/3,"Follicular carcinoma, trabecular",ICDO3_2nd
8332/3,"Follicular adenocarcinoma, moderately differentiated",ICDO3_2nd
8332/3,"Follicular carcinoma, moderately differentiated",ICDO3_2nd
8333/0,"Microfollicular adenoma, NOS",ICDO3_2nd
8333/0,Fetal adenoma,ICDO3_2nd
8333/3,Fetal adenocarcinoma,ICDO3_2nd
8334/0,Macrofollicular adenoma,ICDO3_2nd
8334/0,Colloid adenoma,ICDO3_2nd
8335/1,Follicular tumor of uncertain malignant potential,ICDO3_2nd
8335/1,"Follicular carcinoma, encapsulated, NOS",ICDO3_2nd
8335/3,"Follicular carcinoma, minimally invasive",ICDO3_2nd
8336/1,Hyalinizing trabecular tumor,ICDO3_2nd
8336/1,Hyalinizing trabecular adenoma,ICDO3_2nd
8337/3,Poorly differentiated thyroid carcinoma,ICDO3_2nd
8337/3,Insular carcinoma,ICDO3_2nd
8339/3,"Follicular carcinoma, encapsulated, angioinvasive",ICDO3_2nd
8340/3,"Papillary carcinoma, follicular variant",ICDO3_2nd
8340/3,"Papillary adenocarcinoma, follicular variant",ICDO3_2nd
8340/3,Papillary and follicular adenocarcinoma,ICDO3_2nd
8340/3,Papillary and follicular carcinoma,ICDO3_2nd
8341/3,Papillary microcarcinoma,ICDO3_2nd
8342/3,"Papillary carcinoma, oncocytic variant",ICDO3_2nd
8342/3,"Papillary carcinoma, oxyphilic cell",ICDO3_2nd
8343/3,"Papillary carcinoma, encapsulated, of thyroid",ICDO3_2nd
8344/3,"Papillary carcinoma, columnar cell",ICDO3_2nd
8344/3,"Papillary carcinoma, tall cell",ICDO3_2nd
8345/3,Medullary thyroid carcinoma,ICDO3_2nd
8345/3,C cell carcinoma,ICDO3_2nd
8345/3,Parafollicular cell carcinoma,ICDO3_2nd
8345/3,Medullary carcinoma with amyloid stroma,ICDO3_2nd
8346/3,Mixed medullary-follicular carcinoma,ICDO3_2nd
8347/3,Mixed medullary-papillary carcinoma,ICDO3_2nd
8348/1,Well differentiated tumor of uncertain malignant potential,ICDO3_2nd
8349/1,Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP),ICDO3_2nd
8350/3,Nonencapsulated sclerosing carcinoma,ICDO3_2nd
8350/3,Nonencapsulated sclerosing adenocarcinoma,ICDO3_2nd
8350/3,Nonencapsulated sclerosing tumor,ICDO3_2nd
8350/3,"Papillary carcinoma, diffuse sclerosing",ICDO3_2nd
8360/1,Multiple endocrine adenomas,ICDO3_2nd
8360/1,Endocrine adenomatosis,ICDO3_2nd
8361/0,Juxtaglomerular tumor,ICDO3_2nd
8361/0,Juxtaglomerular cell tumor,ICDO3_2nd
8361/0,Reninoma,ICDO3_2nd
8370/0,"Adrenal cortical adenoma, NOS",ICDO3_2nd
8370/0,"Adrenal cortical tumor, NOS",ICDO3_2nd
8370/0,"Adrenal cortical tumor, benign",ICDO3_2nd
8370/3,Adrenal cortical carcinoma,ICDO3_2nd
8370/3,Adrenal cortical adenocarcinoma,ICDO3_2nd
8370/3,"Adrenal cortical tumor, malignant",ICDO3_2nd
8371/0,"Adrenal cortical adenoma, compact cell",ICDO3_2nd
8372/0,"Adrenal cortical adenoma, pigmented",ICDO3_2nd
8372/0,Black adenoma,ICDO3_2nd
8372/0,Pigmented adenoma,ICDO3_2nd
8373/0,"Adrenal cortical adenoma, clear cell",ICDO3_2nd
8374/0,"Adrenal cortical adenoma, glomerulosa cell",ICDO3_2nd
8375/0,"Adrenal cortical adenoma, mixed cell",ICDO3_2nd
8380/0,"Endometrioid adenoma, NOS",ICDO3_2nd
8380/0,"Endometrioid cystadenoma, NOS",ICDO3_2nd
8380/1,"Endometrioid adenoma, borderline malignancy",ICDO3_2nd
8380/1,"Endometrioid tumor, borderline",ICDO3_2nd
8380/1,Atypical proliferative endometrioid tumor,ICDO3_2nd
8380/1,"Endometrioid cystadenoma, borderline malignancy",ICDO3_2nd
8380/1,Endometrioid tumor of low malignant potential,ICDO3_2nd
8380/2,Endometrioid intraepithelial neoplasia,ICDO3_2nd
8380/2,Atypical hyperplasia of endometrium,ICDO3_2nd
8380/3,"Endometrioid adenocarcinoma, NOS",ICDO3_2nd
8380/3,"Endometrioid carcinoma, NOS",ICDO3_2nd
8380/3,Endometrioid cystadenocarcinoma,ICDO3_2nd
8381/0,"Endometrioid adenofibroma, NOS",ICDO3_2nd
8381/0,"Endometrioid cystadenofibroma, NOS",ICDO3_2nd
8381/1,"Endometrioid adenofibroma, borderline malignancy",ICDO3_2nd
8381/1,"Endometrioid cystadenofibroma, borderline malignancy",ICDO3_2nd
8381/3,"Endometrioid adenofibroma, malignant",ICDO3_2nd
8381/3,"Endometrioid cystadenofibroma, malignant",ICDO3_2nd
8382/3,"Endometrioid adenocarcinoma, secretory variant",ICDO3_2nd
8383/3,"Endometrioid adenocarcinoma, ciliated cell variant",ICDO3_2nd
8384/3,"Adenocarcinoma, endocervical type, NOS",ICDO3_2nd
8390/0,Skin appendage adenoma,ICDO3_2nd
8390/0,"Adnexal tumor, benign",ICDO3_2nd
8390/0,"Skin appendage tumor, benign",ICDO3_2nd
8390/3,"Adnexal adenocarcinoma, NOS",ICDO3_2nd
8390/3,Skin appendage carcinoma,ICDO3_2nd
8390/3,Adnexal carcinoma,ICDO3_2nd
8391/0,Follicular fibroma,ICDO3_2nd
8391/0,Fibrofolliculoma,ICDO3_2nd
8391/0,Perifollicular fibroma,ICDO3_2nd
8391/0,Trichodiscoma,ICDO3_2nd
8391/0,Spindle cell predominant trichodiscoma,ICDO3_2nd
8392/0,Syringofibroadenoma,ICDO3_2nd
8400/0,Sweat gland adenoma,ICDO3_2nd
8400/0,"Syringadenoma, NOS",ICDO3_2nd
8400/0,"Sweat gland tumor, benign",ICDO3_2nd
8400/1,"Sweat gland tumor, NOS",ICDO3_2nd
8400/3,Sweat gland adenocarcinoma,ICDO3_2nd
8400/3,Sweat gland carcinoma,ICDO3_2nd
8400/3,"Sweat gland tumor, malignant",ICDO3_2nd
8401/0,Apocrine adenoma,ICDO3_2nd
8401/0,Apocrine cystadenoma,ICDO3_2nd
8401/3,Apocrine adenocarcinoma,ICDO3_2nd
8401/3,Apocrine carcinoma,ICDO3_2nd
8402/0,"Hidradenoma, NOS",ICDO3_2nd
8402/0,Nodular hidradenoma,ICDO3_2nd
8402/0,Clear cell hidradenoma,ICDO3_2nd
8402/0,Eccrine acrospiroma,ICDO3_2nd
8402/3,Hidradenocarcinoma,ICDO3_2nd
8402/3,"Nodular hidradenoma, malignant",ICDO3_2nd
8403/0,"Spiradenoma, NOS",ICDO3_2nd
8403/0,Eccrine spiradenoma,ICDO3_2nd
8403/3,Malignant eccrine spiradenoma,ICDO3_2nd
8403/3,Malignant neoplasm arising from pre-existing spiradenoma,ICDO3_2nd
8403/3,Malignant neoplasm arising from pre-existing cylindroma,ICDO3_2nd
8403/3,Malignant neoplasm arising from pre-existing spiradenocylindroma,ICDO3_2nd
8404/0,Hidrocystoma,ICDO3_2nd
8404/0,Hidrocystadenoma,ICDO3_2nd
8404/0,Eccrine cystadenoma,ICDO3_2nd
8405/0,Papillary hidradenoma,ICDO3_2nd
8405/0,Hidradenoma papilliferum,ICDO3_2nd
8406/0,Syringocystadenoma papilliferum,ICDO3_2nd
8406/0,Papillary syringadenoma,ICDO3_2nd
8406/0,Papillary syringocystadenoma,ICDO3_2nd
8406/0,Sialadenoma papilliferum,ICDO3_2nd
8406/3,Syringocystadenocarcinoma papilliferum,ICDO3_2nd
8407/0,"Syringoma, NOS",ICDO3_2nd
8407/0,Syringomatous tumor of nipple,ICDO3_2nd
8407/0,Syringomatous adenoma of nipple,ICDO3_2nd
8407/0,Infiltrating syringomatous adenoma of nipple,ICDO3_2nd
8407/3,Microcystic adnexal carcinoma,ICDO3_2nd
8407/3,Sclerosing sweat duct carcinoma,ICDO3_2nd
8407/3,Syringomatous carcinoma,ICDO3_2nd
8408/0,Eccrine papillary adenoma,ICDO3_2nd
8408/3,Digital papillary adenocarcinoma,ICDO3_2nd
8408/3,Aggressive digital papillary adenoma,ICDO3_2nd
8408/3,Eccrine papillary adenocarcinoma,ICDO3_2nd
8409/0,"Poroma, NOS",ICDO3_2nd
8409/0,"Eccrine poroma, NOS",ICDO3_2nd
8409/0,Apocrine poroma,ICDO3_2nd
8409/2,Porocarcinoma in situ,ICDO3_2nd
8409/3,"Porocarcinoma, NOS",ICDO3_2nd
8409/3,"Eccrine poroma, malignant",ICDO3_2nd
8410/0,Sebaceoma,ICDO3_2nd
8410/0,Sebaceous adenoma,ICDO3_2nd
8410/0,Sebaceous epithelioma,ICDO3_2nd
8410/3,Sebaceous carcinoma,ICDO3_2nd
8410/3,Sebaceous adenocarcinoma,ICDO3_2nd
8413/3,Eccrine adenocarcinoma,ICDO3_2nd
8420/0,Ceruminous adenoma,ICDO3_2nd
8420/3,Ceruminous adenocarcinoma,ICDO3_2nd
8420/3,Ceruminous carcinoma,ICDO3_2nd
8430/1,Mucoepidermoid tumor,ICDO3_2nd
8430/3,Mucoepidermoid carcinoma,ICDO3_2nd
8440/0,"Cystadenoma, NOS",ICDO3_2nd
8440/0,"Cystoma, NOS",ICDO3_2nd
8440/3,"Cystadenocarcinoma, NOS",ICDO3_2nd
8441/0,"Serous cystadenoma, NOS",ICDO3_2nd
8441/0,Serous cystoma,ICDO3_2nd
8441/0,Serous microcystic adenoma,ICDO3_2nd
8441/0,"Papillary serous cystadenoma, NOS",ICDO3_2nd
8441/2,Serous intraepithelial carcinoma,ICDO3_2nd
8441/2,Serous tubal intraepithelial carcinoma (STIC),ICDO3_2nd
8441/2,Serous endometrial intraepithelial carcinoma,ICDO3_2nd
8441/3,"Serous carcinoma, NOS",ICDO3_2nd
8441/3,"Serous cystadenocarcinoma, NOS",ICDO3_2nd
8441/3,"Serous adenocarcinoma, NOS",ICDO3_2nd
8441/3,"Serous papillary adenocarcinoma, NOS",ICDO3_2nd
8441/3,Papillary serous cystadenocarcinoma,ICDO3_2nd
8441/3,Papillary serous adenocarcinoma,ICDO3_2nd
8441/3,Serous surface papillary carcinoma,ICDO3_2nd
8442/1,"Serous borderline tumor, NOS",ICDO3_2nd
8442/1,"Serous tumor, atypical proliferative",ICDO3_2nd
8442/1,"Serous cystadenoma, borderline malignancy",ICDO3_2nd
8442/1,"Serous tumor, NOS, of low malignant potential",ICDO3_2nd
8442/1,Serous papillary cystic tumor of borderline malignancy,ICDO3_2nd
8442/1,Atypical proliferative papillary serous tumor,ICDO3_2nd
8442/1,"Papillary serous cystadenoma, borderline malignancy",ICDO3_2nd
8442/1,Papillary serous tumor of low malignant potential,ICDO3_2nd
8442/1,Serous surface papillary tumor of borderline malignancy,ICDO3_2nd
8443/0,Clear cell cystadenoma,ICDO3_2nd
8450/0,"Papillary cystadenoma, NOS",ICDO3_2nd
8450/0,Papillary cystadenofibroma,ICDO3_2nd
8450/3,"Papillary cystadenocarcinoma, NOS",ICDO3_2nd
8450/3,Papillocystic adenocarcinoma,ICDO3_2nd
8451/1,"Papillary cystadenoma, borderline malignancy",ICDO3_2nd
8452/1,Solid pseudopapillary tumor of ovary,ICDO3_2nd
8452/1,Papillary cystic tumor,ICDO3_2nd
8452/1,Solid and cystic tumor,ICDO3_2nd
8452/1,Solid and papillary epithelial neoplasm,ICDO3_2nd
8452/3,Solid pseudopapillary neoplasm of pancreas,ICDO3_2nd
8452/3,Solid pseudopapillary carcinoma,ICDO3_2nd
8453/0,Intraductal papillary mucinous adenoma,ICDO3_2nd
8453/0,Intraductal papillary mucinous tumor with intermediate dysplasia,ICDO3_2nd
8453/0,Intraductal papillary mucinous tumor with low grade dysplasia,ICDO3_2nd
8453/0,Intraductal papillary mucinous neoplasm with low grade dysplasia,ICDO3_2nd
8453/0,Intraductal papillary mucinous tumor with moderate dysplasia,ICDO3_2nd
8453/0,Intraductal papillary mucinous neoplasm with moderate dysplasia,ICDO3_2nd
8453/2,Intraductal papillary mucinous neoplasm with high grade dysplasia,ICDO3_2nd
8453/2,"Intraductal papillary mucinous carcinoma, non-invasive",ICDO3_2nd
8453/3,Intraductal papillary mucinous neoplasm with an associated invasive carcinoma,ICDO3_2nd
8453/3,"Intraductal papillary mucinous carcinoma, invasive",ICDO3_2nd
8454/0,Cystic tumor of atrio-ventricular node,ICDO3_2nd
8460/2,"Serous borderline tumor, micropapillary variant",ICDO3_2nd
8460/2,"Serous carcinoma, non-invasive, low grade",ICDO3_2nd
8460/3,Low grade serous carcinoma,ICDO3_2nd
8460/3,Micropapillary serous carcinoma,ICDO3_2nd
8461/0,Serous surface papilloma,ICDO3_2nd
8461/3,High grade serous carcinoma,ICDO3_2nd
8470/0,"Mucinous cystadenoma, NOS",ICDO3_2nd
8470/0,"Papillary mucinous cystadenoma, NOS",ICDO3_2nd
8470/0,"Papillary pseudomucinous cystadenoma, NOS",ICDO3_2nd
8470/0,"Pseudomucinous cystadenoma, NOS",ICDO3_2nd
8470/0,Mucinous cystoma,ICDO3_2nd
8470/0,Mucinous cystic neoplasm with intermediate grade dysplasia,ICDO3_2nd
8470/0,Mucinous cystic neoplasm with intermediate grade intraepithelial neoplasia,ICDO3_2nd
8470/0,Mucinous cystic neoplasm with low grade dysplasia,ICDO3_2nd
8470/0,Mucinous cystic neoplasm with low grade intraepithelial neoplasia,ICDO3_2nd
8470/0,Mucinous cystic tumor with intermediate dysplasia,ICDO3_2nd
8470/0,Mucinous cystic tumor with low grade dysplasia,ICDO3_2nd
8470/0,Mucinous cystic tumor with moderate dysplasia,ICDO3_2nd
8470/2,Mucinous cystic neoplasm with high grade dysplasia,ICDO3_2nd
8470/2,"Mucinous cystadenocarcinoma, non-invasive",ICDO3_2nd
8470/2,Mucinous cystic tumor with high grade dysplasia,ICDO3_2nd
8470/2,Mucinous cystic neoplasm with high grade intraepithelial neoplasia,ICDO3_2nd
8470/3,"Mucinous cystadenocarcinoma, NOS",ICDO3_2nd
8470/3,"Pseudomucinous cystadenocarcinoma, NOS",ICDO3_2nd
8470/3,Pseudomucinous adenocarcinoma,ICDO3_2nd
8470/3,Mucinous cystic tumor with an associated invasive carcinoma,ICDO3_2nd
8470/3,Mucinous cystic neoplasm with an associated invasive carcinoma,ICDO3_2nd
8470/3,Papillary mucinous cystadenocarcinoma,ICDO3_2nd
8470/3,Papillary pseudomucinous cystadenocarcinoma,ICDO3_2nd
8472/1,Mucinous cystic tumor of borderline malignancy,ICDO3_2nd
8472/1,Mucinous borderline tumor,ICDO3_2nd
8472/1,"Mucinous tumor, NOS, of low malignant potential",ICDO3_2nd
8472/1,Atypical proliferative mucinous tumor,ICDO3_2nd
8472/1,"Mucinous cystadenoma, borderline malignancy",ICDO3_2nd
8472/1,"Pseudomucinous cystadenoma, borderline malignancy",ICDO3_2nd
8472/1,"Papillary mucinous cystadenoma, borderline malignancy",ICDO3_2nd
8472/1,"Papillary pseudomucinous cystadenoma, borderline malignancy",ICDO3_2nd
8472/1,Papillary mucinous tumor of low malignant potential,ICDO3_2nd
8474/0,Seromucinous cystadenoma,ICDO3_2nd
8474/1,Seromucinous borderline tumor,ICDO3_2nd
8474/1,"Seromucinous tumor, atypical proliferative",ICDO3_2nd
8474/3,Seromucinous carcinoma,ICDO3_2nd
8480/0,Mucinous adenoma,ICDO3_2nd
8480/0,Mucous gland adenoma,ICDO3_2nd
8480/1,Low grade appendiceal mucinous neoplasm,ICDO3_2nd
8480/3,Mucinous adenocarcinoma,ICDO3_2nd
8480/3,"Acinar adenocarcinoma, mucinous variant",ICDO3_2nd
8480/3,Colloid adenocarcinoma,ICDO3_2nd
8480/3,Colloid carcinoma,ICDO3_2nd
8480/3,Gelatinous adenocarcinoma,ICDO3_2nd
8480/3,Gelatinous carcinoma,ICDO3_2nd
8480/3,Mucinous carcinoma,ICDO3_2nd
8480/3,Mucoid adenocarcinoma,ICDO3_2nd
8480/3,Mucoid carcinoma,ICDO3_2nd
8480/3,Mucous adenocarcinoma,ICDO3_2nd
8480/3,Mucous carcinoma,ICDO3_2nd
8480/3,Pseudomyxoma peritonei with unknown primary site,ICDO3_2nd
8480/3,Mucinous tubular and spindle cell carcinoma,ICDO3_2nd
8480/6,Pseudomyxoma peritonei,ICDO3_2nd
8481/3,Mucin-producing adenocarcinoma,ICDO3_2nd
8481/3,Mucin-producing carcinoma,ICDO3_2nd
8481/3,Mucin-secreting adenocarcinoma,ICDO3_2nd
8481/3,Mucin-secreting carcinoma,ICDO3_2nd
8482/3,"Mucinous carcinoma, gastric type",ICDO3_2nd
8482/3,"Mucinous adenocarcinoma, endocervical type",ICDO3_2nd
8490/3,Signet ring cell carcinoma,ICDO3_2nd
8490/3,Signet ring cell adenocarcinoma,ICDO3_2nd
8490/3,"Acinar adenocarcinoma, signet ring-like variant",ICDO3_2nd
8490/3,"Mucinous carcinoma, signet ring cell type",ICDO3_2nd
8490/3,Poorly cohesive carcinoma,ICDO3_2nd
8490/3,Signet ring cell/histiocytoid carcinoma,ICDO3_2nd
8490/6,Metastatic signet ring cell carcinoma,ICDO3_2nd
8490/6,Krukenberg tumor,ICDO3_2nd
8500/2,"Intraductal carcinoma, noninfiltrating, NOS",ICDO3_2nd
8500/2,"Intraductal adenocarcinoma, noninfiltrating, NOS",ICDO3_2nd
8500/2,"Intraductal carcinoma, NOS",ICDO3_2nd
8500/2,"Ductal carcinoma in situ, NOS",ICDO3_2nd
8500/2,"DCIS, NOS",ICDO3_2nd
8500/2,DIN 3,ICDO3_2nd
8500/2,Ductal intraepithelial neoplasia 3,ICDO3_2nd
8500/2,"Cystic hypersecretory carcinoma, intraductal",ICDO3_2nd
8500/3,"Infiltrating duct carcinoma, NOS",ICDO3_2nd
8500/3,Invasive breast carcinoma of no special type,ICDO3_2nd
8500/3,"Duct adenocarcinoma, NOS",ICDO3_2nd
8500/3,"Duct carcinoma, NOS",ICDO3_2nd
8500/3,"Ductal carcinoma, NOS",ICDO3_2nd
8500/3,Duct cell carcinoma,ICDO3_2nd
8500/3,Infiltrating duct adenocarcinoma,ICDO3_2nd
8500/3,Basal-like carcinoma of breast,ICDO3_2nd
8500/3,Adenocarcinoma of mammary gland type,ICDO3_2nd
8500/3,Adenocarcinoma of anogenital mammary-like glands,ICDO3_2nd
8500/3,Carcinoma of male breast,ICDO3_2nd
8501/2,"Comedocarcinoma, noninfiltrating",ICDO3_2nd
8501/2,"Ductal carcinoma in situ, comedo type",ICDO3_2nd
8501/2,"DCIS, comedo type",ICDO3_2nd
8501/3,"Comedocarcinoma, NOS",ICDO3_2nd
8502/3,Secretory carcinoma,ICDO3_2nd
8502/3,Juvenile carcinoma of breast,ICDO3_2nd
8503/0,Intraductal papilloma,ICDO3_2nd
8503/0,"Duct adenoma, NOS",ICDO3_2nd
8503/0,Ductal papilloma,ICDO3_2nd
8503/0,"Intraductal papillary neoplasm, NOS",ICDO3_2nd
8503/0,Intracystic papillary neoplasm with low grade intraepithelial neoplasia,ICDO3_2nd
8503/0,Intracystic papillary neoplasm with intermediate grade intraepithelial neoplasia,ICDO3_2nd
8503/0,Intraglandular papillary neoplasm with low grade intraepithelial neoplasia,ICDO3_2nd
8503/0,Intraductal papillary neoplasm with intermediate grade neoplasia,ICDO3_2nd
8503/0,Intraductal papillary neoplasm with low grade intraepithelial neoplasia,ICDO3_2nd
8503/0,"Intraductal tubular-papillary neoplasm, low grade",ICDO3_2nd
8503/0,Intraductal papilloma with atypical ductal hyperplasia,ICDO3_2nd
8503/2,Noninfiltrating intraductal papillary adenocarcinoma,ICDO3_2nd
8503/2,"Intraductal papillary adenocarcinoma, NOS",ICDO3_2nd
8503/2,"Intraductal papillary carcinoma, NOS",ICDO3_2nd
8503/2,"DCIS, papillary",ICDO3_2nd
8503/2,"Ductal carcinoma in situ, papillary",ICDO3_2nd
8503/2,Noninfiltrating intraductal papillary carcinoma,ICDO3_2nd
8503/2,Intraductal papilloma with DCIS,ICDO3_2nd
8503/2,Intraductal papillary neoplasm with high grade intraepithelial neoplasia,ICDO3_2nd
8503/2,Intracystic papillary neoplasm with high grade intraepithelial neoplasia,ICDO3_2nd
8503/2,Intracystic papillary tumor with high grade dysplasia,ICDO3_2nd
8503/2,Intracystic papillary tumor with high grade intraepithelial neoplasia,ICDO3_2nd
8503/2,Intraductal papillary neoplasm with high grade dysplasia,ICDO3_2nd
8503/2,Intraductal papillary tumor with high grade dysplasia,ICDO3_2nd
8503/2,Intraductal papillary tumor with high grade intraepithelial neoplasia,ICDO3_2nd
8503/2,"Intraductal tubular-papillary neoplasm, high grade",ICDO3_2nd
8503/2,Intraductal tubulopapillary neoplasm,ICDO3_2nd
8503/3,Intraductal papillary adenocarcinoma with invasion,ICDO3_2nd
8503/3,Infiltrating papillary adenocarcinoma,ICDO3_2nd
8503/3,Infiltrating and papillary adenocarcinoma,ICDO3_2nd
8503/3,Papillary carcinoma of breast,ICDO3_2nd
8503/3,Intraductal papillary neoplasm with associated invasive carcinoma,ICDO3_2nd
8503/3,Intracystic papillary neoplasm with associated invasive carcinoma,ICDO3_2nd
8504/0,Intracystic papillary adenoma,ICDO3_2nd
8504/0,Intracystic papilloma,ICDO3_2nd
8504/2,Encapsulated papillary carcinoma,ICDO3_2nd
8504/2,Noninfiltrating intracystic carcinoma,ICDO3_2nd
8504/2,Encysted papillary carcinoma,ICDO3_2nd
8504/2,Intracystic papillary carcinoma,ICDO3_2nd
8504/2,"Intracystic carcinoma, NOS",ICDO3_2nd
8504/2,Intracystic papillary adenocarcinoma,ICDO3_2nd
8504/3,Encapsulated papillary carcinoma with invasion,ICDO3_2nd
8504/3,Encysted papillary carcinoma with invasion,ICDO3_2nd
8504/3,Intracystic papillary carcinoma with invasion,ICDO3_2nd
8505/0,"Intraductal papillomatosis, NOS",ICDO3_2nd
8505/0,Diffuse intraductal papillomatosis,ICDO3_2nd
8506/0,Adenoma of nipple,ICDO3_2nd
8506/0,Subareolar duct papillomatosis,ICDO3_2nd
8507/2,Intraductal micropapillary carcinoma,ICDO3_2nd
8507/2,"Ductal carcinoma in situ, micropapillary",ICDO3_2nd
8507/2,"Intraductal carcinoma, clinging, high grade",ICDO3_2nd
8507/3,Invasive micropapillary carcinoma of breast,ICDO3_2nd
8507/3,Micropapillary carcinoma of breast,ICDO3_2nd
8508/3,Cystic hypersecretory carcinoma,ICDO3_2nd
8509/2,Solid papillary carcinoma in situ,ICDO3_2nd
8509/2,Endocrine mucin-producing sweat gland carcinoma in situ,ICDO3_2nd
8509/3,Solid papillary carcinoma with invasion,ICDO3_2nd
8509/3,Endocrine mucin-producing sweat gland carcinoma,ICDO3_2nd
8510/3,"Medullary carcinoma, NOS",ICDO3_2nd
8510/3,Medullary adenocarcinoma,ICDO3_2nd
8510/3,Medullary-like carcinoma,ICDO3_2nd
8512/3,Medullary carcinoma with lymphoid stroma,ICDO3_2nd
8513/3,Atypical medullary carcinoma,ICDO3_2nd
8514/3,"Duct carcinoma, desmoplastic type",ICDO3_2nd
8519/2,"Lobular carcinoma in situ, pleomorphic",ICDO3_2nd
8519/2,"LCIS, pleomorphic",ICDO3_2nd
8520/2,"Lobular carcinoma in situ, NOS",ICDO3_2nd
8520/2,"LCIS, NOS",ICDO3_2nd
8520/2,"Lobular carcinoma, noninfiltrating",ICDO3_2nd
8520/2,"Lobular carcinoma in situ, classic",ICDO3_2nd
8520/2,Intraductal papilloma with lobular carcinoma in situ,ICDO3_2nd
8520/3,"Lobular carcinoma, NOS",ICDO3_2nd
8520/3,"Infiltrating lobular carcinoma, NOS",ICDO3_2nd
8520/3,Lobular adenocarcinoma,ICDO3_2nd
8520/3,Tubulolobular carcinoma,ICDO3_2nd
8520/3,"Lobular carcinoma, pleomorphic",ICDO3_2nd
8521/3,Infiltrating ductular carcinoma,ICDO3_2nd
8522/2,Intraductal carcinoma and lobular carcinoma in situ,ICDO3_2nd
8522/3,Infiltrating duct and lobular carcinoma,ICDO3_2nd
8522/3,Lobular and ductal carcinoma,ICDO3_2nd
8522/3,Intraductal and lobular carcinoma,ICDO3_2nd
8522/3,Infiltrating duct and lobular carcinoma in situ,ICDO3_2nd
8522/3,Infiltrating lobular carcinoma and ductal carcinoma in situ,ICDO3_2nd
8523/3,Infiltrating duct mixed with other types of carcinoma,ICDO3_2nd
8523/3,Infiltrating duct and colloid carcinoma,ICDO3_2nd
8523/3,Infiltrating duct and cribriform carcinoma,ICDO3_2nd
8523/3,Infiltrating duct and mucinous carcinoma,ICDO3_2nd
8523/3,Infiltrating duct and tubular carcinoma,ICDO3_2nd
8524/3,Infiltrating lobular mixed with other types of carcinoma,ICDO3_2nd
8525/3,Polymorphous adenocarcinoma,ICDO3_2nd
8525/3,Polymorphous carcinoma,ICDO3_2nd
8525/3,Terminal duct adenocarcinoma,ICDO3_2nd
8530/3,Inflammatory carcinoma,ICDO3_2nd
8530/3,Inflammatory adenocarcinoma,ICDO3_2nd
8540/3,"Paget disease, mammary",ICDO3_2nd
8540/3,Paget disease of breast,ICDO3_2nd
8540/3,Paget disease of nipple,ICDO3_2nd
8541/3,Paget disease and infiltrating duct carcinoma of breast,ICDO3_2nd
8542/3,"Paget disease, extramammary",ICDO3_2nd
8543/3,Paget disease and intraductal carcinoma of breast,ICDO3_2nd
8550/0,Acinar cell adenoma,ICDO3_2nd
8550/0,Acinar adenoma,ICDO3_2nd
8550/0,Acinic cell adenoma,ICDO3_2nd
8550/1,Acinar cell tumor,ICDO3_2nd
8550/1,Acinic cell tumor,ICDO3_2nd
8550/3,Acinar cell carcinoma,ICDO3_2nd
8550/3,"Acinar adenocarcinoma, NOS",ICDO3_2nd
8550/3,Acinar carcinoma,ICDO3_2nd
8550/3,Acinic cell adenocarcinoma,ICDO3_2nd
8551/3,Acinar cell cystadenocarcinoma,ICDO3_2nd
8551/3,Acinar adenocarcinoma of lung,ICDO3_2nd
8552/3,Mixed acinar-ductal carcinoma,ICDO3_2nd
8560/0,Mixed squamous cell and glandular papilloma,ICDO3_2nd
8560/0,Tubulosquamous polyp,ICDO3_2nd
8560/3,Adenosquamous carcinoma,ICDO3_2nd
8560/3,Mixed adenocarcinoma and epidermoid carcinoma,ICDO3_2nd
8560/3,Mixed adenocarcinoma and squamous cell carcinoma,ICDO3_2nd
8560/3,Squamoid eccrine ductal carcinoma,ICDO3_2nd
8561/0,Adenolymphoma,ICDO3_2nd
8561/0,Papillary cystadenoma lymphomatosum,ICDO3_2nd
8561/0,Warthin tumor,ICDO3_2nd
8562/3,Epithelial-myoepithelial carcinoma,ICDO3_2nd
8563/0,Lymphadenoma,ICDO3_2nd
8570/3,Adenocarcinoma with squamous metaplasia,ICDO3_2nd
8570/3,Adenoacanthoma,ICDO3_2nd
8570/3,Endometrioid carcinoma with squamous differentiation,ICDO3_2nd
8571/3,Adenocarcinoma with cartilaginous and osseous metaplasia,ICDO3_2nd
8571/3,Adenocarcinoma with cartilaginous metaplasia,ICDO3_2nd
8571/3,Adenocarcinoma with chondroid differentiation,ICDO3_2nd
8571/3,Adenocarcinoma with osseous metaplasia,ICDO3_2nd
8572/3,Adenocarcinoma with spindle cell metaplasia,ICDO3_2nd
8572/3,"Acinar adenocarcinoma, sarcomatoid variant",ICDO3_2nd
8572/3,Fibromatosis-like metaplastic carcinoma,ICDO3_2nd
8573/3,Adenocarcinoma with apocrine metaplasia,ICDO3_2nd
8573/3,Carcinoma with apocrine metaplasia,ICDO3_2nd
8574/3,Adenocarcinoma with neuroendocrine differentiation,ICDO3_2nd
8574/3,Carcinoma with neuroendocrine differentiation,ICDO3_2nd
8574/3,Adenocarcinoma admixed with neuroendocrine carcinoma,ICDO3_2nd
8575/3,"Metaplastic carcinoma, NOS",ICDO3_2nd
8576/3,Hepatoid adenocarcinoma,ICDO3_2nd
8576/3,Hepatoid carcinoma,ICDO3_2nd
8580/0,Microscopic thymoma,ICDO3_2nd
8580/0,"Thymoma, benign",ICDO3_2nd
8580/1,Micronodular thymoma with lymphoid stroma,ICDO3_2nd
8580/3,"Thymoma, NOS",ICDO3_2nd
8580/3,Intrapulmonary thymoma,ICDO3_2nd
8580/3,Sclerosing thymoma,ICDO3_2nd
8580/3,Metaplastic thymoma,ICDO3_2nd
8581/3,"Thymoma, type A",ICDO3_2nd
8581/3,"Thymoma, medullary",ICDO3_2nd
8581/3,"Thymoma, spindle cell",ICDO3_2nd
8582/3,"Thymoma, type AB",ICDO3_2nd
8582/3,"Thymoma, mixed type",ICDO3_2nd
8583/3,"Thymoma, type B1",ICDO3_2nd
8583/3,"Thymoma, lymphocyte-rich",ICDO3_2nd
8583/3,"Thymoma, lymphocytic",ICDO3_2nd
8583/3,"Thymoma, organoid",ICDO3_2nd
8583/3,"Thymoma, predominantly cortical",ICDO3_2nd
8584/3,"Thymoma, type B2",ICDO3_2nd
8584/3,"Thymoma, cortical",ICDO3_2nd
8585/3,"Thymoma, type B3",ICDO3_2nd
8585/3,"Thymoma, atypical",ICDO3_2nd
8585/3,"Thymoma, epithelial",ICDO3_2nd
8585/3,Well differentiated thymic carcinoma,ICDO3_2nd
8586/3,"Thymic carcinoma, NOS",ICDO3_2nd
8586/3,"Thymoma, type C",ICDO3_2nd
8587/0,Ectopic hamartomatous thymoma,ICDO3_2nd
8588/3,Spindle epithelial tumor with thymus-like element,ICDO3_2nd
8588/3,SETTLE,ICDO3_2nd
8588/3,Spindle epithelial tumor with thymus-like differentiation,ICDO3_2nd
8589/3,Intrathyroid thymic carcinoma,ICDO3_2nd
8589/3,Carcinoma showing thymus-like element,ICDO3_2nd
8589/3,Carcinoma showing thymus-like differentiation,ICDO3_2nd
8589/3,CASTLE,ICDO3_2nd
8590/0,"Sex cord-stromal tumor, benign",ICDO3_2nd
8590/0,Signet-ring stromal tumor,ICDO3_2nd
8590/0,Microcystic stromal tumor,ICDO3_2nd
8590/1,"Sex cord-gonadal stromal tumor, NOS",ICDO3_2nd
8590/1,"Gonadal stromal tumor, NOS",ICDO3_2nd
8590/1,"Sex cord tumor, NOS",ICDO3_2nd
8590/1,"Sex cord-stromal tumor, NOS",ICDO3_2nd
8590/1,Ovarian stromal tumor,ICDO3_2nd
8590/1,Testicular stromal tumor,ICDO3_2nd
8590/1,Uterine tumor resembling ovarian sex cord tumor,ICDO3_2nd
8591/1,"Sex cord-gonadal stromal tumor, incompletely differentiated",ICDO3_2nd
8591/1,"Sex cord-stromal tumor, unclassified",ICDO3_2nd
8592/1,"Sex cord-gonadal stromal tumor, mixed forms",ICDO3_2nd
8592/1,"Sex cord-gonadal stromal tumor, mixed",ICDO3_2nd
8593/1,Stromal tumor with minor sex cord elements,ICDO3_2nd
8594/1,"Mixed germ cell-sex cord-stromal tumor, NOS",ICDO3_2nd
8594/1,"Mixed germ cell-sex cord-stromal tumor, unclassified",ICDO3_2nd
8600/0,"Thecoma, NOS",ICDO3_2nd
8600/0,Theca cell tumor,ICDO3_2nd
8600/3,"Thecoma, malignant",ICDO3_2nd
8601/0,"Thecoma, luteinized",ICDO3_2nd
8602/0,Sclerosing stromal tumor,ICDO3_2nd
8610/0,"Luteoma, NOS",ICDO3_2nd
8610/0,Luteinoma,ICDO3_2nd
8620/1,Adult granulosa cell tumor of testis,ICDO3_2nd
8620/1,"Granulosa cell tumor of testis, NOS",ICDO3_2nd
8620/3,Adult granulosa cell tumor of ovary,ICDO3_2nd
8620/3,"Granulosa cell tumor, adult type",ICDO3_2nd
8620/3,Granulosa cell carcinoma,ICDO3_2nd
8620/3,"Granulosa cell tumor, sarcomatoid",ICDO3_2nd
8621/1,Granulosa cell-theca cell tumor,ICDO3_2nd
8621/1,Theca cell-granulosa cell tumor,ICDO3_2nd
8622/0,"Granulosa cell tumor of testis, juvenile",ICDO3_2nd
8622/1,"Granulosa cell tumor, juvenile",ICDO3_2nd
8623/1,Sex cord tumor with annular tubules,ICDO3_2nd
8630/0,"Androblastoma, benign",ICDO3_2nd
8630/0,"Arrhenoblastoma, benign",ICDO3_2nd
8630/1,"Androblastoma, NOS",ICDO3_2nd
8630/1,"Arrhenoblastoma, NOS",ICDO3_2nd
8630/3,"Androblastoma, malignant",ICDO3_2nd
8630/3,"Arrhenoblastoma, malignant",ICDO3_2nd
8631/0,"Sertoli-Leydig cell tumor, well differentiated",ICDO3_2nd
8631/1,"Sertoli-Leydig cell tumor of intermediate differentiation, NOS",ICDO3_2nd
8631/1,"Sertoli-Leydig cell tumor, moderately differentiated",ICDO3_2nd
8631/1,"Sertoli-Leydig cell tumor, NOS",ICDO3_2nd
8631/3,"Sertoli-Leydig cell tumor, poorly differentiated",ICDO3_2nd
8631/3,"Sertoli-Leydig cell tumor, sarcomatoid",ICDO3_2nd
8632/1,Gynandroblastoma,ICDO3_2nd
8633/1,"Sertoli-Leydig cell tumor, retiform",ICDO3_2nd
8634/1,"Sertoli-Leydig cell tumor, intermediate differentiation, with heterologous elements",ICDO3_2nd
8634/1,"Sertoli-Leydig cell tumor, moderately differentiated, with heterologous elements",ICDO3_2nd
8634/1,"Sertoli-Leydig cell tumor, retiform, with heterologous elements",ICDO3_2nd
8634/3,"Sertoli-Leydig cell tumor, poorly differentiated, with heterologous elements",ICDO3_2nd
8640/1,"Sertoli cell tumor, NOS",ICDO3_2nd
8640/1,"Tubular androblastoma, NOS",ICDO3_2nd
8640/1,Pick tubular adenoma,ICDO3_2nd
8640/1,Sertoli cell adenoma,ICDO3_2nd
8640/1,Testicular adenoma,ICDO3_2nd
8640/3,Sertoli cell carcinoma,ICDO3_2nd
8641/0,Sertoli cell tumor with lipid storage,ICDO3_2nd
8641/0,Folliculome lipidique,ICDO3_2nd
8641/0,Lipid-rich Sertoli cell tumor,ICDO3_2nd
8641/0,Tubular androblastoma with lipid storage,ICDO3_2nd
8642/1,Large cell calcifying Sertoli cell tumor,ICDO3_2nd
8643/1,Intratubular large cell hyalinizing Sertoli cell neoplasia,ICDO3_2nd
8650/0,"Leydig cell tumor of ovary, NOS",ICDO3_2nd
8650/1,"Leydig cell tumor of testis, NOS",ICDO3_2nd
8650/1,"Interstitial cell tumor, NOS",ICDO3_2nd
8650/3,"Leydig cell tumor, malignant",ICDO3_2nd
8650/3,"Interstitial cell tumor, malignant",ICDO3_2nd
8660/0,Hilus cell tumor,ICDO3_2nd
8660/0,Hilar cell tumor,ICDO3_2nd
8670/0,Lipid cell tumor of ovary,ICDO3_2nd
8670/0,"Steroid cell tumor, NOS",ICDO3_2nd
8670/0,Lipoid cell tumor of ovary,ICDO3_2nd
8670/0,Masculinovoblastoma,ICDO3_2nd
8670/3,"Steroid cell tumor, malignant",ICDO3_2nd
8671/0,Adrenal rest tumor,ICDO3_2nd
8680/3,"Paraganglioma, NOS",ICDO3_2nd
8681/3,Sympathetic paraganglioma,ICDO3_2nd
8682/3,Parasympathetic paraganglioma,ICDO3_2nd
8683/0,Gangliocytic paraganglioma,ICDO3_2nd
8690/3,Middle ear paraganglioma,ICDO3_2nd
8690/3,"Glomus jugulare tumor, NOS",ICDO3_2nd
8690/3,Jugular paraganglioma,ICDO3_2nd
8690/3,Jugulotympanic paraganglioma,ICDO3_2nd
8691/3,Aortic body tumor,ICDO3_2nd
8691/3,Aortic body paraganglioma,ICDO3_2nd
8691/3,Aorticopulmonary paraganglioma,ICDO3_2nd
8692/3,Carotid body paraganglioma,ICDO3_2nd
8692/3,Carotid body tumor,ICDO3_2nd
8693/3,"Extra-adrenal paraganglioma, NOS",ICDO3_2nd
8693/3,"Nonchromaffin paraganglioma, NOS",ICDO3_2nd
8693/3,Laryngeal paraganglioma,ICDO3_2nd
8693/3,Vagal paraganglioma,ICDO3_2nd
8693/3,Chemodectoma,ICDO3_2nd
8693/3,Composite paraganglioma,ICDO3_2nd
8700/3,"Pheochromocytoma, NOS",ICDO3_2nd
8700/3,Adrenal medullary paraganglioma,ICDO3_2nd
8700/3,Chromaffin paraganglioma,ICDO3_2nd
8700/3,Chromaffin tumor,ICDO3_2nd
8700/3,Chromaffinoma,ICDO3_2nd
8700/3,Composite pheochromocytoma,ICDO3_2nd
8700/3,Pheochromoblastoma,ICDO3_2nd
8710/3,Glomangiosarcoma,ICDO3_2nd
8710/3,Glomoid sarcoma,ICDO3_2nd
8711/0,"Glomus tumor, NOS",ICDO3_2nd
8711/1,Glomangiomatosis,ICDO3_2nd
8711/1,Glomus tumor of uncertain malignant potential,ICDO3_2nd
8711/3,"Glomus tumor, malignant",ICDO3_2nd
8712/0,Glomangioma,ICDO3_2nd
8713/0,Glomangiomyoma,ICDO3_2nd
8714/0,"Perivascular epithelioid tumor, benign",ICDO3_2nd
8714/0,"PEComa, benign",ICDO3_2nd
8714/3,"Perivascular epithelioid tumor, malignant",ICDO3_2nd
8714/3,"PEComa, malignant",ICDO3_2nd
8720/0,"Pigmented nevus, NOS",ICDO3_2nd
8720/0,"Nevus, NOS",ICDO3_2nd
8720/0,"Melanocytic nevus, NOS",ICDO3_2nd
8720/0,Hairy nevus,ICDO3_2nd
8720/0,Nevus spilus,ICDO3_2nd
8720/0,Meyerson nevus,ICDO3_2nd
8720/0,Deep penetrating nevus,ICDO3_2nd
8720/0,Combined nevus,ICDO3_2nd
8720/0,Genital nevus,ICDO3_2nd
8720/0,Conjunctival nevus,ICDO3_2nd
8720/2,Melanoma in situ,ICDO3_2nd
8720/3,"Malignant melanoma, NOS",ICDO3_2nd
8720/3,"Melanoma, NOS",ICDO3_2nd
8720/3,Nevoid melanoma,ICDO3_2nd
8720/3,"Melanoma, meningeal",ICDO3_2nd
8721/3,Nodular melanoma,ICDO3_2nd
8722/0,Balloon cell nevus,ICDO3_2nd
8722/3,Balloon cell melanoma,ICDO3_2nd
8723/0,Halo nevus,ICDO3_2nd
8723/0,Regressing nevus,ICDO3_2nd
8723/3,"Malignant melanoma, regressing",ICDO3_2nd
8725/0,Neuronevus,ICDO3_2nd
8726/0,Magnocellular nevus,ICDO3_2nd
8726/0,"Melanocytoma, eyeball",ICDO3_2nd
8726/0,"Melanocytoma, NOS",ICDO3_2nd
8727/0,Dysplastic nevus,ICDO3_2nd
8728/0,Meningeal melanocytosis,ICDO3_2nd
8728/0,Diffuse melanocytosis,ICDO3_2nd
8728/1,Meningeal melanocytoma,ICDO3_2nd
8728/3,Meningeal melanomatosis,ICDO3_2nd
8730/0,Nonpigmented nevus,ICDO3_2nd
8730/0,Achromic nevus,ICDO3_2nd
8730/3,Amelanotic melanoma,ICDO3_2nd
8740/0,"Junctional nevus, NOS",ICDO3_2nd
8740/0,Intraepidermal nevus,ICDO3_2nd
8740/0,Junction nevus,ICDO3_2nd
8740/3,Malignant melanoma in junctional nevus,ICDO3_2nd
8741/2,"Precancerous melanosis, NOS",ICDO3_2nd
8741/3,Malignant melanoma in precancerous melanosis,ICDO3_2nd
8742/0,Lentiginous melanocytic nevus,ICDO3_2nd
8742/0,Simple lentigo,ICDO3_2nd
8742/0,Lentigo simplex,ICDO3_2nd
8742/2,Lentigo maligna,ICDO3_2nd
8742/2,"Hutchinson melanotic freckle, NOS",ICDO3_2nd
8742/3,Lentigo maligna melanoma,ICDO3_2nd
8742/3,Malignant melanoma in Hutchinson melanotic freckle,ICDO3_2nd
8743/3,Low cumulative sun damage melanoma,ICDO3_2nd
8743/3,Superficial spreading melanoma,ICDO3_2nd
8744/0,Acral nevus,ICDO3_2nd
8744/3,Acral melanoma,ICDO3_2nd
8744/3,"Acral lentiginous melanoma, malignant",ICDO3_2nd
8745/3,"Desmoplastic melanoma, NOS",ICDO3_2nd
8745/3,"Desmoplastic melanoma, amelanotic",ICDO3_2nd
8745/3,"Neurotropic melanoma, malignant",ICDO3_2nd
8746/3,Mucosal lentiginous melanoma,ICDO3_2nd
8750/0,Dermal nevus,ICDO3_2nd
8750/0,Intradermal nevus,ICDO3_2nd
8750/0,Stromal nevus,ICDO3_2nd
8760/0,Compound nevus,ICDO3_2nd
8760/0,Dermal and epidermal nevus,ICDO3_2nd
8761/0,"Congenital melanocytic nevus, NOS",ICDO3_2nd
8761/1,"Giant pigmented nevus, NOS",ICDO3_2nd
8761/1,Intermediate and giant congenital nevus,ICDO3_2nd
8761/3,Malignant melanoma arising in giant congenital nevus,ICDO3_2nd
8761/3,Malignant melanoma in giant pigmented nevus,ICDO3_2nd
8761/3,Malignant melanoma in congenital melanocytic nevus,ICDO3_2nd
8762/1,Proliferative dermal lesion in congenital nevus,ICDO3_2nd
8762/1,Proliferative nodule in congenital melanocytic nevus,ICDO3_2nd
8770/0,Epithelioid and spindle cell nevus,ICDO3_2nd
8770/0,Juvenile melanoma,ICDO3_2nd
8770/0,Juvenile nevus,ICDO3_2nd
8770/0,"Spitz nevus, NOS",ICDO3_2nd
8770/0,"Spitz nevus, atypical",ICDO3_2nd
8770/0,Pigmented spindle cell nevus of Reed,ICDO3_2nd
8770/0,Pigmented spindle cell Spitz nevus,ICDO3_2nd
8770/3,Malignant Spitz tumor,ICDO3_2nd
8770/3,Mixed epithelioid and spindle cell melanoma,ICDO3_2nd
8770/3,Spitz melanoma,ICDO3_2nd
8770/3,Spitzoid melanoma,ICDO3_2nd
8771/0,Epithelioid cell nevus,ICDO3_2nd
8771/3,Epithelioid cell melanoma,ICDO3_2nd
8772/0,"Spindle cell nevus, NOS",ICDO3_2nd
8772/3,"Spindle cell melanoma, NOS",ICDO3_2nd
8773/3,"Spindle cell melanoma, type A",ICDO3_2nd
8774/3,"Spindle cell melanoma, type B",ICDO3_2nd
8780/0,"Blue nevus, NOS",ICDO3_2nd
8780/0,Jadassohn blue nevus,ICDO3_2nd
8780/1,Pigmented epithelioid melanocytoma,ICDO3_2nd
8780/1,"Blue nevus, epithelioid",ICDO3_2nd
8780/3,"Blue nevus, malignant",ICDO3_2nd
8780/3,Melanoma arising in blue nevus,ICDO3_2nd
8790/0,Cellular blue nevus,ICDO3_2nd
8800/0,"Soft tissue tumor, benign",ICDO3_2nd
8800/3,"Sarcoma, NOS",ICDO3_2nd
8800/3,"Mesenchymal tumor, malignant",ICDO3_2nd
8800/3,Soft tissue sarcoma,ICDO3_2nd
8800/3,"Soft tissue tumor, malignant",ICDO3_2nd
8800/9,"Sarcomatosis, NOS",ICDO3_2nd
8801/3,Spindle cell sarcoma,ICDO3_2nd
8801/3,"Spindle cell sarcoma, undifferentiated",ICDO3_2nd
8802/1,Pleomorphic hyalinizing angiectatic tumor,ICDO3_2nd
8802/3,Giant cell sarcoma,ICDO3_2nd
8802/3,"Pleomorphic cell sarcoma, NOS",ICDO3_2nd
8802/3,"Pleomorphic cell sarcoma, undifferentiated",ICDO3_2nd
8802/3,Pleomorphic sarcoma,ICDO3_2nd
8802/3,Pleomorphic dermal sarcoma,ICDO3_2nd
8803/3,Small cell sarcoma,ICDO3_2nd
8803/3,"Round cell sarcoma, NOS",ICDO3_2nd
8803/3,"Round cell sarcoma, undifferentiated",ICDO3_2nd
8804/3,"Epithelioid sarcoma, NOS",ICDO3_2nd
8804/3,Epithelioid cell sarcoma,ICDO3_2nd
8804/3,"Epithelioid sarcoma, undifferentiated",ICDO3_2nd
8805/3,Undifferentiated sarcoma,ICDO3_2nd
8806/3,Desmoplastic small round cell tumor,ICDO3_2nd
8810/0,"Fibroma, NOS",ICDO3_2nd
8810/0,Desmoplastic fibroblastoma,ICDO3_2nd
8810/0,Gardner fibroma,ICDO3_2nd
8810/0,Nuchal fibroma,ICDO3_2nd
8810/0,Collagenous fibroma,ICDO3_2nd
8810/0,Plaque-like CD34 positive dermal fibroma,ICDO3_2nd
8810/1,Cellular fibroma,ICDO3_2nd
8810/3,"Fibrosarcoma, NOS",ICDO3_2nd
8811/0,"Fibromyxoma, NOS",ICDO3_2nd
8811/0,"Myxofibroma, NOS",ICDO3_2nd
8811/0,Myxoid fibroma,ICDO3_2nd
8811/0,Plexiform fibromyxoma,ICDO3_2nd
8811/0,Acral fibromyxoma,ICDO3_2nd
8811/1,Myxoinflammatory fibroblastic sarcoma,ICDO3_2nd
8811/1,Atypical myxoinflammatory fibroblastic tumor,ICDO3_2nd
8811/1,Hemosiderotic fibrolipomatous tumor,ICDO3_2nd
8811/3,Myxofibrosarcoma,ICDO3_2nd
8811/3,Fibromyxosarcoma,ICDO3_2nd
8812/0,Periosteal fibroma,ICDO3_2nd
8812/3,Periosteal fibrosarcoma,ICDO3_2nd
8812/3,"Periosteal sarcoma, NOS",ICDO3_2nd
8813/0,Fibroma of tendon sheath,ICDO3_2nd
8813/0,Fascial fibroma,ICDO3_2nd
8813/1,Palmar/plantar type fibromatosis,ICDO3_2nd
8813/1,Superficial fibromatosis,ICDO3_2nd
8813/3,Fascial fibrosarcoma,ICDO3_2nd
8814/3,Infantile fibrosarcoma,ICDO3_2nd
8814/3,Congenital fibrosarcoma,ICDO3_2nd
8815/0,"Solitary fibrous tumor/Hemangiopericytoma, grade 1",ICDO3_2nd
8815/0,"Hemangiopericytoma, benign",ICDO3_2nd
8815/1,"Solitary fibrous tumor, NOS",ICDO3_2nd
8815/1,"Hemangiopericytoma, NOS",ICDO3_2nd
8815/1,Localized fibrous tumor,ICDO3_2nd
8815/1,"Solitary fibrous tumor/Hemangiopericytoma, grade 2",ICDO3_2nd
8815/1,Hemangiopericytic meningioma,ICDO3_2nd
8815/3,"Solitary fibrous tumor, malignant",ICDO3_2nd
8815/3,"Solitary fibrous tumor/Hemangiopericytoma, grade 3",ICDO3_2nd
8815/3,"Hemangiopericytoma, malignant",ICDO3_2nd
8816/0,Calcifying aponeurotic fibroma,ICDO3_2nd
8817/0,Calcifying fibrous tumor,ICDO3_2nd
8818/0,Fibrous dysplasia,ICDO3_2nd
8820/0,Elastofibroma,ICDO3_2nd
8821/1,Aggressive fibromatosis,ICDO3_2nd
8821/1,Desmoid type fibromatosis,ICDO3_2nd
8821/1,"Desmoid, NOS",ICDO3_2nd
8821/1,"Desmoid tumor, NOS",ICDO3_2nd
8821/1,Extra-abdominal desmoid,ICDO3_2nd
8821/1,Invasive fibroma,ICDO3_2nd
8822/1,Abdominal fibromatosis,ICDO3_2nd
8822/1,Abdominal desmoid,ICDO3_2nd
8822/1,Mesenteric fibromatosis,ICDO3_2nd
8822/1,Retroperitoneal fibromatosis,ICDO3_2nd
8823/0,Sclerotic fibroma,ICDO3_2nd
8823/1,Desmoplastic fibroma,ICDO3_2nd
8824/0,Myofibroma,ICDO3_2nd
8824/0,Dermatomyofibroma,ICDO3_2nd
8824/0,Myopericytoma,ICDO3_2nd
8824/1,Myofibromatosis,ICDO3_2nd
8824/1,Congenital generalized fibromatosis,ICDO3_2nd
8824/1,Infantile myofibromatosis,ICDO3_2nd
8825/0,Myofibroblastoma,ICDO3_2nd
8825/1,"Myofibroblastic tumor, NOS",ICDO3_2nd
8825/1,Inflammatory myofibroblastic tumor,ICDO3_2nd
8825/3,Myofibroblastic sarcoma,ICDO3_2nd
8826/0,Angiomyofibroblastoma,ICDO3_2nd
8827/1,"Myofibroblastic tumor, peribronchial",ICDO3_2nd
8827/1,Congenital peribronchial myofibroblastic tumor,ICDO3_2nd
8828/0,Nodular fasciitis,ICDO3_2nd
8828/0,Proliferative fasciitis,ICDO3_2nd
8828/0,Proliferative myositis,ICDO3_2nd
8830/0,"Benign fibrous histiocytoma, NOS",ICDO3_2nd
8830/0,"Fibrous histiocytoma, NOS",ICDO3_2nd
8830/0,"Fibroxanthoma, NOS",ICDO3_2nd
8830/0,Xanthofibroma,ICDO3_2nd
8830/0,Epithelioid fibrous histiocytoma,ICDO3_2nd
8830/1,Atypical fibrous histiocytoma,ICDO3_2nd
8830/1,Atypical fibroxanthoma,ICDO3_2nd
8830/3,Malignant fibrous histiocytoma,ICDO3_2nd
8830/3,Undifferentiated high grade pleomorphic sarcoma of bone,ICDO3_2nd
8830/3,"Fibroxanthoma, malignant",ICDO3_2nd
8831/0,"Histiocytoma, NOS",ICDO3_2nd
8831/0,Deep histiocytoma,ICDO3_2nd
8831/0,Deep benign fibrous histiocytoma,ICDO3_2nd
8831/0,Juvenile histiocytoma,ICDO3_2nd
8831/0,Reticulohistiocytoma,ICDO3_2nd
8831/0,Reticulohistocytosis,ICDO3_2nd
8832/0,"Dermatofibroma, NOS",ICDO3_2nd
8832/0,"Cutaneous histiocytoma, NOS",ICDO3_2nd
8832/0,Dermatofibroma lenticulare,ICDO3_2nd
8832/0,Sclerosing hemangioma,ICDO3_2nd
8832/0,Subepidermal nodular fibrosis,ICDO3_2nd
8832/0,Sclerosing pneumocytoma,ICDO3_2nd
8832/0,Pleomorphic fibroma,ICDO3_2nd
8832/1,"Dermatofibrosarcoma protuberans, NOS",ICDO3_2nd
8832/1,"Dermatofibrosarcoma, NOS",ICDO3_2nd
8832/3,"Dermatofibrosarcoma protuberans, fibrosarcomatous",ICDO3_2nd
8832/3,"Dermatofibrosarcoma, sarcomatous",ICDO3_2nd
8833/1,Pigmented dermatofibrosarcoma protuberans,ICDO3_2nd
8833/1,Bednar tumor,ICDO3_2nd
8834/1,Giant cell fibroblastoma,ICDO3_2nd
8835/1,Plexiform fibrohistiocytic tumor,ICDO3_2nd
8836/1,Angiomatoid fibrous histiocytoma,ICDO3_2nd
8840/0,"Myxoma, NOS",ICDO3_2nd
8840/3,Myxosarcoma,ICDO3_2nd
8840/3,Low grade fibromyxoid sarcoma,ICDO3_2nd
8840/3,Sclerosing epithelioid fibrosarcoma,ICDO3_2nd
8841/0,"Angiomyxoma, NOS",ICDO3_2nd
8841/0,Aggressive angiomyxoma,ICDO3_2nd
8841/0,Superficial angiomyxoma,ICDO3_2nd
8842/0,"Ossifying fibromyxoid tumor, NOS",ICDO3_2nd
8842/3,"Ossifying fibromyxoid tumor, malignant",ICDO3_2nd
8842/3,Pulmonary myxoid sarcoma with EWSR1-CREB1 translocation,ICDO3_2nd
8850/0,"Lipoma, NOS",ICDO3_2nd
8850/0,Thymolipoma,ICDO3_2nd
8850/1,Atypical lipomatous tumor,ICDO3_2nd
8850/1,Atypical lipoma,ICDO3_2nd
8850/1,"Liposarcoma, well differentiated, superficial",ICDO3_2nd
8850/3,"Liposarcoma, NOS",ICDO3_2nd
8850/3,Fibroliposarcoma,ICDO3_2nd
8851/0,Fibrolipoma,ICDO3_2nd
8851/1,Lipofibromatosis,ICDO3_2nd
8851/3,"Liposarcoma, well differentiated, NOS",ICDO3_2nd
8851/3,Lipoma-like liposarcoma,ICDO3_2nd
8851/3,"Liposarcoma, differentiated",ICDO3_2nd
8851/3,Inflammatory liposarcoma,ICDO3_2nd
8851/3,Sclerosing liposarcoma,ICDO3_2nd
8852/0,Fibromyxolipoma,ICDO3_2nd
8852/0,Myxolipoma,ICDO3_2nd
8852/3,Myxoid liposarcoma,ICDO3_2nd
8852/3,Myxoliposarcoma,ICDO3_2nd
8853/3,Round cell liposarcoma,ICDO3_2nd
8854/0,Pleomorphic lipoma,ICDO3_2nd
8854/3,Pleomorphic liposarcoma,ICDO3_2nd
8855/3,Mixed liposarcoma,ICDO3_2nd
8856/0,Intramuscular lipoma,ICDO3_2nd
8856/0,Infiltrating angiolipoma,ICDO3_2nd
8856/0,Infiltrating lipoma,ICDO3_2nd
8857/0,Spindle cell lipoma,ICDO3_2nd
8857/3,Fibroblastic liposarcoma,ICDO3_2nd
8858/3,Dedifferentiated liposarcoma,ICDO3_2nd
8860/0,Angiomyolipoma,ICDO3_2nd
8860/1,"Angiomyolipoma, epithelioid",ICDO3_2nd
8861/0,"Angiolipoma, NOS",ICDO3_2nd
8862/0,Chondroid lipoma,ICDO3_2nd
8870/0,Myelolipoma,ICDO3_2nd
8880/0,Hibernoma,ICDO3_2nd
8880/0,Brown fat tumor,ICDO3_2nd
8880/0,Fetal fat cell lipoma,ICDO3_2nd
8881/0,Lipoblastomatosis,ICDO3_2nd
8881/0,"Fetal lipoma, NOS",ICDO3_2nd
8881/0,Fetal lipomatosis,ICDO3_2nd
8881/0,Lipoblastoma,ICDO3_2nd
8890/0,"Leiomyoma, NOS",ICDO3_2nd
8890/0,Fibroid uterus,ICDO3_2nd
8890/0,Fibromyoma,ICDO3_2nd
8890/0,Leiomyofibroma,ICDO3_2nd
8890/0,Lipoleiomyoma,ICDO3_2nd
8890/0,Lipomatous leiomyoma,ICDO3_2nd
8890/0,Plexiform leiomyoma,ICDO3_2nd
8890/0,"Leiomyoma, apoplectic",ICDO3_2nd
8890/0,"Leiomyoma, hydropic",ICDO3_2nd
8890/0,Myolipoma,ICDO3_2nd
8890/0,Cotyledonoid leiomyoma,ICDO3_2nd
8890/0,Dissecting leiomyoma,ICDO3_2nd
8890/1,"Leiomyomatosis, NOS",ICDO3_2nd
8890/1,"Leiomyomatosis, peritonealis disseminata",ICDO3_2nd
8890/1,Intravascular leiomyomatosis,ICDO3_2nd
8890/1,Intravenous leiomyomatosis,ICDO3_2nd
8890/3,"Leiomyosarcoma, NOS",ICDO3_2nd
8891/0,Epithelioid leiomyoma,ICDO3_2nd
8891/0,Leiomyoblastoma,ICDO3_2nd
8891/3,Epithelioid leiomyosarcoma,ICDO3_2nd
8892/0,Cellular leiomyoma,ICDO3_2nd
8893/0,Bizarre leiomyoma,ICDO3_2nd
8893/0,Atypical leiomyoma,ICDO3_2nd
8893/0,Pleomorphic leiomyoma,ICDO3_2nd
8893/0,Symplastic leiomyoma,ICDO3_2nd
8894/0,Angioleiomyoma,ICDO3_2nd
8894/0,Angiomyoma,ICDO3_2nd
8894/0,Vascular leiomyoma,ICDO3_2nd
8894/3,Angiomyosarcoma,ICDO3_2nd
8895/0,Myoma,ICDO3_2nd
8895/3,Myosarcoma,ICDO3_2nd
8896/0,Myxoid leiomyoma,ICDO3_2nd
8896/3,Myxoid leiomyosarcoma,ICDO3_2nd
8897/1,Smooth muscle tumor of uncertain malignant potential,ICDO3_2nd
8897/1,"Smooth muscle tumor, atypical",ICDO3_2nd
8897/1,"Smooth muscle tumor, NOS",ICDO3_2nd
8897/1,"Leiomyosarcoma, cutaneous",ICDO3_2nd
8898/1,Metastasizing leiomyoma,ICDO3_2nd
8900/0,"Rhabdomyoma, NOS",ICDO3_2nd
8900/3,"Rhabdomyosarcoma, NOS",ICDO3_2nd
8900/3,Rhabdosarcoma,ICDO3_2nd
8901/3,"Pleomorphic rhabdomyosarcoma, adult type",ICDO3_2nd
8901/3,"Pleomorphic rhabdomyosarcoma, NOS",ICDO3_2nd
8901/3,"Rhabdomyosarcoma, pleomorphic type",ICDO3_2nd
8902/3,Mixed type rhabdomyosarcoma,ICDO3_2nd
8902/3,Mixed embryonal rhabdomyosarcoma and alveolar rhabdomyosarcoma,ICDO3_2nd
8903/0,Fetal rhabdomyoma,ICDO3_2nd
8904/0,Adult cellular rhabdomyoma,ICDO3_2nd
8904/0,Adult rhabdomyoma,ICDO3_2nd
8904/0,Glycogenic rhabdomyoma,ICDO3_2nd
8905/0,Genital rhabdomyoma,ICDO3_2nd
8910/3,"Embryonal rhabdomyosarcoma, NOS",ICDO3_2nd
8910/3,"Rhabdomyosarcoma, embryonal type",ICDO3_2nd
8910/3,"Embryonal rhabdomyosarcoma, pleomorphic",ICDO3_2nd
8910/3,Sarcoma botryoides,ICDO3_2nd
8910/3,Botryoid sarcoma,ICDO3_2nd
8912/3,Spindle cell rhabdomyosarcoma,ICDO3_2nd
8912/3,Sclerosing rhabdomyosarcoma,ICDO3_2nd
8912/3,"Rhabdomyosarcoma, spindle cell/sclerosing type",ICDO3_2nd
8920/3,Alveolar rhabdomyosarcoma,ICDO3_2nd
8921/3,Ectomesenchymoma,ICDO3_2nd
8921/3,Rhabdomyosarcoma with ganglionic differentiation,ICDO3_2nd
8930/0,Endometrial stromal nodule,ICDO3_2nd
8930/3,"Endometrial stromal sarcoma, NOS",ICDO3_2nd
8930/3,"Endometrial sarcoma, NOS",ICDO3_2nd
8930/3,"Endometrial stromal sarcoma, high grade",ICDO3_2nd
8930/3,"Endometrioid stromal sarcoma, high grade",ICDO3_2nd
8931/3,"Endometrial stromal sarcoma, low grade",ICDO3_2nd
8931/3,Endolymphatic stromal myosis,ICDO3_2nd
8931/3,"Endometrioid stromal sarcoma, low grade",ICDO3_2nd
8931/3,Endometrial stromatosis,ICDO3_2nd
8931/3,Stromal endometriosis,ICDO3_2nd
8931/3,"Stromal myosis, NOS",ICDO3_2nd
8932/0,"Adenomyoma, NOS",ICDO3_2nd
8932/0,Atypical polypoid adenomyoma,ICDO3_2nd
8933/3,Adenosarcoma,ICDO3_2nd
8934/3,Carcinofibroma,ICDO3_2nd
8935/0,"Stromal tumor, benign",ICDO3_2nd
8935/1,"Stromal tumor, NOS",ICDO3_2nd
8935/1,Metanephric stromal tumor,ICDO3_2nd
8935/1,Stromal tumor of uncertain malignant potential,ICDO3_2nd
8935/3,"Stromal sarcoma, NOS",ICDO3_2nd
8936/3,Gastrointestinal stromal tumor,ICDO3_2nd
8936/3,GIST,ICDO3_2nd
8936/3,Gastrointestinal autonomic nerve tumor,ICDO3_2nd
8936/3,GANT,ICDO3_2nd
8936/3,Gastrointestinal pacemaker cell tumor,ICDO3_2nd
8936/3,Gastrointestinal stromal sarcoma,ICDO3_2nd
8940/0,Pleomorphic adenoma,ICDO3_2nd
8940/0,"Mixed tumor, NOS",ICDO3_2nd
8940/0,"Mixed tumor, salivary gland type, NOS",ICDO3_2nd
8940/0,"Chondroid syringoma, NOS",ICDO3_2nd
8940/3,"Mixed tumor, malignant, NOS",ICDO3_2nd
8940/3,"Mixed tumor, salivary gland type, malignant",ICDO3_2nd
8940/3,Malignant chondroid syringoma,ICDO3_2nd
8941/3,Carcinoma ex pleomorphic adenoma,ICDO3_2nd
8941/3,Carcinoma in pleomorphic adenoma,ICDO3_2nd
8950/3,Mullerian mixed tumor,ICDO3_2nd
8951/3,Mesodermal mixed tumor,ICDO3_2nd
8959/0,Benign cystic nephroma,ICDO3_2nd
8959/0,Mixed epithelial and stromal tumor,ICDO3_2nd
8959/0,Pediatric cystic nephroma,ICDO3_2nd
8959/0,Adult cystic nephroma,ICDO3_2nd
8959/1,Cystic partially differentiated nephroblastoma,ICDO3_2nd
8959/3,Malignant cystic nephroma,ICDO3_2nd
8959/3,Malignant multilocular cystic nephroma,ICDO3_2nd
8960/1,Mesoblastic nephroma,ICDO3_2nd
8960/3,"Nephroblastoma, NOS",ICDO3_2nd
8960/3,"Nephroma, NOS",ICDO3_2nd
8960/3,Wilms tumor,ICDO3_2nd
8963/3,"Rhabdoid tumor, NOS",ICDO3_2nd
8963/3,Malignant rhabdoid tumor,ICDO3_2nd
8963/3,Rhabdoid sarcoma,ICDO3_2nd
8964/3,Clear cell sarcoma of kidney,ICDO3_2nd
8966/0,Renomedullary interstitial cell tumor,ICDO3_2nd
8966/0,Renomedullary fibroma,ICDO3_2nd
8966/0,Medullary fibroma,ICDO3_2nd
8967/0,Ossifying renal tumor,ICDO3_2nd
8970/3,"Hepatoblastoma, NOS",ICDO3_2nd
8970/3,Embryonal hepatoma,ICDO3_2nd
8970/3,"Hepatoblastoma, epithelioid",ICDO3_2nd
8970/3,"Hepatoblastoma, mixed epithelial-mesenchymal",ICDO3_2nd
8971/3,Pancreatoblastoma,ICDO3_2nd
8972/3,Pulmonary blastoma,ICDO3_2nd
8972/3,Pneumoblastoma,ICDO3_2nd
8973/3,Pleuropulmonary blastoma,ICDO3_2nd
8974/1,Sialoblastoma,ICDO3_2nd
8975/1,Calcifying nested stromal-epithelial tumor,ICDO3_2nd
8980/3,"Carcinosarcoma, NOS",ICDO3_2nd
8981/3,"Carcinosarcoma, embryonal",ICDO3_2nd
8982/0,"Myoepithelioma, NOS",ICDO3_2nd
8982/0,Myoepithelial adenoma,ICDO3_2nd
8982/0,Myoepithelial tumor,ICDO3_2nd
8982/0,Ectomesenchymal chondromyxoid tumor,ICDO3_2nd
8982/3,Myoepithelial carcinoma,ICDO3_2nd
8982/3,Malignant myoepithelioma,ICDO3_2nd
8982/3,"Myoepithelioma, infiltrating",ICDO3_2nd
8983/0,"Adenomyoepithelioma, NOS",ICDO3_2nd
8983/0,"Adenomyoepithelioma, benign",ICDO3_2nd
8983/3,Adenomyoepithelioma with carcinoma,ICDO3_2nd
8983/3,Malignant adenomyoepithelioma,ICDO3_2nd
8990/0,"Mesenchymoma, benign",ICDO3_2nd
8990/0,"Phosphaturic mesenchymal tumor, benign",ICDO3_2nd
8990/0,"Phosphaturic mesenchymal tumor, NOS",ICDO3_2nd
8990/1,"Mesenchymoma, NOS",ICDO3_2nd
8990/1,Mixed mesenchymal tumor,ICDO3_2nd
8990/1,Primitive non-neural granular cell tumor,ICDO3_2nd
8990/3,"Mesenchymoma, malignant",ICDO3_2nd
8990/3,Mixed mesenchymal sarcoma,ICDO3_2nd
8990/3,"Phosphaturic mesenchymal tumor, malignant",ICDO3_2nd
8991/3,Embryonal sarcoma,ICDO3_2nd
8992/0,Pulmonary hamartoma,ICDO3_2nd
9000/0,"Brenner tumor, NOS",ICDO3_2nd
9000/1,"Brenner tumor, borderline malignancy",ICDO3_2nd
9000/1,Borderline Brenner tumor,ICDO3_2nd
9000/1,"Brenner tumor, atypical proliferative",ICDO3_2nd
9000/1,"Brenner tumor, proliferating",ICDO3_2nd
9000/3,"Brenner tumor, malignant",ICDO3_2nd
9010/0,"Fibroadenoma, NOS",ICDO3_2nd
9010/0,Lipofibroadenoma,ICDO3_2nd
9011/0,Intracanalicular fibroadenoma,ICDO3_2nd
9012/0,Pericanalicular fibroadenoma,ICDO3_2nd
9013/0,"Adenofibroma, NOS",ICDO3_2nd
9013/0,Metanephric adenofibroma,ICDO3_2nd
9013/0,Nephrogenic adenofibroma,ICDO3_2nd
9013/0,"Cystadenofibroma, NOS",ICDO3_2nd
9013/0,Papillary adenofibroma,ICDO3_2nd
9014/0,"Serous adenofibroma, NOS",ICDO3_2nd
9014/0,"Serous cystadenofibroma, NOS",ICDO3_2nd
9014/0,Seromucinous adenofibroma,ICDO3_2nd
9014/1,Serous adenofibroma of borderline malignancy,ICDO3_2nd
9014/1,Serous cystadenofibroma of borderline malignancy,ICDO3_2nd
9014/3,Serous adenocarcinofibroma,ICDO3_2nd
9014/3,Malignant serous adenofibroma,ICDO3_2nd
9014/3,Serous cystadenocarcinofibroma,ICDO3_2nd
9014/3,Malignant serous cystadenofibroma,ICDO3_2nd
9015/0,"Mucinous adenofibroma, NOS",ICDO3_2nd
9015/0,"Mucinous cystadenofibroma, NOS",ICDO3_2nd
9015/1,Mucinous adenofibroma of borderline malignancy,ICDO3_2nd
9015/1,Mucinous cystadenofibroma of borderline malignancy,ICDO3_2nd
9015/3,Mucinous adenocarcinofibroma,ICDO3_2nd
9015/3,Malignant mucinous adenofibroma,ICDO3_2nd
9015/3,Mucinous cystadenocarcinofibroma,ICDO3_2nd
9015/3,Malignant mucinous cystadenofibroma,ICDO3_2nd
9016/0,Giant fibroadenoma,ICDO3_2nd
9020/0,"Phyllodes tumor, benign",ICDO3_2nd
9020/0,"Cystosarcoma phyllodes, benign",ICDO3_2nd
9020/1,"Phyllodes tumor, borderline",ICDO3_2nd
9020/1,"Cystosarcoma phyllodes, NOS",ICDO3_2nd
9020/1,"Phyllodes tumor, NOS",ICDO3_2nd
9020/3,"Phyllodes tumor, malignant",ICDO3_2nd
9020/3,"Cystosarcoma phyllodes, malignant",ICDO3_2nd
9020/3,"Periductal stromal tumor, low grade",ICDO3_2nd
9030/0,Juvenile fibroadenoma,ICDO3_2nd
9040/0,"Synovioma, benign",ICDO3_2nd
9040/3,"Synovial sarcoma, NOS",ICDO3_2nd
9040/3,"Synovioma, NOS",ICDO3_2nd
9040/3,"Synovioma, malignant",ICDO3_2nd
9041/3,"Synovial sarcoma, spindle cell",ICDO3_2nd
9041/3,"Synovial sarcoma, monophasic fibrous",ICDO3_2nd
9042/3,"Synovial sarcoma, epithelioid cell",ICDO3_2nd
9043/3,"Synovial sarcoma, biphasic",ICDO3_2nd
9044/3,"Clear cell sarcoma, NOS",ICDO3_2nd
9044/3,Malignant melanoma of soft parts,ICDO3_2nd
9045/3,Biphenotypic sinonasal sarcoma,ICDO3_2nd
9050/0,"Mesothelioma, benign",ICDO3_2nd
9050/3,"Mesothelioma, malignant",ICDO3_2nd
9050/3,"Mesothelioma, NOS",ICDO3_2nd
9051/0,"Fibrous mesothelioma, benign",ICDO3_2nd
9051/3,"Fibrous mesothelioma, malignant",ICDO3_2nd
9051/3,"Fibrous mesothelioma, NOS",ICDO3_2nd
9051/3,Desmoplastic mesothelioma,ICDO3_2nd
9051/3,Sarcomatoid mesothelioma,ICDO3_2nd
9051/3,Spindled mesothelioma,ICDO3_2nd
9052/0,"Epithelioid mesothelioma, benign",ICDO3_2nd
9052/0,Well differentiated papillary mesothelioma,ICDO3_2nd
9052/0,Mesothelial papilloma,ICDO3_2nd
9052/1,Well differentiated papillary mesothelioma of pleura,ICDO3_2nd
9052/3,"Epithelioid mesothelioma, malignant",ICDO3_2nd
9052/3,"Epithelioid mesothelioma, NOS",ICDO3_2nd
9053/3,"Mesothelioma, biphasic, malignant",ICDO3_2nd
9053/3,"Mesothelioma, biphasic, NOS",ICDO3_2nd
9054/0,"Adenomatoid tumor, NOS",ICDO3_2nd
9055/0,Peritoneal inclusion cysts,ICDO3_2nd
9055/0,Cystic mesothelioma,ICDO3_2nd
9055/0,Multicystic mesothelioma,ICDO3_2nd
9060/3,Dysgerminoma,ICDO3_2nd
9061/3,"Seminoma, NOS",ICDO3_2nd
9062/3,"Seminoma, anaplastic",ICDO3_2nd
9062/3,Seminoma with high mitotic index,ICDO3_2nd
9063/3,Spermatocytic seminoma,ICDO3_2nd
9063/3,Spermatocytoma,ICDO3_2nd
9063/3,Spermatocytic tumor,ICDO3_2nd
9064/2,Intratubular malignant germ cells,ICDO3_2nd
9064/2,Intratubular germ cell neoplasia,ICDO3_2nd
9064/2,Germ cell neoplasia in situ,ICDO3_2nd
9064/3,Germinoma,ICDO3_2nd
9064/3,"Germ cell tumor, NOS",ICDO3_2nd
9065/3,"Germ cell tumor, nonseminomatous",ICDO3_2nd
9070/3,"Embryonal carcinoma, NOS",ICDO3_2nd
9070/3,Embryonal adenocarcinoma,ICDO3_2nd
9071/3,"Yolk sac tumor, NOS",ICDO3_2nd
9071/3,"Embryonal carcinoma, infantile",ICDO3_2nd
9071/3,"Yolk sac tumor, pre-pubertal type",ICDO3_2nd
9071/3,Endodermal sinus tumor,ICDO3_2nd
9071/3,Orchioblastoma,ICDO3_2nd
9071/3,Polyvesicular vitelline tumor,ICDO3_2nd
9071/3,Hepatoid yolk sac tumor,ICDO3_2nd
9071/3,"Yolk sac tumor, post-pubertal type",ICDO3_2nd
9072/3,Polyembryoma,ICDO3_2nd
9072/3,"Embryonal carcinoma, polyembryonal type",ICDO3_2nd
9073/1,Gonadoblastoma,ICDO3_2nd
9073/1,Gonocytoma,ICDO3_2nd
9080/0,"Teratoma, benign",ICDO3_2nd
9080/0,"Adult teratoma, NOS",ICDO3_2nd
9080/0,"Cystic teratoma, NOS",ICDO3_2nd
9080/0,Adult cystic teratoma,ICDO3_2nd
9080/0,"Mature teratoma, NOS",ICDO3_2nd
9080/0,"Teratoma, differentiated",ICDO3_2nd
9080/1,"Teratoma, NOS",ICDO3_2nd
9080/1,Solid teratoma,ICDO3_2nd
9080/1,"Germ cell tumor, regressed",ICDO3_2nd
9080/1,Immature teratoma of lung,ICDO3_2nd
9080/1,Immature teratoma of thymus,ICDO3_2nd
9080/1,Immature teratoma of thyroid,ICDO3_2nd
9080/3,"Teratoma, malignant, NOS",ICDO3_2nd
9080/3,Embryonal teratoma,ICDO3_2nd
9080/3,"Teratoblastoma, malignant",ICDO3_2nd
9080/3,"Immature teratoma, malignant",ICDO3_2nd
9080/3,"Immature teratoma, NOS",ICDO3_2nd
9081/3,Teratocarcinoma,ICDO3_2nd
9081/3,Mixed embryonal carcinoma and teratoma,ICDO3_2nd
9081/3,Teratocarcinosarcoma,ICDO3_2nd
9082/3,"Malignant teratoma, undifferentiated",ICDO3_2nd
9082/3,"Malignant teratoma, anaplastic",ICDO3_2nd
9083/3,"Malignant teratoma, intermediate",ICDO3_2nd
9084/0,"Dermoid cyst, NOS",ICDO3_2nd
9084/0,"Dermoid, NOS",ICDO3_2nd
9084/0,"Teratoma, prepubertal type",ICDO3_2nd
9084/0,"Teratoma, mature, prepubertal type",ICDO3_2nd
9084/3,Teratoma with malignant transformation,ICDO3_2nd
9084/3,Teratoma with somatic type malignancies,ICDO3_2nd
9084/3,Dermoid cyst with malignant transformation,ICDO3_2nd
9084/3,Dermoid cyst with secondary tumor,ICDO3_2nd
9085/3,Mixed germ cell tumor,ICDO3_2nd
9085/3,Mixed teratoma and seminoma,ICDO3_2nd
9086/3,Germ cell tumor with associated hematological malignancy,ICDO3_2nd
9090/0,"Struma ovarii, NOS",ICDO3_2nd
9090/3,"Struma ovarii, malignant",ICDO3_2nd
9091/1,Strumal carcinoid,ICDO3_2nd
9091/1,Struma ovarii and carcinoid,ICDO3_2nd
9100/0,"Hydatidiform mole, NOS",ICDO3_2nd
9100/0,Complete hydatidiform mole,ICDO3_2nd
9100/0,Hydatid mole,ICDO3_2nd
9100/1,Invasive hydatidiform mole,ICDO3_2nd
9100/1,"Invasive mole, NOS",ICDO3_2nd
9100/1,"Chorioadenoma, NOS",ICDO3_2nd
9100/1,Chorioadenoma destruens,ICDO3_2nd
9100/1,Malignant hydatidiform mole,ICDO3_2nd
9100/3,"Choriocarcinoma, NOS",ICDO3_2nd
9100/3,Chorioepithelioma,ICDO3_2nd
9100/3,Chorionepithelioma,ICDO3_2nd
9101/3,Choriocarcinoma combined with other germ cell elements,ICDO3_2nd
9101/3,Choriocarcinoma combined with embryonal carcinoma,ICDO3_2nd
9101/3,Choriocarcinoma combined with teratoma,ICDO3_2nd
9102/3,"Malignant teratoma, trophoblastic",ICDO3_2nd
9103/0,Partial hydatidiform mole,ICDO3_2nd
9104/1,Placental site trophoblastic tumor,ICDO3_2nd
9105/3,"Trophoblastic tumor, epithelioid",ICDO3_2nd
9110/0,Adenoma of rete ovarii,ICDO3_2nd
9110/0,"Mesonephroma, benign",ICDO3_2nd
9110/0,Mesonephric adenoma,ICDO3_2nd
9110/0,Wolffian duct adenoma,ICDO3_2nd
9110/1,Wolffian tumor,ICDO3_2nd
9110/1,Wolffian duct tumor,ICDO3_2nd
9110/1,Mesonephric tumor,ICDO3_2nd
9110/3,"Mesonephroma, malignant",ICDO3_2nd
9110/3,"Mesonephroma, NOS",ICDO3_2nd
9110/3,Mesonephric adenocarcinoma,ICDO3_2nd
9110/3,Wolffian duct carcinoma,ICDO3_2nd
9110/3,Adenocarcinoma of rete ovarii,ICDO3_2nd
9120/0,"Hemangioma, NOS",ICDO3_2nd
9120/0,"Angioma, NOS",ICDO3_2nd
9120/0,Chorioangioma,ICDO3_2nd
9120/0,Cherry hemangioma,ICDO3_2nd
9120/0,Sinusoidal hemangioma,ICDO3_2nd
9120/0,Microvenular hemangioma,ICDO3_2nd
9120/0,Glomeruloid hemangioma,ICDO3_2nd
9120/0,Spindle cell hemangioma,ICDO3_2nd
9120/0,Hobnail hemangioma,ICDO3_2nd
9120/3,Hemangiosarcoma,ICDO3_2nd
9120/3,Angiosarcoma,ICDO3_2nd
9121/0,Cavernous hemangioma,ICDO3_2nd
9122/0,Venous hemangioma,ICDO3_2nd
9123/0,Racemose hemangioma,ICDO3_2nd
9123/0,Arteriovenous hemangioma,ICDO3_2nd
9124/3,Kupffer cell sarcoma,ICDO3_2nd
9125/0,Epithelioid hemangioma,ICDO3_2nd
9125/0,Histiocytoid hemangioma,ICDO3_2nd
9125/0,Cutaneous epithelioid angiomatoid nodule,ICDO3_2nd
9126/0,Atypical vascular lesion,ICDO3_2nd
9130/0,"Hemangioendothelioma, benign",ICDO3_2nd
9130/1,"Hemangioendothelioma, NOS",ICDO3_2nd
9130/1,Angioendothelioma,ICDO3_2nd
9130/1,Kaposiform hemangioendothelioma,ICDO3_2nd
9130/3,"Hemangioendothelioma, malignant",ICDO3_2nd
9130/3,Hemangioendothelial sarcoma,ICDO3_2nd
9131/0,Capillary hemangioma,ICDO3_2nd
9131/0,Hemangioma simplex,ICDO3_2nd
9131/0,Infantile hemangioma,ICDO3_2nd
9131/0,Juvenile hemangioma,ICDO3_2nd
9131/0,Plexiform hemangioma,ICDO3_2nd
9131/0,Lobular capillary hemangioma,ICDO3_2nd
9131/0,"Congenital hemangioma, NOS",ICDO3_2nd
9131/0,"Congenital hemangioma, rapidly involuting",ICDO3_2nd
9131/0,"Congenital hemangioma, non-involuting",ICDO3_2nd
9132/0,Intramuscular hemangioma,ICDO3_2nd
9132/0,Intramuscular angioma,ICDO3_2nd
9133/3,"Epithelioid hemangioendothelioma, NOS",ICDO3_2nd
9133/3,"Epithelioid hemangioendothelioma, malignant",ICDO3_2nd
9133/3,Intravascular bronchial alveolar tumor,ICDO3_2nd
9135/1,Papillary intralymphatic angioendothelioma,ICDO3_2nd
9135/1,Endovascular papillary angioendothelioma,ICDO3_2nd
9135/1,Dabska tumor,ICDO3_2nd
9136/1,Spindle cell hemangioendothelioma,ICDO3_2nd
9136/1,Spindle cell angioendothelioma,ICDO3_2nd
9136/1,Retiform hemangioendothelioma,ICDO3_2nd
9136/1,Composite hemangioendothelioma,ICDO3_2nd
9137/0,Myointimoma,ICDO3_2nd
9137/3,Intimal sarcoma,ICDO3_2nd
9138/1,Pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma,ICDO3_2nd
9140/3,Kaposi sarcoma,ICDO3_2nd
9140/3,Multiple hemorrhagic sarcoma,ICDO3_2nd
9141/0,Angiokeratoma,ICDO3_2nd
9142/0,Verrucous keratotic hemangioma,ICDO3_2nd
9142/0,Verrucous venous malformation,ICDO3_2nd
9160/0,"Angiofibroma, NOS",ICDO3_2nd
9160/0,Fibrous papule of nose,ICDO3_2nd
9160/0,Involuting nevus,ICDO3_2nd
9160/0,Juvenile angiofibroma,ICDO3_2nd
9160/0,Cellular angiofibroma,ICDO3_2nd
9160/0,Giant cell angiofibroma,ICDO3_2nd
9161/0,Acquired tufted hemangioma,ICDO3_2nd
9161/0,Tufted hemangioma,ICDO3_2nd
9161/1,Hemangioblastoma,ICDO3_2nd
9161/1,Angioblastoma,ICDO3_2nd
9170/0,"Lymphangioma, NOS",ICDO3_2nd
9170/0,"Lymphangioendothelioma, NOS",ICDO3_2nd
9170/3,Lymphangiosarcoma,ICDO3_2nd
9170/3,Lymphangioendothelial sarcoma,ICDO3_2nd
9170/3,"Lymphangioendothelioma, malignant",ICDO3_2nd
9171/0,Capillary lymphangioma,ICDO3_2nd
9172/0,Cavernous lymphangioma,ICDO3_2nd
9173/0,Cystic lymphangioma,ICDO3_2nd
9173/0,"Hygroma, NOS",ICDO3_2nd
9173/0,Cystic hygroma,ICDO3_2nd
9174/0,Lymphangiomyoma,ICDO3_2nd
9174/1,Lymphangioleiomyomatosis,ICDO3_2nd
9174/1,Lymphangiomyomatosis,ICDO3_2nd
9175/0,Hemolymphangioma,ICDO3_2nd
9180/0,"Osteoma, NOS",ICDO3_2nd
9180/3,"Osteosarcoma, NOS",ICDO3_2nd
9180/3,"Osteogenic sarcoma, NOS",ICDO3_2nd
9180/3,Osteoblastic sarcoma,ICDO3_2nd
9180/3,Osteochondrosarcoma,ICDO3_2nd
9180/3,"Osteosarcoma, extraskeletal",ICDO3_2nd
9181/3,Chondroblastic osteosarcoma,ICDO3_2nd
9182/3,Fibroblastic osteosarcoma,ICDO3_2nd
9182/3,Osteofibrosarcoma,ICDO3_2nd
9183/3,Telangiectatic osteosarcoma,ICDO3_2nd
9184/3,Osteosarcoma in Paget disease of bone,ICDO3_2nd
9184/3,Secondary osteosarcoma,ICDO3_2nd
9185/3,Small cell osteosarcoma,ICDO3_2nd
9185/3,Round cell osteosarcoma,ICDO3_2nd
9186/3,"Central osteosarcoma, NOS",ICDO3_2nd
9186/3,Conventional central osteosarcoma,ICDO3_2nd
9186/3,Medullary osteosarcoma,ICDO3_2nd
9187/3,Low grade central osteosarcoma,ICDO3_2nd
9187/3,Low grade intramedullary osteosarcoma,ICDO3_2nd
9187/3,Intraosseous well differentiated osteosarcoma,ICDO3_2nd
9187/3,Intraosseous low grade osteosarcoma,ICDO3_2nd
9191/0,"Osteoid osteoma, NOS",ICDO3_2nd
9192/3,Parosteal osteosarcoma,ICDO3_2nd
9192/3,Juxtacortical osteosarcoma,ICDO3_2nd
9193/3,Periosteal osteosarcoma,ICDO3_2nd
9194/3,High grade surface osteosarcoma,ICDO3_2nd
9195/3,Intracortical osteosarcoma,ICDO3_2nd
9200/0,"Osteoblastoma, NOS",ICDO3_2nd
9200/0,Giant osteoid osteoma,ICDO3_2nd
9200/1,Aggressive osteoblastoma,ICDO3_2nd
9210/0,Osteochondroma,ICDO3_2nd
9210/0,Cartilaginous exostosis,ICDO3_2nd
9210/0,Ecchondroma,ICDO3_2nd
9210/0,Osteocartilaginous exostosis,ICDO3_2nd
9210/1,"Osteochondromatosis, NOS",ICDO3_2nd
9210/1,Ecchondrosis,ICDO3_2nd
9211/0,Osteochondromyxoma,ICDO3_2nd
9212/0,Bizarre parosteal osteochondromatous proliferation,ICDO3_2nd
9213/0,Subungual exostosis,ICDO3_2nd
9220/0,"Chondroma, NOS",ICDO3_2nd
9220/0,Enchondroma,ICDO3_2nd
9220/1,"Chondromatosis, NOS",ICDO3_2nd
9220/3,"Chondrosarcoma, NOS",ICDO3_2nd
9220/3,Fibrochondrosarcoma,ICDO3_2nd
9220/3,"Chondrosarcoma, grade 2",ICDO3_2nd
9220/3,"Chondrosarcoma, grade 3",ICDO3_2nd
9221/0,Periosteal chondroma,ICDO3_2nd
9221/0,Juxtacortical chondroma,ICDO3_2nd
9221/3,Periosteal chondrosarcoma,ICDO3_2nd
9221/3,Juxtacortical chondrosarcoma,ICDO3_2nd
9222/1,Atypical cartilaginous tumor,ICDO3_2nd
9222/1,"Chondrosarcoma, grade 1",ICDO3_2nd
9230/1,"Chondroblastoma, NOS",ICDO3_2nd
9230/1,Chondromatous giant cell tumor,ICDO3_2nd
9230/1,Codman tumor,ICDO3_2nd
9230/3,"Chondroblastoma, malignant",ICDO3_2nd
9231/3,Myxoid chondrosarcoma,ICDO3_2nd
9240/3,Mesenchymal chondrosarcoma,ICDO3_2nd
9241/0,Chondromyxoid fibroma,ICDO3_2nd
9242/3,Clear cell chondrosarcoma,ICDO3_2nd
9243/3,Dedifferentiated chondrosarcoma,ICDO3_2nd
9250/1,"Giant cell tumor of bone, NOS",ICDO3_2nd
9250/1,"Osteoclastoma, NOS",ICDO3_2nd
9250/3,"Giant cell tumor of bone, malignant",ICDO3_2nd
9250/3,Giant cell sarcoma of bone,ICDO3_2nd
9250/3,"Osteoclastoma, malignant",ICDO3_2nd
9251/1,"Giant cell tumor of soft parts, NOS",ICDO3_2nd
9251/3,Malignant giant cell tumor of soft parts,ICDO3_2nd
9252/0,"Tenosynovial giant cell tumor, NOS",ICDO3_2nd
9252/0,"Tenosynovial giant cell tumor, localised",ICDO3_2nd
9252/0,Fibrous histiocytoma of tendon sheath,ICDO3_2nd
9252/0,"Giant cell tumor of tendon sheath, NOS",ICDO3_2nd
9252/1,"Tenosynovial giant cell tumor, diffuse",ICDO3_2nd
9252/1,Pigmented villonodular synovitis,ICDO3_2nd
9252/3,Malignant tenosynovial giant cell tumor,ICDO3_2nd
9252/3,"Giant cell tumor of tendon sheath, malignant",ICDO3_2nd
9260/0,Aneurysmal bone cyst,ICDO3_2nd
9261/3,Adamantinoma of long bones,ICDO3_2nd
9262/0,Ossifying fibroma,ICDO3_2nd
9262/0,Fibro-osteoma,ICDO3_2nd
9262/0,Osteofibroma,ICDO3_2nd
9270/0,"Odontogenic tumor, benign",ICDO3_2nd
9270/1,"Odontogenic tumor, NOS",ICDO3_2nd
9270/3,"Odontogenic tumor, malignant",ICDO3_2nd
9270/3,Ameloblastic carcinoma,ICDO3_2nd
9270/3,Odontogenic carcinoma,ICDO3_2nd
9270/3,Odontogenic sarcoma,ICDO3_2nd
9270/3,Primary intraosseous carcinoma,ICDO3_2nd
9271/0,Ameloblastic fibrodentinoma,ICDO3_2nd
9271/0,Dentinoma,ICDO3_2nd
9272/0,"Cementoma, NOS",ICDO3_2nd
9272/0,Periapical cemental dysplasia,ICDO3_2nd
9272/0,Periapical cemento-osseous dysplasia,ICDO3_2nd
9273/0,"Cementoblastoma, benign",ICDO3_2nd
9274/0,Cemento-ossifying fibroma,ICDO3_2nd
9274/0,Cementifying fibroma,ICDO3_2nd
9275/0,Gigantiform cementoma,ICDO3_2nd
9275/0,Florid osseous dysplasia,ICDO3_2nd
9280/0,"Odontoma, NOS",ICDO3_2nd
9281/0,Compound odontoma,ICDO3_2nd
9282/0,Complex odontoma,ICDO3_2nd
9290/0,Ameloblastic fibro-odontoma,ICDO3_2nd
9290/0,Fibroameloblastic odontoma,ICDO3_2nd
9290/3,Ameloblastic odontosarcoma,ICDO3_2nd
9290/3,Ameloblastic fibro-odontosarcoma,ICDO3_2nd
9290/3,Ameloblastic fibrodentinosarcoma,ICDO3_2nd
9300/0,Adenomatoid odontogenic tumor,ICDO3_2nd
9300/0,Adenoameloblastoma,ICDO3_2nd
9301/0,Calcifying odontogenic cyst,ICDO3_2nd
9302/0,Dentinogenic ghost cell tumor,ICDO3_2nd
9302/0,Odontogenic ghost cell tumor,ICDO3_2nd
9302/3,Ghost cell odontogenic carcinoma,ICDO3_2nd
9310/0,"Ameloblastoma, NOS",ICDO3_2nd
9310/0,"Adamantinoma, NOS",ICDO3_2nd
9310/3,"Ameloblastoma, metastasizing",ICDO3_2nd
9310/3,"Ameloblastoma, malignant",ICDO3_2nd
9310/3,"Adamantinoma, malignant",ICDO3_2nd
9311/0,Odontoameloblastoma,ICDO3_2nd
9312/0,Squamous odontogenic tumor,ICDO3_2nd
9320/0,Odontogenic myxoma,ICDO3_2nd
9320/0,Odontogenic myxofibroma,ICDO3_2nd
9321/0,"Odontogenic fibroma, NOS",ICDO3_2nd
9321/0,Central odontogenic fibroma,ICDO3_2nd
9322/0,Peripheral odontogenic fibroma,ICDO3_2nd
9330/0,Ameloblastic fibroma,ICDO3_2nd
9330/3,Ameloblastic fibrosarcoma,ICDO3_2nd
9330/3,Ameloblastic sarcoma,ICDO3_2nd
9330/3,Odontogenic fibrosarcoma,ICDO3_2nd
9340/0,Calcifying epithelial odontogenic tumor,ICDO3_2nd
9340/0,Pindborg tumor,ICDO3_2nd
9341/3,Clear cell odontogenic carcinoma,ICDO3_2nd
9341/3,Clear cell odontogenic tumor,ICDO3_2nd
9342/3,Odontogenic carcinosarcoma,ICDO3_2nd
9350/1,"Craniopharyngioma, NOS",ICDO3_2nd
9350/1,Rathke pouch tumor,ICDO3_2nd
9351/1,"Craniopharyngioma, adamantinomatous",ICDO3_2nd
9352/1,"Craniopharyngioma, papillary",ICDO3_2nd
9360/1,Pinealoma,ICDO3_2nd
9361/1,Pineocytoma,ICDO3_2nd
9362/3,Pineoblastoma,ICDO3_2nd
9362/3,Mixed pineal tumor,ICDO3_2nd
9362/3,Mixed pineocytoma-pineoblastoma,ICDO3_2nd
9362/3,Pineal parenchymal tumor of intermediate differentiation,ICDO3_2nd
9362/3,Transitional pineal tumor,ICDO3_2nd
9363/0,Melanotic neuroectodermal tumor,ICDO3_2nd
9363/0,Melanoameloblastoma,ICDO3_2nd
9363/0,Melanotic progonoma,ICDO3_2nd
9363/0,Retinal anlage tumor,ICDO3_2nd
9364/3,Ewing sarcoma,ICDO3_2nd
9364/3,Ewing tumor,ICDO3_2nd
9364/3,Peripheral neuroectodermal tumor,ICDO3_2nd
9364/3,"Neuroectodermal tumor, NOS",ICDO3_2nd
9364/3,Peripheral primitive neuroectodermal tumor,ICDO3_2nd
9364/3,PPNET,ICDO3_2nd
9365/3,Askin tumor,ICDO3_2nd
9370/0,Benign notochordal cell tumor,ICDO3_2nd
9370/3,"Chordoma, NOS",ICDO3_2nd
9371/3,Chondroid chordoma,ICDO3_2nd
9372/3,Dedifferentiated chordoma,ICDO3_2nd
9373/0,Parachordoma,ICDO3_2nd
9380/3,"Glioma, malignant",ICDO3_2nd
9380/3,"Glioma, NOS",ICDO3_2nd
9381/3,Gliomatosis cerebri,ICDO3_2nd
9382/3,"Oligoastrocytoma, NOS",ICDO3_2nd
9382/3,Mixed glioma,ICDO3_2nd
9382/3,Anaplastic oligoastrocytoma,ICDO3_2nd
9383/1,Subependymoma,ICDO3_2nd
9383/1,"Subependymal astrocytoma, NOS",ICDO3_2nd
9383/1,Subependymal glioma,ICDO3_2nd
9383/1,Mixed subependymoma-ependymoma,ICDO3_2nd
9384/1,Subependymal giant cell astrocytoma,ICDO3_2nd
9385/3,"Diffuse midline glioma, H3 K27M-mutant",ICDO3_2nd
9385/3,"Diffuse intrinsic pontine glioma, H3 K27M-mutant",ICDO3_2nd
9390/0,"Choroid plexus papilloma, NOS",ICDO3_2nd
9390/1,Atypical choroid plexus papilloma,ICDO3_2nd
9390/3,Choroid plexus carcinoma,ICDO3_2nd
9390/3,"Choroid plexus papilloma, anaplastic",ICDO3_2nd
9390/3,"Choroid plexus papilloma, malignant",ICDO3_2nd
9391/1,Sellar ependymoma,ICDO3_2nd
9391/3,"Ependymoma, NOS",ICDO3_2nd
9391/3,Epithelial ependymoma,ICDO3_2nd
9391/3,Cellular ependymoma,ICDO3_2nd
9391/3,Clear cell ependymoma,ICDO3_2nd
9391/3,Tanycytic ependymoma,ICDO3_2nd
9392/3,"Ependymoma, anaplastic",ICDO3_2nd
9392/3,Ependymoblastoma,ICDO3_2nd
9393/3,Papillary ependymoma,ICDO3_2nd
9394/1,Myxopapillary ependymoma,ICDO3_2nd
9395/3,Papillary tumor of pineal region,ICDO3_2nd
9396/3,"Ependymoma, RELA fusion positive",ICDO3_2nd
9400/3,"Astrocytoma, NOS",ICDO3_2nd
9400/3,Astrocytic glioma,ICDO3_2nd
9400/3,Astroglioma,ICDO3_2nd
9400/3,"Astrocytoma, low grade",ICDO3_2nd
9400/3,Cystic astrocytoma,ICDO3_2nd
9400/3,"Diffuse astrocytoma, NOS",ICDO3_2nd
9400/3,"Diffuse astrocytoma, low grade",ICDO3_2nd
9400/3,"Diffuse astrocytoma, IDH-mutant",ICDO3_2nd
9400/3,"Diffuse astrocytoma, IDH-wildtype",ICDO3_2nd
9401/3,"Astrocytoma, anaplastic, NOS",ICDO3_2nd
9401/3,"Astrocytoma, anaplastic, IDH-mutant",ICDO3_2nd
9401/3,"Astrocytoma, anaplastic, IDH-wildtype",ICDO3_2nd
9410/3,Protoplasmic astrocytoma,ICDO3_2nd
9411/3,"Gemistocytic astrocytoma, NOS",ICDO3_2nd
9411/3,"Gemistocytic astrocytoma, IDH-mutant",ICDO3_2nd
9411/3,Gemistocytoma,ICDO3_2nd
9412/1,Desmoplastic infantile astrocytoma,ICDO3_2nd
9412/1,Desmoplastic infantile ganglioglioma,ICDO3_2nd
9413/0,Dysembryoplastic neuroepithelial tumor,ICDO3_2nd
9420/3,Fibrillary astrocytoma,ICDO3_2nd
9420/3,Fibrous astrocytoma,ICDO3_2nd
9421/1,Pilocytic astrocytoma,ICDO3_2nd
9421/1,"Spongioblastoma, NOS",ICDO3_2nd
9421/1,Juvenile astrocytoma,ICDO3_2nd
9421/1,Piloid astrocytoma,ICDO3_2nd
9423/3,Polar spongioblastoma,ICDO3_2nd
9423/3,Primitive polar spongioblastoma,ICDO3_2nd
9423/3,Spongioblastoma polare,ICDO3_2nd
9424/3,"Pleomorphic xanthoastrocytoma, NOS",ICDO3_2nd
9424/3,Anaplastic pleomorphic xanthoastrocytoma,ICDO3_2nd
9425/3,Pilomyxoid astrocytoma,ICDO3_2nd
9430/3,Astroblastoma,ICDO3_2nd
9431/1,Angiocentric glioma,ICDO3_2nd
9432/1,Pituicytoma,ICDO3_2nd
9440/3,"Glioblastoma, NOS",ICDO3_2nd
9440/3,Epithelioid glioblastoma,ICDO3_2nd
9440/3,"Glioblastoma, IDH-wildtype",ICDO3_2nd
9440/3,"Glioblastoma, primary, NOS",ICDO3_2nd
9440/3,Glioblastoma multiforme,ICDO3_2nd
9440/3,Spongioblastoma multiforme,ICDO3_2nd
9440/3,"Diffuse midline glioma, NOS",ICDO3_2nd
9440/3,Diffuse intrinsic pontine glioma,ICDO3_2nd
9441/3,Giant cell glioblastoma,ICDO3_2nd
9441/3,Monstrocellular sarcoma,ICDO3_2nd
9442/1,Gliofibroma,ICDO3_2nd
9442/3,Gliosarcoma,ICDO3_2nd
9442/3,Glioblastoma with sarcomatous component,ICDO3_2nd
9444/1,Chordoid glioma,ICDO3_2nd
9444/1,Chordoid glioma of third ventricle,ICDO3_2nd
9445/3,"Glioblastoma, IDH-mutant",ICDO3_2nd
9445/3,"Glioblastoma, secondary, IDH-mutant",ICDO3_2nd
9445/3,"Glioblastoma, secondary, NOS",ICDO3_2nd
9450/3,"Oligodendroglioma, NOS",ICDO3_2nd
9450/3,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted",ICDO3_2nd
9451/3,"Oligodendroglioma, anaplastic, NOS",ICDO3_2nd
9451/3,"Oligodendroglioma, anaplastic, IDH-mutant and 1p/19q codeleted",ICDO3_2nd
9460/3,Oligodendroblastoma,ICDO3_2nd
9470/3,"Medulloblastoma, NOS",ICDO3_2nd
9470/3,Classic medulloblastoma,ICDO3_2nd
9470/3,Melanotic medulloblastoma,ICDO3_2nd
9471/3,Desmoplastic nodular medulloblastoma,ICDO3_2nd
9471/3,Circumscribed arachnoidal cerebellar sarcoma,ICDO3_2nd
9471/3,"Desmoplastic medulloblastoma, NOS",ICDO3_2nd
9471/3,Medulloblastoma with extensive nodularity,ICDO3_2nd
9471/3,"Medulloblastoma, SHH-activated and TP53-wildtype",ICDO3_2nd
9471/3,"Medulloblastoma, SHH activated, NOS",ICDO3_2nd
9472/3,Medullomyoblastoma,ICDO3_2nd
9473/3,"CNS embryonal tumor, NOS",ICDO3_2nd
9473/3,"Primitive neuroectodermal tumor, NOS",ICDO3_2nd
9473/3,"PNET, NOS",ICDO3_2nd
9473/3,Central primitive neuroectodermal tumor,ICDO3_2nd
9473/3,CPNET,ICDO3_2nd
9473/3,Supratentorial PNET,ICDO3_2nd
9474/3,Large cell medulloblastoma,ICDO3_2nd
9474/3,Anaplastic medulloblastoma,ICDO3_2nd
9475/3,"Medulloblastoma, WNT-activated, NOS",ICDO3_2nd
9475/3,"Medulloblastoma, WNT-activated, classic",ICDO3_2nd
9475/3,"Medulloblastoma, WNT-activated, large cell type",ICDO3_2nd
9475/3,"Medulloblastoma, WNT-activated, anaplastic type",ICDO3_2nd
9476/3,"Medulloblastoma, SHH-activated and TP53-mutant",ICDO3_2nd
9477/3,"Medulloblastoma, non-WNT/non-SHH",ICDO3_2nd
9477/3,"Medulloblastoma, group 3",ICDO3_2nd
9477/3,"Medulloblastoma, group 4",ICDO3_2nd
9478/3,Embryonal tumor with multilayered rosettes with C19MC alteration,ICDO3_2nd
9478/3,"Embryonal tumor with multilayered rosettes, NOS",ICDO3_2nd
9480/3,"Cerebellar sarcoma, NOS",ICDO3_2nd
9490/0,Ganglioneuroma,ICDO3_2nd
9490/3,Ganglioneuroblastoma,ICDO3_2nd
9490/3,CNS ganglioneuroblastoma,ICDO3_2nd
9491/0,Ganglioneuromatosis,ICDO3_2nd
9492/0,"Gangliocytoma, NOS",ICDO3_2nd
9493/0,Dysplastic gangliocytoma of cerebellum (Lhermitte-Duclos),ICDO3_2nd
9500/3,"Neuroblastoma, NOS",ICDO3_2nd
9500/3,Central neuroblastoma,ICDO3_2nd
9500/3,CNS neuroblastoma,ICDO3_2nd
9500/3,Sympathicoblastoma,ICDO3_2nd
9501/0,"Medulloepithelioma, benign",ICDO3_2nd
9501/0,"Diktyoma, benign",ICDO3_2nd
9501/3,"Medulloepithelioma, NOS",ICDO3_2nd
9501/3,"Diktyoma, malignant",ICDO3_2nd
9502/0,"Teratoid medulloepithelioma, benign",ICDO3_2nd
9502/3,"Teratoid medulloepithelioma, NOS",ICDO3_2nd
9503/3,"Neuroepithelioma, NOS",ICDO3_2nd
9504/3,Spongioneuroblastoma,ICDO3_2nd
9505/1,"Ganglioglioma, NOS",ICDO3_2nd
9505/1,Glioneuroma,ICDO3_2nd
9505/1,Neuroastrocytoma,ICDO3_2nd
9505/3,"Ganglioglioma, anaplastic",ICDO3_2nd
9506/1,Central neurocytoma,ICDO3_2nd
9506/1,"Neurocytoma, NOS",ICDO3_2nd
9506/1,Cerebellar liponeurocytoma,ICDO3_2nd
9506/1,Lipomatous medulloblastoma,ICDO3_2nd
9506/1,Medullocytoma,ICDO3_2nd
9506/1,Neurolipocytoma,ICDO3_2nd
9506/1,Extraventricular neurocytoma,ICDO3_2nd
9507/0,Pacinian tumor,ICDO3_2nd
9508/3,Atypical teratoid/rhabdoid tumor,ICDO3_2nd
9508/3,CNS embryonal tumor with rhabdoid features,ICDO3_2nd
9509/1,Papillary glioneuronal tumor,ICDO3_2nd
9509/1,Rosette-forming glioneuronal tumor,ICDO3_2nd
9510/0,Retinocytoma,ICDO3_2nd
9510/3,"Retinoblastoma, NOS",ICDO3_2nd
9511/3,"Retinoblastoma, differentiated",ICDO3_2nd
9512/3,"Retinoblastoma, undifferentiated",ICDO3_2nd
9513/3,"Retinoblastoma, diffuse",ICDO3_2nd
9514/1,"Retinoblastoma, spontaneously regressed",ICDO3_2nd
9520/3,Olfactory neurogenic tumor,ICDO3_2nd
9521/3,Olfactory neurocytoma,ICDO3_2nd
9521/3,Esthesioneurocytoma,ICDO3_2nd
9522/3,Olfactory neuroblastoma,ICDO3_2nd
9522/3,Esthesioneuroblastoma,ICDO3_2nd
9523/3,Olfactory neuroepithelioma,ICDO3_2nd
9523/3,Esthesioneuroepithelioma,ICDO3_2nd
9530/0,"Meningioma, NOS",ICDO3_2nd
9530/0,Lymphoplasmacyte-rich meningioma,ICDO3_2nd
9530/0,Metaplastic meningioma,ICDO3_2nd
9530/0,Microcystic meningioma,ICDO3_2nd
9530/0,Secretory meningioma,ICDO3_2nd
9530/3,"Meningioma, malignant",ICDO3_2nd
9530/3,Leptomeningeal sarcoma,ICDO3_2nd
9530/3,Meningeal sarcoma,ICDO3_2nd
9530/3,"Meningioma, anaplastic",ICDO3_2nd
9530/3,Meningothelial sarcoma,ICDO3_2nd
9531/0,Meningothelial meningioma,ICDO3_2nd
9531/0,Endotheliomatous meningioma,ICDO3_2nd
9531/0,Syncytial meningioma,ICDO3_2nd
9532/0,Fibrous meningioma,ICDO3_2nd
9532/0,Fibroblastic meningioma,ICDO3_2nd
9533/0,Psammomatous meningioma,ICDO3_2nd
9534/0,Angiomatous meningioma,ICDO3_2nd
9535/0,Hemangioblastic meningioma,ICDO3_2nd
9535/0,Angioblastic meningioma,ICDO3_2nd
9537/0,Transitional meningioma,ICDO3_2nd
9537/0,Mixed meningioma,ICDO3_2nd
9538/1,Clear cell meningioma,ICDO3_2nd
9538/1,Chordoid meningioma,ICDO3_2nd
9538/3,Papillary meningioma,ICDO3_2nd
9538/3,Rhabdoid meningioma,ICDO3_2nd
9539/1,Atypical meningioma,ICDO3_2nd
9539/3,Meningeal sarcomatosis,ICDO3_2nd
9540/0,"Neurofibroma, NOS",ICDO3_2nd
9540/3,"Malignant peripheral nerve sheath tumor, NOS",ICDO3_2nd
9540/3,"MPNST, NOS",ICDO3_2nd
9540/3,Neurofibrosarcoma,ICDO3_2nd
9540/3,Neurogenic sarcoma,ICDO3_2nd
9540/3,Neurosarcoma,ICDO3_2nd
9540/3,Melanotic MPNST,ICDO3_2nd
9540/3,Melanotic psammomatous MPNST,ICDO3_2nd
9540/3,MPNST with glandular differentiation,ICDO3_2nd
9540/3,MPNST with mesenchymal differentiation,ICDO3_2nd
9540/3,MPNST with perineurial differentiation,ICDO3_2nd
9541/0,Melanotic neurofibroma,ICDO3_2nd
9542/3,"Malignant peripheral nerve sheath tumor, epithelioid",ICDO3_2nd
9542/3,Epithelioid MPNST,ICDO3_2nd
9550/0,Plexiform neurofibroma,ICDO3_2nd
9550/0,Plexiform neuroma,ICDO3_2nd
9560/0,"Schwannoma, NOS",ICDO3_2nd
9560/0,"Neurilemoma, NOS",ICDO3_2nd
9560/0,Neurinoma,ICDO3_2nd
9560/0,Acoustic neuroma,ICDO3_2nd
9560/0,Ancient schwannoma,ICDO3_2nd
9560/0,Cellular schwannoma,ICDO3_2nd
9560/0,Degenerated schwannoma,ICDO3_2nd
9560/0,Plexiform schwannoma,ICDO3_2nd
9560/0,Psammomatous schwannoma,ICDO3_2nd
9560/1,Melanotic schwannoma,ICDO3_2nd
9560/1,Pigmented schwannoma,ICDO3_2nd
9560/3,"Neurilemoma, malignant",ICDO3_2nd
9560/3,"Malignant schwannoma, NOS",ICDO3_2nd
9560/3,Neurilemosarcoma,ICDO3_2nd
9561/3,Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation,ICDO3_2nd
9561/3,Malignant schwannoma with rhabdomyoblastic differentiation,ICDO3_2nd
9561/3,MPNST with rhabdomyoblastic differentiation,ICDO3_2nd
9561/3,"Triton tumor, malignant",ICDO3_2nd
9562/0,Nerve sheath myxoma,ICDO3_2nd
9562/0,Neurothekeoma,ICDO3_2nd
9562/0,Cellular neurothekeoma,ICDO3_2nd
9563/0,"Nerve sheath tumor, NOS",ICDO3_2nd
9563/0,Hybrid nerve sheath tumor,ICDO3_2nd
9570/0,"Neuroma, NOS",ICDO3_2nd
9570/0,Solitary circumscribed neuroma,ICDO3_2nd
9571/0,"Perineurioma, NOS",ICDO3_2nd
9571/0,Intraneural perineurioma,ICDO3_2nd
9571/0,Soft tissue perineurioma,ICDO3_2nd
9571/3,"Perineurioma, malignant",ICDO3_2nd
9580/0,"Granular cell tumor, NOS",ICDO3_2nd
9580/0,"Granular cell myoblastoma, NOS",ICDO3_2nd
9580/3,"Granular cell tumor, malignant",ICDO3_2nd
9580/3,"Granular cell myoblastoma, malignant",ICDO3_2nd
9581/3,Alveolar soft part sarcoma,ICDO3_2nd
9582/0,Granular cell tumor of sellar region,ICDO3_2nd
9590/3,"Malignant lymphoma, NOS",ICDO3_2nd
9590/3,"Lymphoma, NOS",ICDO3_2nd
9590/3,Microglioma,ICDO3_2nd
9591/1,"Monoclonal B-cell lymphocytosis, NOS",ICDO3_2nd
9591/1,"Monoclonal B-cell lymphocytosis, non-CLL type",ICDO3_2nd
9591/3,"Malignant lymphoma, non-Hodgkin, NOS",ICDO3_2nd
9591/3,"Non-Hodgkin lymphoma, NOS",ICDO3_2nd
9591/3,"B-cell lymphoma, NOS",ICDO3_2nd
9591/3,"Lymphosarcoma, NOS",ICDO3_2nd
9591/3,"Lymphosarcoma, diffuse",ICDO3_2nd
9591/3,"Malignant lymphoma, diffuse, NOS",ICDO3_2nd
9591/3,"Malignant lymphoma, non-cleaved cell, NOS",ICDO3_2nd
9591/3,"Reticulum cell sarcoma, NOS",ICDO3_2nd
9591/3,"Reticulosarcoma, NOS",ICDO3_2nd
9591/3,"Reticulum cell sarcoma, diffuse",ICDO3_2nd
9591/3,"Reticulosarcoma, diffuse",ICDO3_2nd
9591/3,Hairy cell leukemia variant,ICDO3_2nd
9591/3,"Malignant lymphoma, lymphocytic, intermediate differentiation, nodular",ICDO3_2nd
9591/3,"Malignant lymphoma, lymphocytic, poorly differentiated, diffuse",ICDO3_2nd
9591/3,"Malignant lymphoma, cleaved cell, NOS",ICDO3_2nd
9591/3,"Malignant lymphoma, small cleaved cell, NOS",ICDO3_2nd
9591/3,"Malignant lymphoma, small cell, noncleaved, diffuse",ICDO3_2nd
9591/3,"Malignant lymphoma, undifferentiated cell type, NOS",ICDO3_2nd
9591/3,"Malignant lymphoma, undifferentiated cell, non-Burkitt",ICDO3_2nd
9591/3,"Malignant lymphoma, small cleaved cell, diffuse",ICDO3_2nd
9591/3,"Splenic B-cell lymphoma/leukemia, unclassifiable",ICDO3_2nd
9591/3,Splenic diffuse red pulp small B-cell lymphoma,ICDO3_2nd
9596/3,Composite Hodgkin and non-Hodgkin lymphoma,ICDO3_2nd
9596/3,"B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma",ICDO3_2nd
9597/3,Primary cutaneous follicle center lymphoma,ICDO3_2nd
9650/3,"Hodgkin lymphoma, NOS",ICDO3_2nd
9650/3,"Hodgkin disease, NOS",ICDO3_2nd
9650/3,"Malignant lymphoma, Hodgkin",ICDO3_2nd
9650/3,Classical Hodgkin lymphoma post-transplant lymphoproliferative disease,ICDO3_2nd
9651/3,"Hodgkin lymphoma, lymphocyte-rich",ICDO3_2nd
9651/3,"Classical Hodgkin lymphoma, lymphocyte-rich",ICDO3_2nd
9651/3,"Hodgkin disease, lymphocyte predominance, NOS",ICDO3_2nd
9651/3,"Hodgkin disease, lymphocyte predominance, diffuse",ICDO3_2nd
9651/3,"Hodgkin disease, lymphocytic-histiocytic predominance",ICDO3_2nd
9652/3,"Hodgkin lymphoma, mixed cellularity, NOS",ICDO3_2nd
9652/3,"Classical Hodgkin lymphoma, mixed cellularity, NOS",ICDO3_2nd
9653/3,"Hodgkin lymphoma, lymphocyte depletion, NOS",ICDO3_2nd
9653/3,"Classical Hodgkin lymphoma, lymphocyte depletion, NOS",ICDO3_2nd
9654/3,"Hodgkin lymphoma, lymphocyte depletion, diffuse fibrosis",ICDO3_2nd
9654/3,"Classical Hodgkin lymphoma, lymphocyte depletion, diffuse fibrosis",ICDO3_2nd
9655/3,"Hodgkin lymphoma, lymphocyte depletion, reticular",ICDO3_2nd
9655/3,"Classical Hodgkin lymphoma, lymphocyte depletion, reticular",ICDO3_2nd
9659/3,"Hodgkin lymphoma, nodular lymphocyte predominant",ICDO3_2nd
9659/3,"Hodgkin paragranuloma, NOS",ICDO3_2nd
9659/3,"Hodgkin paragranuloma, nodular",ICDO3_2nd
9661/3,Hodgkin granuloma,ICDO3_2nd
9662/3,Hodgkin sarcoma,ICDO3_2nd
9663/3,"Hodgkin lymphoma, nodular sclerosis, NOS",ICDO3_2nd
9663/3,"Classical Hodgkin lymphoma, nodular sclerosis, NOS",ICDO3_2nd
9663/3,"Hodgkin disease, nodular sclerosis, NOS",ICDO3_2nd
9664/3,"Hodgkin lymphoma, nodular sclerosis, cellular phase",ICDO3_2nd
9664/3,"Classical Hodgkin lymphoma, nodular sclerosis, cellular phase",ICDO3_2nd
9665/3,"Hodgkin lymphoma, nodular sclerosis, grade 1",ICDO3_2nd
9665/3,"Classical Hodgkin lymphoma, nodular sclerosis, grade 1",ICDO3_2nd
9665/3,"Hodgkin disease, nodular sclerosis, lymphocyte predominance",ICDO3_2nd
9665/3,"Hodgkin disease, nodular sclerosis, mixed cellularity",ICDO3_2nd
9667/3,"Hodgkin lymphoma, nodular sclerosis, grade 2",ICDO3_2nd
9667/3,"Classical Hodgkin lymphoma, nodular sclerosis, grade 2",ICDO3_2nd
9667/3,"Hodgkin disease, nodular sclerosis, lymphocyte depletion",ICDO3_2nd
9667/3,"Hodgkin disease, nodular sclerosis, syncytial variant",ICDO3_2nd
9671/3,Lymphoplasmacytic lymphoma,ICDO3_2nd
9671/3,"Malignant lymphoma, lymphoplasmacytoid",ICDO3_2nd
9671/3,Immunocytoma,ICDO3_2nd
9671/3,"Malignant lymphoma, plasmacytoid",ICDO3_2nd
9671/3,Plasmacytic lymphoma,ICDO3_2nd
9673/1,In situ mantle cell neoplasia,ICDO3_2nd
9673/1,In situ mantle cell lymphoma,ICDO3_2nd
9673/3,Mantle cell lymphoma,ICDO3_2nd
9673/3,"Malignant lymphoma, centrocytic",ICDO3_2nd
9673/3,"Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse",ICDO3_2nd
9673/3,Malignant lymphomatous polyposis,ICDO3_2nd
9673/3,Mantle zone lymphoma,ICDO3_2nd
9675/3,"Malignant lymphoma, mixed small and large cell, diffuse",ICDO3_2nd
9675/3,"Malignant lymphoma, centroblastic-centrocytic, NOS",ICDO3_2nd
9675/3,"Malignant lymphoma, centroblastic-centrocytic, diffuse",ICDO3_2nd
9675/3,"Malignant lymphoma, mixed cell type, diffuse",ICDO3_2nd
9675/3,"Malignant lymphoma, mixed lymphocytic-histiocytic, diffuse",ICDO3_2nd
9678/3,Primary effusion lymphoma,ICDO3_2nd
9679/3,Mediastinal large B-cell lymphoma,ICDO3_2nd
9679/3,Thymic large B-cell lymphoma,ICDO3_2nd
9680/1,EBV positive mucocutaneous ulcer,ICDO3_2nd
9680/3,"Diffuse large B-cell lymphoma, NOS",ICDO3_2nd
9680/3,"Malignant lymphoma, large B-cell, diffuse, NOS",ICDO3_2nd
9680/3,"Malignant lymphoma, histiocytic, NOS",ICDO3_2nd
9680/3,"Malignant lymphoma, large B-cell, NOS",ICDO3_2nd
9680/3,"Malignant lymphoma, large B-cell, diffuse, centroblastic, NOS",ICDO3_2nd
9680/3,"Malignant lymphoma, large cell, NOS",ICDO3_2nd
9680/3,"Malignant lymphoma, large cell, cleaved, NOS",ICDO3_2nd
9680/3,"Malignant lymphoma, large cell, diffuse, NOS",ICDO3_2nd
9680/3,"Malignant lymphoma, large cell, noncleaved, NOS",ICDO3_2nd
9680/3,"Malignant lymphoma, noncleaved, NOS",ICDO3_2nd
9680/3,"Malignant lymphoma, noncleaved, diffuse, NOS",ICDO3_2nd
9680/3,"Malignant lymphoma, histiocytic, diffuse",ICDO3_2nd
9680/3,"Malignant lymphoma, large cell, cleaved and noncleaved",ICDO3_2nd
9680/3,"Malignant lymphoma, large cell, cleaved, diffuse",ICDO3_2nd
9680/3,"Malignant lymphoma, large cell, noncleaved, diffuse",ICDO3_2nd
9680/3,"Malignant lymphoma, centroblastic, NOS",ICDO3_2nd
9680/3,"Diffuse large B-cell lymphoma, germinal center B-cell subtype",ICDO3_2nd
9680/3,"Diffuse large B-cell lymphoma, activated B-cell subtype",ICDO3_2nd
9680/3,"Malignant lymphoma, centroblastic, diffuse",ICDO3_2nd
9680/3,Anaplastic large B-cell lymphoma,ICDO3_2nd
9680/3,"B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma",ICDO3_2nd
9680/3,Diffuse large B-cell lymphoma associated with chronic inflammation,ICDO3_2nd
9680/3,EBV positive diffuse large B-cell lymphoma,ICDO3_2nd
9680/3,"Primary cutaneous diffuse large B-cell lymphoma, leg type",ICDO3_2nd
9680/3,Primary diffuse large B-cell lymphoma of CNS,ICDO3_2nd
9680/3,"High grade B-cell lymphoma, NOS",ICDO3_2nd
9680/3,High grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements,ICDO3_2nd
9680/3,Vitreoretinal lymphoma,ICDO3_2nd
9684/3,"Malignant lymphoma, large B-cell, diffuse, immunoblastic, NOS",ICDO3_2nd
9684/3,"Malignant lymphoma, immunoblastic, NOS",ICDO3_2nd
9684/3,Immunoblastic sarcoma,ICDO3_2nd
9684/3,"Malignant lymphoma, large cell, immunoblastic",ICDO3_2nd
9687/3,"Burkitt lymphoma, NOS",ICDO3_2nd
9687/3,Burkitt tumor,ICDO3_2nd
9687/3,"Malignant lymphoma, small noncleaved, Burkitt type",ICDO3_2nd
9687/3,"Malignant lymphoma, undifferentiated, Burkitt type",ICDO3_2nd
9687/3,"Burkitt-like lymphoma, NOS",ICDO3_2nd
9687/3,Burkitt-like lymphoma with 11q aberration,ICDO3_2nd
9687/3,Burkitt cell leukemia,ICDO3_2nd
9687/3,"Acute leukemia, Burkitt type",ICDO3_2nd
9687/3,"Acute lymphoblastic leukemia, mature B-cell type",ICDO3_2nd
9687/3,B-ALL,ICDO3_2nd
9687/3,FAB L3,ICDO3_2nd
9688/3,T-cell/histiocyte rich large B-cell lymphoma,ICDO3_2nd
9688/3,T-cell rich large B-cell lymphoma,ICDO3_2nd
9688/3,Histiocyte-rich large B-cell lymphoma,ICDO3_2nd
9689/3,Splenic marginal zone B-cell lymphoma,ICDO3_2nd
9689/3,"Splenic marginal zone lymphoma, NOS",ICDO3_2nd
9689/3,Splenic lymphoma with villous lymphocytes,ICDO3_2nd
9690/3,"Follicular lymphoma, NOS",ICDO3_2nd
9690/3,"Malignant lymphoma, follicle center, NOS",ICDO3_2nd
9690/3,"Malignant lymphoma, follicular, NOS",ICDO3_2nd
9690/3,"Malignant lymphoma, lymphocytic, nodular, NOS",ICDO3_2nd
9690/3,"Malignant lymphoma, nodular, NOS",ICDO3_2nd
9690/3,"Malignant lymphoma, centroblastic-centrocytic, follicular",ICDO3_2nd
9690/3,"Malignant lymphoma, follicle center, follicular",ICDO3_2nd
9690/3,"Follicular lymphoma, pediatric type",ICDO3_2nd
9691/3,"Follicular lymphoma, grade 2",ICDO3_2nd
9691/3,"Malignant lymphoma, mixed cell type, follicular",ICDO3_2nd
9691/3,"Malignant lymphoma, mixed cell type, nodular",ICDO3_2nd
9691/3,"Malignant lymphoma, mixed lymphocytic-histiocytic, nodular",ICDO3_2nd
9691/3,"Malignant lymphoma, mixed small cleaved and large cell, follicular",ICDO3_2nd
9695/1,In situ follicular neoplasia,ICDO3_2nd
9695/1,In situ follicular lymphoma,ICDO3_2nd
9695/3,"Follicular lymphoma, grade 1",ICDO3_2nd
9695/3,"Follicular lymphoma, small cleaved cell",ICDO3_2nd
9695/3,"Malignant lymphoma, lymphocytic, poorly differentiated, nodular",ICDO3_2nd
9695/3,"Malignant lymphoma, small cleaved cell, follicular",ICDO3_2nd
9695/3,"Follicular lymphoma, duodenal type",ICDO3_2nd
9698/3,"Follicular lymphoma, grade 3",ICDO3_2nd
9698/3,"Malignant lymphoma, large cell, follicular, NOS",ICDO3_2nd
9698/3,"Malignant lymphoma, noncleaved cell, follicular, NOS",ICDO3_2nd
9698/3,"Follicular lymphoma, grade 3A",ICDO3_2nd
9698/3,"Follicular lymphoma, grade 3B",ICDO3_2nd
9698/3,"Malignant lymphoma, centroblastic, follicular",ICDO3_2nd
9698/3,"Malignant lymphoma, histiocytic, nodular",ICDO3_2nd
9698/3,"Malignant lymphoma, large cell, noncleaved, follicular",ICDO3_2nd
9698/3,"Malignant lymphoma, large cleaved cell, follicular",ICDO3_2nd
9698/3,"Malignant lymphoma, lymphocytic, well differentiated, nodular",ICDO3_2nd
9698/3,Large B-cell lymphoma with IRF4 rearrangement,ICDO3_2nd
9699/3,"Marginal zone B-cell lymphoma, NOS",ICDO3_2nd
9699/3,"Marginal zone lymphoma, NOS",ICDO3_2nd
9699/3,BALT lymphoma,ICDO3_2nd
9699/3,Bronchus-associated lymphoid tissue lymphoma,ICDO3_2nd
9699/3,MALT lymphoma,ICDO3_2nd
9699/3,Monocytoid B-cell lymphoma,ICDO3_2nd
9699/3,Mucosa-associated lymphoid tissue lymphoma,ICDO3_2nd
9699/3,Nodal marginal zone lymphoma,ICDO3_2nd
9699/3,SALT lymphoma,ICDO3_2nd
9699/3,Skin-associated lymphoid tissue lymphoma,ICDO3_2nd
9699/3,Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue,ICDO3_2nd
9699/3,Primary choroidal lymphoma,ICDO3_2nd
9700/3,Mycosis fungoides,ICDO3_2nd
9700/3,Pagetoid reticulosis,ICDO3_2nd
9700/3,Granulomatous slack skin,ICDO3_2nd
9701/3,Sezary syndrome,ICDO3_2nd
9701/3,Sezary disease,ICDO3_2nd
9702/1,Indolent T-cell lymphoproliferative disorder of gastrointestinal tract,ICDO3_2nd
9702/3,"Mature T-cell lymphoma, NOS",ICDO3_2nd
9702/3,"Peripheral T-cell lymphoma, NOS",ICDO3_2nd
9702/3,"T-cell lymphoma, NOS",ICDO3_2nd
9702/3,"Peripheral T-cell lymphoma, large cell",ICDO3_2nd
9702/3,"Peripheral T-cell lymphoma, pleomorphic medium and large cell",ICDO3_2nd
9702/3,"Peripheral T-cell lymphoma, pleomorphic small cell",ICDO3_2nd
9702/3,T-zone lymphoma,ICDO3_2nd
9702/3,Lymphoepithelioid lymphoma,ICDO3_2nd
9702/3,Lennert lymphoma,ICDO3_2nd
9702/3,Follicular T-cell lymphoma,ICDO3_2nd
9702/3,Nodal peripheral T-cell lymphoma with T follicular helper phenotype,ICDO3_2nd
9705/3,Angioimmunoblastic T-cell lymphoma,ICDO3_2nd
9705/3,Angioimmunoblastic lymphoma,ICDO3_2nd
9705/3,"Peripheral T-cell lymphoma, AILD (Angioimmunoblastic Lymphadenopathy with Dysproteinemia)",ICDO3_2nd
9708/3,Subcutaneous panniculitis-like T-cell lymphoma,ICDO3_2nd
9709/1,Primary cutaneous CD4 positive small/medium T-cell lymphoproliferative disorder,ICDO3_2nd
9709/1,Primary cutaneous CD4 positive small/medium T-cell lymphoma,ICDO3_2nd
9709/3,"Cutaneous T-cell lymphoma, NOS",ICDO3_2nd
9709/3,"Cutaneous lymphoma, NOS",ICDO3_2nd
9709/3,Primary cutaneous CD8 positive aggressive epidermotropic cytotoxic T-cell lymphoma,ICDO3_2nd
9709/3,Primary cutaneous acral CD8 positive T-cell lymphoma,ICDO3_2nd
9712/3,Intravascular large B-cell lymphoma,ICDO3_2nd
9712/3,Intravascular B-cell lymphoma,ICDO3_2nd
9712/3,Angioendotheliomatosis,ICDO3_2nd
9712/3,Angiotropic lymphoma,ICDO3_2nd
9714/3,"Anaplastic large cell lymphoma, T-cell and Null-cell type",ICDO3_2nd
9714/3,Large cell (Ki-1 positive) lymphoma,ICDO3_2nd
9714/3,"Anaplastic large cell lymphoma, NOS",ICDO3_2nd
9714/3,"Anaplastic large cell lymphoma, CD30 positive",ICDO3_2nd
9714/3,"Anaplastic large cell lymphoma, ALK positive",ICDO3_2nd
9715/3,"Anaplastic large cell lymphoma, ALK negative",ICDO3_2nd
9715/3,Breast implant-associated anaplastic large cell lymphoma,ICDO3_2nd
9716/3,Hepatosplenic T-cell lymphoma,ICDO3_2nd
9716/3,Hepatosplenic gamma-delta cell lymphoma,ICDO3_2nd
9717/3,Intestinal T-cell lymphoma,ICDO3_2nd
9717/3,Enteropathy-associated T-cell lymphoma,ICDO3_2nd
9717/3,Enteropathy type intestinal T-cell lymphoma,ICDO3_2nd
9717/3,Monomorphic epitheliotropic intestinal T-cell lymphoma,ICDO3_2nd
9718/1,Primary cutaneous CD30 positive T-cell lymphoproliferative disorder,ICDO3_2nd
9718/1,Lymphomatoid papulosis,ICDO3_2nd
9718/3,Primary cutaneous anaplastic large cell lymphoma,ICDO3_2nd
9718/3,Primary cutaneous CD30 positive large T-cell lymphoma,ICDO3_2nd
9719/3,"NK/T-cell lymphoma, nasal and nasal type",ICDO3_2nd
9719/3,"Malignant reticulosis, NOS",ICDO3_2nd
9719/3,Angiocentric T-cell lymphoma,ICDO3_2nd
9719/3,"Extranodal NK/T-cell lymphoma, nasal type",ICDO3_2nd
9719/3,Malignant midline reticulosis,ICDO3_2nd
9719/3,Polymorphic reticulosis,ICDO3_2nd
9719/3,T/NK-cell lymphoma,ICDO3_2nd
9724/3,Systemic EBV positive T-cell lymphoproliferative disease of childhood,ICDO3_2nd
9725/1,Hydroa vacciniforme-like lymphoproliferative disorder,ICDO3_2nd
9725/1,Hydroa vacciniforme-like lymphoma,ICDO3_2nd
9726/3,Primary cutaneous gamma-delta T-cell lymphoma,ICDO3_2nd
9727/3,"Precursor cell lymphoblastic lymphoma, NOS",ICDO3_2nd
9727/3,"Malignant lymphoma, lymphoblastic, NOS",ICDO3_2nd
9727/3,Lymphoblastoma,ICDO3_2nd
9727/3,"Malignant lymphoma, convoluted cell",ICDO3_2nd
9727/3,Blastic NK-cell lymphoma,ICDO3_2nd
9727/3,Blastic plasmacytoid dendritic cell neoplasm,ICDO3_2nd
9731/3,"Plasmacytoma, NOS",ICDO3_2nd
9731/3,Plasma cell tumor,ICDO3_2nd
9731/3,Plasmacytoma of bone,ICDO3_2nd
9731/3,Solitary myeloma,ICDO3_2nd
9731/3,Solitary plasmacytoma,ICDO3_2nd
9732/3,Plasma cell myeloma,ICDO3_2nd
9732/3,Multiple myeloma,ICDO3_2nd
9732/3,"Myeloma, NOS",ICDO3_2nd
9732/3,Myelomatosis,ICDO3_2nd
9733/3,Plasma cell leukemia,ICDO3_2nd
9733/3,Plasmacytic leukemia,ICDO3_2nd
9734/3,"Plasmacytoma, extramedullary",ICDO3_2nd
9734/3,Extraosseous plasmacytoma,ICDO3_2nd
9735/3,Plasmablastic lymphoma,ICDO3_2nd
9737/3,ALK positive large B-cell lymphoma,ICDO3_2nd
9738/3,HHV8 positive diffuse large B-cell lymphoma,ICDO3_2nd
9738/3,Large B-cell lymphoma arising in HHV8-associated multicentric Castleman disease,ICDO3_2nd
9740/1,"Mastocytoma, NOS",ICDO3_2nd
9740/1,"Mast cell tumor, NOS",ICDO3_2nd
9740/1,"Cutaneous mastocytosis, NOS",ICDO3_2nd
9740/1,Diffuse cutaneous mastocytosis,ICDO3_2nd
9740/1,Extracutaneous mastocytoma,ICDO3_2nd
9740/1,Solitary mastocytoma of skin,ICDO3_2nd
9740/1,Urticaria pigmentosa,ICDO3_2nd
9740/3,Mast cell sarcoma,ICDO3_2nd
9740/3,Malignant mast cell tumor,ICDO3_2nd
9740/3,Malignant mastocytoma,ICDO3_2nd
9741/1,Indolent systemic mastocytosis,ICDO3_2nd
9741/3,Malignant mastocytosis,ICDO3_2nd
9741/3,Systemic tissue mast cell disease,ICDO3_2nd
9741/3,Aggressive systemic mastocytosis,ICDO3_2nd
9741/3,Systemic mastocytosis with AHNMD,ICDO3_2nd
9741/3,Systemic mastocytosis with associated hematological clonal non-mast cell disorder,ICDO3_2nd
9742/3,Mast cell leukemia,ICDO3_2nd
9749/3,Erdheim-Chester disease,ICDO3_2nd
9750/3,Malignant histiocytosis,ICDO3_2nd
9750/3,Histiocytic medullary reticulosis,ICDO3_2nd
9751/1,"Langerhans cell histiocytosis, NOS",ICDO3_2nd
9751/1,"Langerhans cell histiocytosis, monostotic",ICDO3_2nd
9751/1,"Langerhans cell histiocytosis, polystotic",ICDO3_2nd
9751/3,"Langerhans cell histiocytosis, disseminated",ICDO3_2nd
9751/3,Langerhans cell granulomatosis,ICDO3_2nd
9751/3,Eosinophilic granuloma,ICDO3_2nd
9751/3,Acute progressive histiocytosis X,ICDO3_2nd
9751/3,"Histiocytosis X, NOS",ICDO3_2nd
9751/3,Hand-Schuller-Christian disease,ICDO3_2nd
9751/3,Letterer-Siwe disease,ICDO3_2nd
9751/3,Nonlipid reticuloendotheliosis,ICDO3_2nd
9755/3,Histiocytic sarcoma,ICDO3_2nd
9755/3,True histiocytic lymphoma,ICDO3_2nd
9756/3,Langerhans cell sarcoma,ICDO3_2nd
9757/3,Interdigitating dendritic cell sarcoma,ICDO3_2nd
9757/3,Interdigitating cell sarcoma,ICDO3_2nd
9757/3,"Dendritic cell sarcoma, NOS",ICDO3_2nd
9757/3,Indeterminate dendritic cell tumor,ICDO3_2nd
9758/3,Follicular dendritic cell sarcoma,ICDO3_2nd
9758/3,Follicular dendritic cell tumor,ICDO3_2nd
9759/3,Fibroblastic reticular cell tumor,ICDO3_2nd
9760/3,"Immunoproliferative disease, NOS",ICDO3_2nd
9761/1,IgM monoclonal gammopathy of undetermined significance,ICDO3_2nd
9761/3,Waldenstrom macroglobulinemia,ICDO3_2nd
9762/3,"Heavy chain disease, NOS",ICDO3_2nd
9762/3,Alpha heavy chain disease,ICDO3_2nd
9762/3,Gamma heavy chain disease,ICDO3_2nd
9762/3,Franklin disease,ICDO3_2nd
9762/3,Mu heavy chain disease,ICDO3_2nd
9764/3,Immunoproliferative small intestinal disease,ICDO3_2nd
9764/3,Mediterranean lymphoma,ICDO3_2nd
9765/1,"Monoclonal gammopathy of undetermined significance, NOS",ICDO3_2nd
9765/1,MGUS,ICDO3_2nd
9765/1,"Monoclonal gammopathy, NOS",ICDO3_2nd
9766/1,Angiocentric immunoproliferative lesion,ICDO3_2nd
9766/1,"Lymphomatoid granulomatosis, NOS",ICDO3_2nd
9766/1,"Lymphomatoid granulomatosis, grade 1",ICDO3_2nd
9766/1,"Lymphomatoid granulomatosis, grade 2",ICDO3_2nd
9766/3,"Lymphomatoid granulomatosis, grade 3",ICDO3_2nd
9767/1,Angioimmunoblastic lymphadenopathy (AIL),ICDO3_2nd
9767/1,Immunoblastic lymphadenopathy (IBL),ICDO3_2nd
9768/1,T-gamma lymphoproliferative disease,ICDO3_2nd
9769/1,Immunoglobulin deposition disease,ICDO3_2nd
9769/1,Primary amyloidosis,ICDO3_2nd
9769/1,Systemic light chain disease,ICDO3_2nd
9800/3,"Leukemia, NOS",ICDO3_2nd
9800/3,"Aleukemic leukemia, NOS",ICDO3_2nd
9800/3,"Chronic leukemia, NOS",ICDO3_2nd
9800/3,"Subacute leukemia, NOS",ICDO3_2nd
9801/3,"Acute leukemia, NOS",ICDO3_2nd
9801/3,Blast cell leukemia,ICDO3_2nd
9801/3,Stem cell leukemia,ICDO3_2nd
9801/3,Undifferentiated leukemia,ICDO3_2nd
9805/3,Acute biphenotypic leukemia,ICDO3_2nd
9805/3,Acute bilineal leukemia,ICDO3_2nd
9805/3,Acute mixed lineage leukemia,ICDO3_2nd
9806/3,Mixed phenotype acute leukemia with t(9;22)(q34;q11.2); BCR-ABL1,ICDO3_2nd
9807/3,Mixed phenotype acute leukemia with t(v;11q23); MLL rearranged,ICDO3_2nd
9808/3,"Mixed phenotype acute leukemia, B/myeloid, NOS",ICDO3_2nd
9809/3,"Mixed phenotype acute leukemia, T/myeloid, NOS",ICDO3_2nd
9811/3,"B lymphoblastic leukemia/lymphoma, NOS",ICDO3_2nd
9811/3,c-ALL,ICDO3_2nd
9811/3,Common ALL,ICDO3_2nd
9811/3,Common precursor B ALL,ICDO3_2nd
9811/3,Pre-B ALL,ICDO3_2nd
9811/3,Pre-pre-B ALL,ICDO3_2nd
9811/3,Pro-B ALL,ICDO3_2nd
9811/3,Precursor B-cell lymphoblastic lymphoma,ICDO3_2nd
9811/3,Precursor B-cell lymphoblastic leukemia,ICDO3_2nd
9811/3,B lymphoblastic leukemia/lymphoma with iAMP21,ICDO3_2nd
9812/3,B lymphoblastic leukemia/lymphoma with t(9;22)(q34;q11.2); BCR-ABL1,ICDO3_2nd
9813/3,B lymphoblastic leukemia/lymphoma with t(v;11q23); MLL rearranged,ICDO3_2nd
9814/3,B lymphoblastic leukemia/lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1),ICDO3_2nd
9815/3,B lymphoblastic leukemia/lymphoma with hyperdiploidy,ICDO3_2nd
9816/3,B lymphoblastic leukemia/lymphoma with hypodiploidy (Hypodiploid ALL),ICDO3_2nd
9817/3,B lymphoblastic leukemia/lymphoma with t(5;14)(q31;q32); IL3-IGH,ICDO3_2nd
9818/3,B lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1),ICDO3_2nd
9819/3,"B lymphoblastic leukemia/lymphoma, BCR-ABL1-like",ICDO3_2nd
9820/3,"Lymphoid leukemia, NOS",ICDO3_2nd
9820/3,"Lymphatic leukemia, NOS",ICDO3_2nd
9820/3,"Lymphocytic leukemia, NOS",ICDO3_2nd
9820/3,Aleukemic lymphoid leukemia,ICDO3_2nd
9820/3,Aleukemic lymphatic leukemia,ICDO3_2nd
9820/3,Aleukemic lymphocytic leukemia,ICDO3_2nd
9820/3,Lymphosarcoma cell leukemia,ICDO3_2nd
9820/3,Subacute lymphoid leukemia,ICDO3_2nd
9820/3,Subacute lymphatic leukemia,ICDO3_2nd
9820/3,Subacute lymphocytic leukemia,ICDO3_2nd
9823/1,"Monoclonal B-cell lymphocytosis, CLL type",ICDO3_2nd
9823/3,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma,ICDO3_2nd
9823/3,Chronic lymphatic leukemia,ICDO3_2nd
9823/3,Chronic lymphocytic leukemia,ICDO3_2nd
9823/3,"Chronic lymphocytic leukemia, B-cell type",ICDO3_2nd
9823/3,Chronic lymphoid leukemia,ICDO3_2nd
9823/3,"Malignant lymphoma, small B lymphocytic, NOS",ICDO3_2nd
9823/3,"Malignant lymphoma, lymphocytic, NOS",ICDO3_2nd
9823/3,"Malignant lymphoma, lymphocytic, diffuse, NOS",ICDO3_2nd
9823/3,"Malignant lymphoma, small cell, NOS",ICDO3_2nd
9823/3,"Malignant lymphoma, small lymphocytic, NOS",ICDO3_2nd
9823/3,"Malignant lymphoma, lymphocytic, well differentiated, diffuse",ICDO3_2nd
9823/3,"Malignant lymphoma, small cell diffuse",ICDO3_2nd
9823/3,"Malignant lymphoma, small lymphocytic, diffuse",ICDO3_2nd
9827/3,Adult T-cell leukemia/lymphoma (HTLV-1 positive),ICDO3_2nd
9827/3,Adult T-cell leukemia,ICDO3_2nd
9827/3,Adult T-cell lymphoma,ICDO3_2nd
9827/3,Adult T-cell lymphoma/leukemia,ICDO3_2nd
9831/3,T-cell large granular lymphocytic leukemia,ICDO3_2nd
9831/3,"Large granular lymphocytosis, NOS",ICDO3_2nd
9831/3,NK-cell large granular lymphocytic leukemia,ICDO3_2nd
9831/3,T-cell large granular lymphocytosis,ICDO3_2nd
9831/3,Chronic lymphoproliferative disorder of NK cells,ICDO3_2nd
9832/3,"Prolymphocytic leukemia, NOS",ICDO3_2nd
9833/3,"Prolymphocytic leukemia, B-cell type",ICDO3_2nd
9834/3,"Prolymphocytic leukemia, T-cell type",ICDO3_2nd
9835/3,"Precursor cell lymphoblastic leukemia, NOS",ICDO3_2nd
9835/3,"Acute lymphoblastic leukemia, NOS",ICDO3_2nd
9835/3,"Acute lymphoblastic leukemia, L2 type, NOS",ICDO3_2nd
9835/3,"Acute lymphoblastic leukemia-lymphoma, NOS",ICDO3_2nd
9835/3,"Lymphoblastic leukemia, NOS",ICDO3_2nd
9835/3,Acute lymphatic leukemia,ICDO3_2nd
9835/3,Acute lymphocytic leukemia,ICDO3_2nd
9835/3,Acute lymphoid leukemia,ICDO3_2nd
9835/3,FAB L1,ICDO3_2nd
9835/3,FAB L2,ICDO3_2nd
9835/3,"Precursor cell lymphoblastic leukemia, not phenotyped",ICDO3_2nd
9835/3,"Acute lymphoblastic leukemia, precursor-cell type",ICDO3_2nd
9837/3,Precursor T-cell lymphoblastic leukemia,ICDO3_2nd
9837/3,Cortical T ALL,ICDO3_2nd
9837/3,Mature T ALL,ICDO3_2nd
9837/3,Pre-T ALL,ICDO3_2nd
9837/3,Pro-T ALL,ICDO3_2nd
9837/3,Precursor T-cell lymphoblastic lymphoma,ICDO3_2nd
9837/3,T lymphoblastic leukemia/lymphoma,ICDO3_2nd
9837/3,Early T-cell precursor acute lymphoblastic leukemia,ICDO3_2nd
9840/3,Acute erythroid leukemia,ICDO3_2nd
9840/3,"Acute myeloid leukemia, M6 type",ICDO3_2nd
9840/3,Acute erythremia,ICDO3_2nd
9840/3,Acute erythremic myelosis,ICDO3_2nd
9840/3,AML M6,ICDO3_2nd
9840/3,Di Guglielmo disease,ICDO3_2nd
9840/3,"Erythremic myelosis, NOS",ICDO3_2nd
9840/3,Erythroleukemia,ICDO3_2nd
9840/3,FAB M6,ICDO3_2nd
9840/3,M6A,ICDO3_2nd
9840/3,M6B,ICDO3_2nd
9860/3,"Myeloid leukemia, NOS",ICDO3_2nd
9860/3,"Granulocytic leukemia, NOS",ICDO3_2nd
9860/3,"Myelocytic leukemia, NOS",ICDO3_2nd
9860/3,"Myelogenous leukemia, NOS",ICDO3_2nd
9860/3,"Myelomonocytic leukemia, NOS",ICDO3_2nd
9860/3,"Non-lymphocytic leukemia, NOS",ICDO3_2nd
9860/3,Aleukemic myeloid leukemia,ICDO3_2nd
9860/3,Aleukemic granulocytic leukemia,ICDO3_2nd
9860/3,Aleukemic myelogenous leukemia,ICDO3_2nd
9860/3,Aleukemic monocytic leukemia,ICDO3_2nd
9860/3,Chronic monocytic leukemia,ICDO3_2nd
9860/3,"Eosinophilic leukemia, NOS",ICDO3_2nd
9860/3,"Monocytic leukemia, NOS",ICDO3_2nd
9860/3,Subacute monocytic leukemia,ICDO3_2nd
9860/3,Subacute myeloid leukemia,ICDO3_2nd
9860/3,Subacute granulocytic leukemia,ICDO3_2nd
9860/3,Subacute myelogenous leukemia,ICDO3_2nd
9861/3,"Acute myeloid leukemia, NOS",ICDO3_2nd
9861/3,Acute granulocytic leukemia,ICDO3_2nd
9861/3,Acute myelocytic leukemia,ICDO3_2nd
9861/3,Acute myelogenous leukemia,ICDO3_2nd
9861/3,Acute non-lymphocytic leukemia,ICDO3_2nd
9863/3,"Chronic myeloid leukemia, NOS",ICDO3_2nd
9863/3,"Chronic granulocytic leukemia, NOS",ICDO3_2nd
9863/3,"Chronic myelocytic leukemia, NOS",ICDO3_2nd
9863/3,"Chronic myelogenous leukemia, NOS",ICDO3_2nd
9865/3,Acute myeloid leukemia with t(6;9)(p23;q34); DEK-NUP214,ICDO3_2nd
9866/3,"Acute promyelocytic leukemia, t(15;17)(q22;q11-12)",ICDO3_2nd
9866/3,"Acute promyelocytic leukemia, NOS",ICDO3_2nd
9866/3,"Acute myeloid leukemia, PML/RAR-alpha",ICDO3_2nd
9866/3,"Acute myeloid leukemia, t(15;17)(q22;q11-12)",ICDO3_2nd
9866/3,"Acute promyelocytic leukemia, PML/RAR-alpha",ICDO3_2nd
9866/3,FAB M3,ICDO3_2nd
9867/3,"Acute myelomonocytic leukemia, NOS",ICDO3_2nd
9867/3,FAB M4,ICDO3_2nd
9869/3,Acute myeloid leukemia with inv(3)(q21;q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,ICDO3_2nd
9870/3,Acute basophilic leukemia,ICDO3_2nd
9871/3,Acute myeloid leukemia with abnormal marrow eosinophils,ICDO3_2nd
9871/3,"Acute myeloid leukemia, CBF-beta/MYH11",ICDO3_2nd
9871/3,"Acute myeloid leukemia, inv(16)(p13;q22)",ICDO3_2nd
9871/3,"Acute myeloid leukemia, t(16;16)(p13;q11)",ICDO3_2nd
9871/3,Acute myelomonocytic leukemia with abnormal eosinophils,ICDO3_2nd
9871/3,FAB M4Eo,ICDO3_2nd
9872/3,"Acute myeloid leukemia, minimal differentiation",ICDO3_2nd
9872/3,Acute myeloblastic leukemia,ICDO3_2nd
9872/3,FAB M0,ICDO3_2nd
9873/3,Acute myeloid leukemia without maturation,ICDO3_2nd
9873/3,FAB M1,ICDO3_2nd
9874/3,Acute myeloid leukemia with maturation,ICDO3_2nd
9874/3,"FAB M2, NOS",ICDO3_2nd
9875/3,"Chronic myeloid leukemia, BCR/ABL positive",ICDO3_2nd
9875/3,"Chronic myelogenous leukemia, BCR/ABL positive",ICDO3_2nd
9875/3,"Chronic granulocytic leukemia, BCR/ABL",ICDO3_2nd
9875/3,"Chronic granulocytic leukemia, Philadelphia chromosome (Ph1) positive",ICDO3_2nd
9875/3,"Chronic granulocytic leukemia, t(9;22)(q34;q11)",ICDO3_2nd
9875/3,"Chronic myeloid leukemia, Philadelphia chromosome (Ph1) positive",ICDO3_2nd
9875/3,"Chronic myelogenous leukemia, Philadelphia chromosome (Ph1) positive",ICDO3_2nd
9875/3,"Chronic myeloid leukemia, t(9;22)(q34;q11)",ICDO3_2nd
9875/3,"Chronic myelogenous leukemia, t(9;22)(q34;q11)",ICDO3_2nd
9876/3,"Atypical chronic myeloid leukemia, BCR/ABL negative",ICDO3_2nd
9876/3,"Atypical chronic myeloid leukemia, Philadelphia chromosome (Ph1) negative",ICDO3_2nd
9877/3,Acute myeloid leukemia with mutated NPM1,ICDO3_2nd
9878/3,Acute myeloid leukemia with biallelic mutation of CEBPA,ICDO3_2nd
9879/3,Acute myeloid leukemia with mutated RUNX1,ICDO3_2nd
9891/3,Acute monocytic leukemia,ICDO3_2nd
9891/3,"Monoblastic leukemia, NOS",ICDO3_2nd
9891/3,Acute monoblastic leukemia,ICDO3_2nd
9891/3,FAB M5,ICDO3_2nd
9891/3,Acute monoblastic and monocytic leukemia,ICDO3_2nd
9895/3,Acute myeloid leukemia with myelodysplasia-related changes,ICDO3_2nd
9895/3,Acute myeloid leukemia with multilineage dysplasia,ICDO3_2nd
9895/3,Acute myeloid leukemia with prior myelodysplastic syndrome,ICDO3_2nd
9895/3,Acute myeloid leukemia without prior myelodysplastic syndrome,ICDO3_2nd
9896/3,"Acute myeloid leukemia, t(8;21)(q22;q22)",ICDO3_2nd
9896/3,"Acute myeloid leukemia, AML1(CBF-alpha)/ETO",ICDO3_2nd
9896/3,Acute myeloid leukemia with t(8;21)(q22;q22); RUNX1-RUNX1T1,ICDO3_2nd
9896/3,"FAB M2, AML1(CBF-alpha)/ETO",ICDO3_2nd
9896/3,"FAB M2, t(8;21)(q22;q22)",ICDO3_2nd
9897/3,"Acute myeloid leukemia, 11q23 abnormalities",ICDO3_2nd
9897/3,"Acute myeloid leukemia, MLL",ICDO3_2nd
9897/3,Acute myeloid leukemia with t(9;11)(p22;q23); MLLT3-MLL,ICDO3_2nd
9898/1,Transient abnormal myelopoiesis,ICDO3_2nd
9898/3,Myeloid leukemia associated with Down syndrome,ICDO3_2nd
9910/3,Acute megakaryoblastic leukemia,ICDO3_2nd
9910/3,Megakaryocytic leukemia,ICDO3_2nd
9910/3,FAB M7,ICDO3_2nd
9911/3,Acute myeloid leukemia (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1,ICDO3_2nd
9912/3,Acute myeloid leukemia with BCR-ABL1,ICDO3_2nd
9920/3,Therapy-related myeloid neoplasm,ICDO3_2nd
9920/3,"Therapy-related acute myeloid leukemia, NOS",ICDO3_2nd
9920/3,"Therapy-related acute myeloid leukemia, alkylating agent related",ICDO3_2nd
9920/3,"Therapy-related acute myeloid leukemia, epipodophyllotoxin-related",ICDO3_2nd
9930/3,Myeloid sarcoma,ICDO3_2nd
9930/3,Chloroma,ICDO3_2nd
9930/3,Granulocytic sarcoma,ICDO3_2nd
9931/3,Acute panmyelosis with myelofibrosis,ICDO3_2nd
9931/3,"Acute myelosclerosis, NOS",ICDO3_2nd
9931/3,"Acute panmyelosis, NOS",ICDO3_2nd
9931/3,Acute myelofibrosis,ICDO3_2nd
9931/3,Malignant myelosclerosis,ICDO3_2nd
9940/3,"Hairy cell leukemia, NOS",ICDO3_2nd
9940/3,Leukemic reticuloendotheliosis,ICDO3_2nd
9945/3,"Chronic myelomonocytic leukemia, NOS",ICDO3_2nd
9945/3,"Chronic myelomonocytic leukemia, type I",ICDO3_2nd
9945/3,"Chronic myelomonocytic leukemia, type II",ICDO3_2nd
9945/3,Chronic myelomonocytic leukemia in transformation,ICDO3_2nd
9946/3,"Juvenile myelomonocytic leukemia, NOS",ICDO3_2nd
9946/3,Juvenile chronic myelomonocytic leukemia,ICDO3_2nd
9948/3,Aggressive NK-cell leukemia,ICDO3_2nd
9950/3,Polycythemia vera,ICDO3_2nd
9950/3,Chronic erythremia,ICDO3_2nd
9950/3,Polycythemia rubra vera,ICDO3_2nd
9950/3,Proliferative polycythemia,ICDO3_2nd
9960/3,"Myeloproliferative neoplasm, NOS",ICDO3_2nd
9960/3,"Chronic myeloproliferative disease, NOS",ICDO3_2nd
9960/3,Chronic myeloproliferative disorder,ICDO3_2nd
9960/3,"Myeloproliferative disease, NOS",ICDO3_2nd
9961/3,Primary myelofibrosis,ICDO3_2nd
9961/3,Agnogenic myeloid metaplasia,ICDO3_2nd
9961/3,Chronic idiopathic myelofibrosis,ICDO3_2nd
9961/3,Megakaryocytic myelosclerosis,ICDO3_2nd
9961/3,Myelofibrosis as a result of myeloproliferative disease,ICDO3_2nd
9961/3,Myelofibrosis with myeloid metaplasia,ICDO3_2nd
9961/3,Myelosclerosis with myeloid metaplasia,ICDO3_2nd
9962/3,Essential thrombocythemia,ICDO3_2nd
9962/3,Essential hemorrhagic thrombocythemia,ICDO3_2nd
9962/3,Idiopathic hemorrhagic thrombocythemia,ICDO3_2nd
9962/3,Idiopathic thrombocythemia,ICDO3_2nd
9963/3,Chronic neutrophilic leukemia,ICDO3_2nd
9964/3,Chronic eosinophilic leukemia,ICDO3_2nd
9964/3,Hypereosinophilic syndrome,ICDO3_2nd
9965/3,Myeloid or lymphoid neoplasm with PDGFRA rearrangement,ICDO3_2nd
9966/3,Myeloid neoplasm with PDGFRB rearrangement,ICDO3_2nd
9967/3,Myeloid or lymphoid neoplasm with FGFR1 abnormalities,ICDO3_2nd
9968/3,Myeloid or lymphoid neoplasm with PCM1-JAK2,ICDO3_2nd
9970/1,"Lymphoproliferative disorder, NOS",ICDO3_2nd
9970/1,"Lymphoproliferative disease, NOS",ICDO3_2nd
9971/1,"Post-transplant lymphoproliferative disorder, NOS",ICDO3_2nd
9971/1,"PTLD, NOS",ICDO3_2nd
9971/1,Polymorphic post-transplant lymphoproliferative disorder,ICDO3_2nd
9975/3,"Myeloproliferative neoplasm, unclassifiable",ICDO3_2nd
9975/3,"Myelodysplastic/myeloproliferative neoplasm, unclassifiable",ICDO3_2nd
9980/3,Myelodysplastic syndrome with single lineage dysplasia,ICDO3_2nd
9980/3,"Refractory anemia, NOS",ICDO3_2nd
9980/3,Refractory anemia without sideroblasts,ICDO3_2nd
9980/3,Refractory neutropenia,ICDO3_2nd
9980/3,Refractory thrombocytopenia,ICDO3_2nd
9982/3,Myelodysplastic syndrome with ring sideroblasts and single lineage dysplasia,ICDO3_2nd
9982/3,Refractory anemia with sideroblasts,ICDO3_2nd
9982/3,RARS,ICDO3_2nd
9982/3,Refractory anemia with ring sideroblasts associated with marked thrombocytosis,ICDO3_2nd
9982/3,"Refractory anemia with ring sideroblasts, NOS",ICDO3_2nd
9982/3,"Myelodysplastic syndrome with ring sideroblasts, NOS",ICDO3_2nd
9983/3,Myelodysplastic syndrome with excess blasts,ICDO3_2nd
9983/3,"Refractory anemia with excess blasts, NOS",ICDO3_2nd
9983/3,"RAEB, NOS",ICDO3_2nd
9983/3,RAEB I,ICDO3_2nd
9983/3,RAEB II,ICDO3_2nd
9984/3,Refractory anemia with excess blasts in transformation,ICDO3_2nd
9984/3,RAEB-T,ICDO3_2nd
9985/3,Myelodysplastic syndrome with multilineage dysplasia,ICDO3_2nd
9985/3,Refractory cytopenia with multilineage dysplasia,ICDO3_2nd
9985/3,Refractory cytopenia of childhood,ICDO3_2nd
9986/3,Myelodysplastic syndrome with isolated del (5q),ICDO3_2nd
9986/3,Myelodysplastic syndrome with 5q deletion (5q-) syndrome,ICDO3_2nd
9987/3,"Therapy-related myelodysplastic syndrome, NOS",ICDO3_2nd
9987/3,"Therapy-related myelodysplastic syndrome, alkylating agent related",ICDO3_2nd
9987/3,"Therapy-related myelodysplastic syndrome, epipodophyllotoxin-related",ICDO3_2nd
9989/3,"Myelodysplastic syndrome, NOS",ICDO3_2nd
9989/3,Preleukemia,ICDO3_2nd
9989/3,Preleukemic syndrome,ICDO3_2nd
9989/3,"Myelodysplastic syndrome, unclassifiable",ICDO3_2nd